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Abstract
Phytopatology,  as  a  discipline  that  deals  with  the complexity of  living  communities,  needs
methods to screen what could be considered ‘useful’ data from ‘background noise’. Until the
Nineties, this was achieved by simplifications that were deemed adequate enough: from Koch’s
postulates that require microorganisms to be culturable, to DNA barcoding that assumed genetic
markers to be universal and precise enough to distinguish minute differences, to the disease tri-
angle model that mostly downplayed the role of the micro-community context the pathogens
find themselves in.
With the introduction of whole genome sequencing (WGS) technologies in the last thirty years,
we started to realise that those simplifications, while not wrong, constituted sufficient but not
necessary conditions: some pathogens (e.g. phytoplasmas) are remarkably difficult to cultivate
in vitro, DNA structural variations can produce diverse strains without changing markers, and
the micro-community can significantly impact on a pathogen’s ability to spread.
This work shows, from different perspectives all tied by the use of WGS data and analysis, how
a deeper understanding of these complex dynamics can prompt new practical concepts to man-
age economically impactful plant diseases:
• The characterisation  of  Pseudomonas sp.  strain  Pf4 shows how the  most  fit
strains, both from pathogens and biocontrol agents, derive their qualities from
sizable sets of ‘secondary’ – but in fact crucial, as we are now aware – metabol-
ites (SM) gene clusters;
• The comparison of the biocontrol activity of Pf4 and Pf11 shows that while a
wide set of SM clusters is important, the inclusion of such set doesn’t necessar-
ily translate into a ‘stronger’ control activity, but points to a better adaptability
to changing environmental conditions;
• The use of third-generation WGS, which produces longer (~10,000 nts) reads,
was essential to characterise the CRAFRU 12.29 and 14.08 strains (one produ-
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cing hypersensitive response (HR) on leaves, the other not), as their difference
lies in a transposon-mediated structural variation that would not have been pos-
sible to identify with older sequencing methods;
• Developing the Phytoassembly pipeline contributed to a novel method of obtain-
ing phytoplasma (and other non-culturable organisms) genome, which circum-
vent the laborious in vitro protocols employed so far to obtain similar results;
• The  Phytoassembly pipeline  showed  its  potentiality  by  not  only  isolating  a
Chicory Phyllody (ChP) phytoplasma, but allowing to detect the presence of a
companion spiroplasma, later shown to frequently occur together in mixed in-
fections of chicory;
• Phytoassembly also helped characterising a Cassava Frogskin Disease (CFSD)
phytoplasma, which showed some differences from other representatives in the
group;
• The spatialisation of the genomic samples from the kiwifruit endophyte popula-
tions allows to correlate their spatial and temporal variation to the severity of the
symptoms displayed by the plants and the time of Pseudomonas syringae pt. ac-
tinidiae (Psa) infection.
On the whole, the research projects presented in this work give insights into the greater com-
plexity of microbial genome structure and variation, the dynamics between pathogens and the
wider microbial community, the necessity for research methodologies based on more complex
data, and the essential role that WGS technologies plays and will play in plant protection re-
search and development.
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 1  Introduction
 1.1  Whole Genome Sequencing
Genome sequencing, the process of determining the complete DNA sequence of an organism’s
chromosomal, mitochondrial and (for plants) chloroplast DNA, has come to fulfil an essential
role in biological research, as a detailed map of an organism’s genetic assets allows a greater un-
derstanding of the mechanisms of its adaptation to an environment (or in case of pathogens, its
host),  its  potential  weaknesses  and  its  phylogenetic  position  relative  to  its  closest  species.
Strengths and weaknesses can be suggested by the sets of proteins available, such as enzymes,
regulators and transporters, while transposable elements can potentially deactivate genes by in-
serting in the middle of their sequences.
Initially, sequencing was a laborious, manual procedure; one of the earliest sequencings was
done for the bacteriophage MS2 coat protein (Jou et al., 1972), about 3500 nts long, and was
carried out using 2D gel electrophoresis, an adaptation of a technique developed by Sanger and
colleagues  (Adams et al., 1969). The Sanger method, formalised in 1975 (see below) quickly
became the golden standard for sequencing methods for the reliability and (at the time) relative
speed of its output. During the Nineties however its limits became too tight, and with the intro-
duction of new techniques sequencing became faster, more economical, and allowed for longer
uninterrupted sequences to be produced (Shendure and Ji, 2008). Sequencing technologies can
be roughly divided in three ‘generations’, each improving on the size and speed of the output.
 1.1.1  First Generation: the Sanger method
The ‘first  generation’,  exemplified by the Sanger and the Maxam–Gilbert  methods, have in
common an electrophoretic run as their last step, and as such are limited in the length of the se-
quence that can be determined, but are on the other hand quite accurate. The Sanger method was
developed by Frederick Sanger in 1975  (Sanger and Coulson, 1975), is still used  e.g. for se-
quencing individual fragments generated through polymerase chain reaction (PCR) and is still
regarded as the benchmark against which other methods are calibrated and compared.
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Figure 1.1 – An example of Sanger sequencing. Each band correspond to a fragment of n bases,
and each lane is marked for one base. Optical readings of radio-labelled bands can be translated 
in intensity peaks for automatic transcription. [Source: https://dodona.ugent.be/en/exercises/
144497797/]
Figure 1.2 – Illumina (Solexa) sequencing method. 100–500 nt long fragments are binded to the
surface of a flow cell, then amplified to obtain optically-detectable clusters; the complementary 
strand is then synthesised one nucleotide at a time, producing a flash which is captured by an 
optical sensor. [Source: https://www.sec.gov/Archives/edgar/data/913275/000095013407000492/
f26433a1e425.htm#010]
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This method can sequence up to around 900 nts and takes advantage of the property of modified
di-deoxynucleotidetriphosphates (ddNTPs) of interrupting the extension of DNA, due to the
lack of a 3′-OH group, preventing the formation of a phosphodiester bond with the successive
nucleotide (Sanger et al., 1977). In a PCR amplification, this ideally produces as many groups
of fragments as the number of the specific ddNTP base. In sequencing machines the ddNTPs
can be fluorescently labelled for automatic detection.
A typical Sanger reaction employs four parallel PCR reactions, each containing all of the stand-
ard dNTPs and one type of ddNTP. The resulting fragments are denatured and separated with
gel electrophoresis according to size. Aligning the four gel lanes, the relative positions of the
bands correspond to the DNA sequence (Figure 1.1). In automated Sanger sequencers, up to 380
reactions can be run in parallel  and optically read,  producing intensity curves whose peaks
translate to individual bases (Hutchison, 2007).
The main limitations of the Sanger method are that the amplification quality for the first 15–40
bases is rather poor due to primer binding, and the quality of sequencing traces deteriorates
again after 700–900 bases, as beyond that length it becomes difficult to separate fragments that
differ in length by one nucleotide.
 1.1.2  Second Generation: the Illumina method
As mentioned, the main problem of early sequencing methods like Sanger is that it can only se-
quence about 1000 bases at a time, while a small bacterial genome comprises millions of bases.
A second problem is that at least initially it was a manual task and not a trivial one to complete;
while the latest Sanger sequencers raised the output to about 380,000 bases per run, they still re-
quired significant economical resources that only major research centers could afford. The need
for faster, more accessible acquisition of larger portions of genome led to the development of
automated Whole Genome Sequencing (WGS) technologies during the Nineties.
This ‘second generation’ sequencing achieved full-genome length by mean of various strategies;
of those still in use, the most common method involves splitting the genome into numerous
reads, to be later assembled by software. Many methods have been developed between the ’90s
and the early 2000s, to name a few: Massively Parallel Signature Sequencing, 454 Pyrosequen-
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cing (phased out in 2016), Illumina (formerly Solexa) Sequencing and Ion Torrent Semicon-
ductor Sequencing. One of the most common methods – and the one used for most of the papers
included in this thesis – is that by Illumina, which uses DNA polymerase fluorescent substrates
with reversible 3′-terminators (Canard and Sarfati, 1994). A typical procedure includes (Figure
1.2):
1. The DNA is randomly fragmented and adapters are ligated to the 5′ and 3′ ex-
tremities (“tagmentation”). The ligated fragments are PCR-amplified and gel-
purified.
2. The amplified fragments are bounded to the surface of an acrylamide-coated
flow cell, where each ‘lane’ is a cluster of fragment duplicates (usually around
1000 per lane) generated by bridge amplification. The reverse sequences are
then removed.
3. The lanes are complemented with fluorescent-tagged nucleotides.  The  3′-ter-
minators prevent the polymerase from joining more than one base at a time, al-
lowing to image each lane in one shot. The fluorescent labels are then removed
and the process is repeated until the end of the sequence.
4. In paired-end sequencing, the lanes undergo a second bridge amplification to in-
vert the sequences, then the bases are read one by one a second time.
The consensus sequences from each lane are individual reads. It is not possible to determine a
priori where each read belong into the whole sequence; shotgun sequencing relies on the likeli-
hood that, with enough coverage, any point in a genome is represented by at least one read. In
practice, this is often not the case: the major downside of splitting the genome into reads is that
the subsequent assembling (in some cases, based on heuristic techniques) is highly reliant on
their quality, can be misled by repetitive sequences and some portions of the genome might not
be covered altogether.
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 1.1.3  Third Generation: the PacBio method
The current ‘third generation’ or ‘long-read’ sequencing (since around 2008) methods attempt to
circumvent  the assembling issues  by transcribing the sequences on a  single-molecule  level,
therefore obtaining much longer reads, and can potentially allow for direct detection of epigen-
etic markers (Simpson et al., 2017). The most known methods are those by Pacific Biosciences
(PacBio) and Oxford Nanopore Technology.
The PacBio method, also known as Single Molecule Real-Time (SMRT) sequencing, utilised in
one of the papers of this thesis, is based on zero-mode waveguides (ZMWs), structures that can
guide optical waves into picolitre wells, and phospholinked nucleotides (Levene, 2003; Eid et
al., 2009). 
Figure 1.3 – Pacific Biosciences SMRT sequencing. a: the zero-mode waveguide (ZMW) re-
duces the observation volume and the number of stray fluorescently labelled molecules that 
enter the detection layer for a given period; b: The residence time of phospholinked nucleotides 
is usually on the millisecond scale. The released, dye-labelled pentaphosphate by-product 
quickly diffuses away, dropping the fluorescence signal to background levels. The template is 
then translocated before binding and incorporating the next incoming phospholinked nucleotide.
[Source: https://www.nature.com/nrg/journal/v11/n1/fig_tab/nrg2626_F4.html]
1. A SMRT cell is comprised of tens of thousands of ZMWs wells, about 50×100
nm in size; a DNA template-polymerase complex sits at the bottom, which is il-
luminated from below (Figure 1.3).
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2. Phospholinked nucleotides, labeled with coloured fluorophores, are released on
the SMRT cell.
3. Ligation of the nucleotides releases the fluorophore and emits a light pulse, with
little background noise because of the small size of the well.
Third generation methods attempt not only to produce longer reads, but also to reduce the back-
ground noise from the fluorophore flashes occurring in nearby wells or clusters. The drawback
of many of these methods is that sequencing errors are often unrecoverable, so they can be less
suitable for e.g. de novo assembling (see below); but in applications like metagenomics or large
structural variant calling, which are more tolerant to errors, these newer technologies can often
outperform their predecessors.
The ideal sequencing tool would of course be able to sequence the whole genome from start to
end, without interruptions and with negligible error rates. While the current technologies are
still far from that ideal, in the last few years many strategies have been proposed that come reas-
onably close to it, and increasingly more sophisticated post-sequencing tools can help ‘fill the
gap’ with current sequencers. One notable class of such tools is that of de novo assemblers.
 1.2  De novo sequence assembly
Whole genome (‘shotgun’) sequencing produces fragments of various length (100–500 nts with
second generation, 10,000–60,000 with third generation), which need to be aligned and merged
to reconstruct the original sequence by forming contigs (Figure 1.4) (Johnson et al., 2012). This,
of course, is not a trivial procedure, as it has to deal with repetitive sequences, reading errors,
and fragments not belonging to the same organism. Also, while some early algorithms were de-
vised to combine  e.g. a few Sanger  sequences, WGS requires assembling many millions of
reads, which requires more sophisticated strategies to complete the assembly in a reasonable
time frame.
Assembling can be divided in two main types: mapping, or aligning reads against an already ex-
isting,  similar but not necessarily identical,  reference sequence; and  de novo, in which full-
length sequences are generated without previous knowledge.
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Mapping algorithms compare each read to a reference and are relatively straightforward, al-
though they need to accommodate for the possible presence of insertions, deletions, transposi-
tions and other sources of variability. A more in-depth discussion of sequence aligners is present
in Chapter 1.4 “Comparative genomics”.
Figure 1.4 – De novo assembling of reads involves joining their overlapping extremities to form
contigs (from “contiguous”); additional information can be used to scaffold the contigs into a 
single sequence. [Source: (Johnson et al., 2012)]
De novo algorithms have an O(n2) complexity, as they need to compare every read with every
other read. The speed of assembling depends on various contrasting factors,  e.g. shorter reads
align faster, but overlaps are less univocal  (Henson  et al., 2012). Early assemblers employed
‘greedy’ algorithms: first they calculate pairwise distances, clustering reads with greatest over-
lap, then assembling these reads into contigs. These algorithms are optimised for local  optima
and are less suitable for larger sets (Bang-Jensen et al., 2004). Once commonly used greedy as-
semblers were  SEQAID (Peltola  et al., 1984) and  Phrap (Machado  et al.,  2011), part of the
Phred-Phrap-Consed package that introduced the Phred quality score, later adopted for the ?????
format (Cock et al., 2009).
Later assemblers have been programmed with WGS in mind, adopting De Bruijn graph methods
that search global optima: reads are broken into smaller fragments of specified size (k-mers),
which are then used as nodes in a graph; nodes that overlap by some amount are then connected
and sequences are constructed based on the graph (Myers, 1995). Commonly used assemblers of
this type are SPAdes (Bankevich et al., 2012) and the A5 pipeline (Tritt et al., 2012), along with
many others (Bradnam et al., 2013). It might be interesting to note that while early assemblers,
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and other types of genomic software, were for the most commercial products, many of the more
recent ones are being developed under open source licenses (Koboldt, 2015).
 1.3  Genome annotation
Once the raw, full sequence has been obtained from the organism of interest, in-deep analysis of
its content becomes possible. One of the first desirable steps is often annotating the coding re-
gions and their functions (Figure 1.5), by identifying protein-coding portions, transposons, pre-
dicting genes and gene clusters, delimiting pathogenicity islands and secondary metabolite pro-
duction-associated  clusters,  verifying  repetitive  sequences,  and  separating  plasmid  genomes
from the main sequence (Stein, 2001).
One of the first major problems of genome annotation is identifying the correct Open Reading
Frames  (ORFs)  of  the  sequence,  the  translation  from triplets  of  nucleotides  to  aminoacids
between and including a  start  and a  stop codon (Figure 1.6).  As DNA has two antiparallel
strands, there are 6 possible ORFs for any given sequence. There is rarely, if ever, a single ORF
for a whole sequence: interruptions such as mutations and Single-Nucleotide Polymorphisms
(SNPs) can shift the reading frame, and the reading direction can switch (Sharma et al., 2011).
Initially, for short sequences, annotation was a lengthy procedure done entirely manually by ex-
perienced annotators, often using search tools such as  BLAST (NCBI Resource Coordinators,
2013) to find homologous genes in specific or multipurpose databases. Manual annotation of
whole genomes is of course unfeasible, so pipelines have been developed to automatise the pro-
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cess; manual annotation is however still necessary, as annotators’ output can be unreliable, de-
pends on databases that can be incomplete, and sequences might have different attributions de-
pending on the species analysed (Koonin and Galperin, 2003). Some of the most common an-
notation  softwares  are  the  NCBI  Prokaryotic  Genome  Annotation  Pipeline
[https://www.ncbi.nlm.nih.gov/genome/annotation_prok/],  the  RAST  server  (Aziz  et  al.,
2008) and the MG-RAST server (Glass and Meyer, 2011).
Annotation can be  structural, identifying the genomic components like ORFs, coding regions
and gene structures, or functional, attributing roles at the genomic components,  e.g. regulative
or expressive; often both types are done sequentially. The main challenge however remains pre-
dicting and attributing functions to proteins, tasks that still require long computational times
even with the aid of computers, although mass-spectrometry can help improve the speed and
quality of annotation (Gupta et al., 2007).
Figure 1.6 – The three possible open reading frames (ORFs) of a single DNA strand; with the 
antiparallel strand, the possible ORFs are up to six. The start codon is most commonly ATG, 
while the stop codon is usually TAA, TAG or TGA. ORFs enclose both exons and introns (see 
the next Figure) [Source: http://slideplayer.com/slide/5750865/]
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 1.4  Comparative genomics
Once a genome has been sequenced, and preferably annotated, it is often interesting to compare
it  to  pre-existent  sequences of  close relatives,  to  e.g. find functional  or structural  variances
between strains or species. Features that are investigated include genes, clusters, SNPs and in-
trons. The comparison can be simply between two sequences (pairwise,  Figure 1.7) or across
many (Figure 1.8).
The simplest case is that of aligning short sequences to a longer reference, or comparing very
short  sequences;  complexity increases  with longer  sequences,  multiple  alignments  and with
greater divergence between sequences. Pairwise alignments can be global, which assumes that
the sequences have similar length, or  local, where a smaller query is aligned more precisely
over a portion of the longer reference, although the exact location of the alignment can be am-
biguous (Polyanovsky et al., 2011). A smaller query aligned globally over the reference would
result in wide gaps inserted in the query, likely making the alignment nonsensical.
Figure 1.7 – Alignment of reads against a reference sequence, using the software Tablet. 
[Source: http://2014.igem.org/Team:Imperial/Gluconacetobacter]
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Some of the most commonly used mapping tools of this type are  Bowtie (Langmead  et al.,
2009), BWA (Li and Durbin, 2010) and SOAPdenovo (Luo et al., 2012); for visualisation, two
commonly used programs are  Tablet (Milne  et al., 2013) and the  Integrative Genome Viewer
(Thorvaldsdottir et al., 2013).
Extending the comparison to multiple genomes is a step in identifying evolutionary relation-
ships between samples, by clustering sequences on the basis of their similiarity, a method that is
Figure 1.8 – Multiple sequence alignment, using the software ClustalX. [Source: http://bioin-
fopoint.com/index.php/code/3-multiple-sequence-alignment-with-bioperl-and-muscle]
 also utilised to produce phylogenetic trees (Figure 1.9). Commonly used programs for multiple
sequence alignment are MUMmer (Kurtz et al., 2004), Clustal (Larkin et al., 2007) and Mauve
(Darling, 2004). An important step in mapping similiarities and differences in related genomes
is the identification of orthologs, genes with equivalent functions shared between related species
that can shift position due to changes such as insertions or transpositions (Kuzniar et al., 2008);
specific software is being developed to help identifying orthologs, such as the OMA browser
(Altenhoff et al., 2015).
18
Figure 1.9 – Example of a phylogenetic tree. The lengths of the ‘branches’ are proportional to 
the calculated distances between samples.
 1.5  Whole genome sequencing and plant pathology
Previous chapters gave a panoramic of the various tools currently available to genomic-based
plant pathology research. The main problem in phytopatology, in common with other disciplines
like ecology, is that the subject of its research is very complex and dynamic (Mazzocchi, 2008).
To borrow signal processing terminology, it therefore needs to improve the ‘signal-to-noise ra-
tio’ by excluding what could be considered ‘negligible’ information. Until recent times, this im-
plied simplifications that were deemed reasonable: Robert H. Koch postulated that to derive a
causative relationship between a microbe and a disease, the microorganism needs to be isolated
and grown in pure culture (Koch, 1876). The classic disease triangle model, attributed to R.B.
Stevens, characterise a disease as a relation between the pathogen, the host and the environment
(Francl, 2001), the last essentially being ‘everything else’. DNA barcoding is used on the as-
sumption that genetic markers such as 16S rRNA or ITS are universally applicable and precise
enough to distinguish minute differences between pathogen strains (Hajibabaei et al., 2007).
The introduction of WGS tecnologies in the last thirty years provided the obvious advantage of
allowing access to whole genomes within reasonable times even to small research labs, but they
also led to the realisation that many of those simplifications, while not entirely wrong, consti-
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tuted sufficient but not necessary conditions: defining a causative relationship between microbes
and diseases required to include those pathogens that are remarkably difficult to cultivate  in
vitro (such as phytoplasmas or bacteria like Xylella fastidiosa, see chapter 4), who would other-
wise be excluded. More refined disease models should include the microbial community context
in which pathogens live, since the interactions within and between bacterial species can pro-
foundly impact the outcome of their competition  (Hibbing  et al., 2010). DNA structural vari-
ations, more complex and involving longer sections of the genome (DePristo et al., 2011), can
produce diverse strains  without  modifying the barcode markers,  and as noted the microbial
community can influence these variations.
The deeper understanding that the wealth of now available data required, in turn led to the im-
plementation of more sophisticated analytical and synthetic tools (Green et al., 2005) and meth-
odologies outlined in the  Introduction, but also suggests new, more sophisticated strategies to
contain or contrast plant disease causative agents, especially those of more recent introduction,
which are challenging to control with traditional methods and occasionally (as in the case of the
kiwifruit canker agent,  Pseudomonas syringae pv.  actinidiae) can produce the opposite effect,
e.g. unexpectedly selecting more resistant strains.
 1.6  Aims and objective of the thesis
Objective of this thesis is to illustrate how rigorous bioinformatic analyses, backed by cutting-
edge computing techniques, are essential to understand the data provided by Whole Genome Se-
quencing, and how they can help answer new and more complex questions.
In the following chapters relevant applications of these techniques will be presented, with an in-
creasingly wide perspective: from the use of genomics to understand bacterial interactions with
the environment, to a metagenomic approach for the characterisation of fastidious prokaryotes,
to the metagenomic characterisation of whole communities; at each level, be it single bacterial
genomes, types of microorganisms or communities in their entirety, WGS provided a better in-
sights and suggested new strategies. An introduction to each topic will be given in each chapter.
20
 1.7  Bibliography
Adams, J. M. et al. (1969) ‘Nucleotide Sequence from the Coat Protein Cistron of R17 Bac-
teriophage RNA’, Nature, 223(1009).
Altenhoff, A. M. et al. (2015) ‘The OMA orthology database in 2015: function predictions, bet-
ter plant support, synteny view and other improvements’, Nucleic Acids Research, 
43(D1), pp. D240–D249. doi: 10.1093/nar/gku1158.
Aziz, R. K. et al. (2008) ‘The RAST Server: Rapid Annotations using Subsystems Technology’, 
BMC Genomics, 9(1), p. 75. doi: 10.1186/1471-2164-9-75.
Bang-Jensen, J., Gutin, G. and Yeo, A. (2004) ‘When the greedy algorithm fails’, Discrete Op-
timization, 1(2), pp. 121–127. doi: 10.1016/j.disopt.2004.03.007.
Bankevich, A. et al. (2012) ‘SPAdes: A New Genome Assembly Algorithm and Its Applications 
to Single-Cell Sequencing’, Journal of Computational Biology, 19(5), pp. 455–477. doi: 
10.1089/cmb.2012.0021.
Bradnam, K. R. et al. (2013) ‘Assemblathon 2: evaluating de novo methods of genome as-
sembly in three vertebrate species’, GigaScience, 2(1), p. 10. doi: 10.1186/2047-217X-2-
10.
Canard, B. and Sarfati, R. S. (1994) ‘DNA polymerase fluorescent substrates with reversible 3′-
tags’, Gene, 148(1), pp. 1–6. doi: 10.1016/0378-1119(94)90226-7.
Cock, P. J. A. et al. (2009) ‘The Sanger FASTQ file format for sequences with quality scores, 
and the Solexa/Illumina FASTQ variants’, Nucleic Acids Research, 38(6), pp. 1767–1771.
doi: 10.1093/nar/gkp1137.
Darling, A. C. E. (2004) ‘Mauve: Multiple Alignment of Conserved Genomic Sequence With 
Rearrangements’, Genome Research, 14(7), pp. 1394–1403. doi: 10.1101/gr.2289704.
DePristo, M. A. et al. (2011) ‘A framework for variation discovery and genotyping using next-
generation DNA sequencing data’, Nature Genetics, 43(5), pp. 491–498. doi: 
10.1038/ng.806.
Eid, J. et al. (2009) ‘Real-Time DNA Sequencing from Single Polymerase Molecules’, Science, 
323(5910), pp. 133–138. doi: 10.1126/science.1162986.
Francl, L. J. (2001) ‘The Disease Triangle: A Plant Pathological Paradigm Revisited’, The Plant
Health Instructor. doi: 10.1094/PHI-T-2001-0517-01.
Glass, E. M. and Meyer, F. (2011) ‘The Metagenomics RAST Server: A Public Resource for the 
Automatic Phylogenetic and Functional Analysis of Metagenomes’, Handbook of Mo-
21
lecular Microbial Ecology I: Metagenomics and Complementary Approaches, 8, pp. 325–
331. doi: 10.1002/9781118010518.ch37.
Green, J. L. et al. (2005) ‘Complexity in Ecology and Conservation: Mathematical, Statistical, 
and Computational Challenges’, BioScience, 55(6), pp. 501–510. doi: 10.1641/0006-
3568(2005)055[0501:CIEACM]2.0.CO;2.
Gupta, N. et al. (2007) ‘Whole proteome analysis of post-translational modifications: Applica-
tions of mass-spectrometry for proteogenomic annotation’, Genome Research, 17(9), pp. 
1362–1377. doi: 10.1101/gr.6427907.
Hajibabaei, M. et al. (2007) ‘DNA barcoding: how it complements taxonomy, molecular phylo-
genetics and population genetics’, Trends in Genetics, 23(4), pp. 167–172. doi: 
10.1016/j.tig.2007.02.001.
Henson, J., Tischler, G. and Ning, Z. (2012) ‘Next-generation sequencing and large genome as-
semblies’, Pharmacogenomics, 13(8), pp. 901–915. doi: 10.2217/pgs.12.72.
Hibbing, M. E. et al. (2010) ‘Bacterial competition: surviving and thriving in the microbial 
jungle.’, Nature reviews. Microbiology. NIH Public Access, 8(1), pp. 15–25. doi: 
10.1038/nrmicro2259.
Hutchison, C. A. (2007) ‘DNA sequencing: bench to bedside and beyond’, Nucleic Acids Re-
search, 35(18), pp. 6227–6237. doi: 10.1093/nar/gkm688.
Johnson, M. T. J. et al. (2012) ‘Evaluating Methods for Isolating Total RNA and Predicting the 
Success of Sequencing Phylogenetically Diverse Plant Transcriptomes’, PLoS ONE. Ed-
ited by C. Quince, 7(11), p. e50226. doi: 10.1371/journal.pone.0050226.
Jou, W. M. et al. (1972) ‘Nucleotide Sequence of the Gene Coding for the Bacteriophage MS2 
Coat Protein’, Nature, 237(5350), pp. 82–88. doi: 10.1038/237082a0.
Koboldt, D. (2015) The Open Source Software Debate in NGS Bioinformatics. Available at: 
http://massgenomics.org/2015/11/open-source-ngs-bioinformatics.html.
Koch, R. (1876) ‘Untersuchungen ueber Bakterien V. Die Aetiologie der Milzbrand-Krankheit, 
begruendent auf die Entwicklungsgeschichte des Bacillus Anthracis’, Beitrage zur Biolo-
gie der Pflanzen, pp. 277–310. doi: http://edoc.rki.de/documents/rk/508-5-26/PDF/5-
26.pdf.
Koonin, E. V. and Galperin, M. Y. (2003) ‘Genome Annotation and Analysis’, in Sequence - 
Evolution - Function: Computational Approaches in Comparative Genomics. Boston: 
Kluwer Academic. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21089240.
Kurtz, S. et al. (2004) ‘Versatile and open software for comparing large genomes.’, Genome 
biology, 5(2), p. R12. doi: 10.1186/gb-2004-5-2-r12.
22
Kuzniar, A. et al. (2008) ‘The quest for orthologs: finding the corresponding gene across gen-
omes’, Trends in Genetics, 24(11), pp. 539–551. doi: 10.1016/j.tig.2008.08.009.
Langmead, B. et al. (2009) ‘Ultrafast and memory-efficient alignment of short DNA sequences 
to the human genome’, Genome Biology, 10(3), p. R25. doi: 10.1186/gb-2009-10-3-r25.
Larkin, M. A. et al. (2007) ‘Clustal W and Clustal X version 2.0’, Bioinformatics, 23(21), pp. 
2947–2948. doi: 10.1093/bioinformatics/btm404.
Levene, M. J. (2003) ‘Zero-Mode Waveguides for Single-Molecule Analysis at High Concentra-
tions’, Science. Nature Publishing Group, 299(5607), pp. 682–686. doi: 
10.1126/science.1079700.
Li, H. and Durbin, R. (2010) ‘Fast and accurate long-read alignment with Burrows–Wheeler 
transform’, Bioinformatics, 26(5), pp. 589–595. doi: 10.1093/bioinformatics/btp698.
Luo, R. et al. (2012) ‘SOAPdenovo2: an empirically improved memory-efficient short-read de 
novo assembler’, GigaScience, 1(1), p. 18. doi: 10.1186/2047-217X-1-18.
Machado, M. et al. (2011) ‘Phred-Phrap package to analyses tools: a pipeline to facilitate popu-
lation genetics re-sequencing studies’, Investigative Genetics, 2(1), p. 3. doi: 
10.1186/2041-2223-2-3.
Mazzocchi, F. (2008) ‘Complexity in biology. Exceeding the limits of reductionism and determ-
inism using complexity theory’, EMBO reports, 9(1), pp. 10–14. doi: 
10.1038/sj.embor.7401147.
Milne, I. et al. (2013) ‘Using Tablet for visual exploration of second-generation sequencing 
data’, Briefings in Bioinformatics, 14(2), pp. 193–202. doi: 10.1093/bib/bbs012.
Moruzzi, S. et al. (2017) ‘Genomic-assisted characterisation of Pseudomonas sp. strain Pf4, a 
potential biocontrol agent in hydroponics’, Biocontrol Science and Technology, 27(8), pp.
969–991. doi: 10.1080/09583157.2017.1368454.
Myers, E. W. (1995) ‘Toward Simplifying and Accurately Formulating Fragment Assembly’, 
Journal of Computational Biology, 2(2), pp. 275–290. doi: 10.1089/cmb.1995.2.275.
NCBI Resource Coordinators (2013) ‘Database resources of the National Center for Biotechno-
logy Information’, Nucleic Acids Research, 41(D1), pp. D8–D20. doi: 
10.1093/nar/gks1189.
Peltola, H., Söderlund, H. and Ukkonen, E. (1984) ‘SEQAID: a DNA sequence assembling pro-
gram based on a mathematical model’, Nucleic Acids Research, 12(1Part1), pp. 307–321. 
doi: 10.1093/nar/12.1Part1.307.
23
Polyanovsky, V. O., Roytberg, M. A. and Tumanyan, V. G. (2011) ‘Comparative analysis of the 
quality of a global algorithm and a local algorithm for alignment of two sequences’, Al-
gorithms for Molecular Biology, 6(1), p. 25. doi: 10.1186/1748-7188-6-25.
Sanger, F. and Coulson, A. R. (1975) ‘A rapid method for determining sequences in DNA by 
primed synthesis with DNA polymerase’, Journal of Molecular Biology, 94(3), pp. 441–
448. doi: 10.1016/0022-2836(75)90213-2.
Sanger, F., Nicklen, S. and Coulson, A. R. (1977) ‘DNA sequencing with chain-terminating in-
hibitors.’, Proceedings of the National Academy of Sciences of the United States of Amer-
ica, 74(12), pp. 5463–7. Available at: http://www.pubmedcentral.nih.gov/articlerender-
.fcgi?artid=431765&tool=pmcentrez&rendertype=abstract (Accessed: 29 October 2012).
Sharma, V. et al. (2011) ‘A pilot study of bacterial genes with disrupted ORFs reveals a surpris-
ing profusion of protein sequence recoding mediated by ribosomal frameshifting and 
transcriptional realignment’, Molecular Biology and Evolution, 28(11), pp. 3195–3211. 
doi: 10.1093/molbev/msr155.
Shendure, J. and Ji, H. (2008) ‘Next-generation DNA sequencing’, Nature Biotechnology, 
26(10), pp. 1135–1145. doi: 10.1038/nbt1486.
Simpson, J. T. et al. (2017) ‘Detecting DNA cytosine methylation using nanopore sequencing’, 
Nature Methods, 14(4), pp. 407–410. doi: 10.1038/nmeth.4184.
Stein, L. (2001) ‘Genome annotation: from sequence to biology’, Nature Reviews Genetics, 
2(7), pp. 493–503. doi: 10.1038/35080529.
Thorvaldsdottir, H., Robinson, J. T. and Mesirov, J. P. (2013) ‘Integrative Genomics Viewer 
(IGV): high-performance genomics data visualization and exploration’, Briefings in 
Bioinformatics, 14(2), pp. 178–192. doi: 10.1093/bib/bbs017.
Tritt, A. et al. (2012) ‘An Integrated Pipeline for de Novo Assembly of Microbial Genomes’, 
PLoS ONE. Edited by D. Zhu, 7(9), p. e42304. doi: 10.1371/journal.pone.0042304.
24
 2  Genomics as a tool to understand bacterial interactions with 
the environment that are relevant for plant pathology
A typical example of a pathogen that can effectively be analysed using WGS tools, due to the
number of studies published and the availability of genome sequences of most of its pathovars,
is Pseudomonas syringae, a Gram-negative, rod-shaped, flagellated bacterium characterised and
named by C.J.J. van Hall in 1904 (Prasanth et al., 2015).  P. syringae is a causal agent of dis-
eases in a wide range of plant species (including  Arabidopsis thaliana,  tobacco and tomato,
species often used as model plants in experimental research for their ease of cultivation) and
comprises more than 50 pathovars (infraspecies taxon that are distinguished by pathogenic abili-
ties, without clearly established phylogenetic relationships with the others) with variable speci-
ficity.
P. syringae is of interest because of its various mechanisms of pathogenicity. The bacterium is
not able to create an opening in the plant by itself, but can use chemical signals to find its way
to natural openings (Ichinose  et al., 2013). It can produce a biofilm to adhere to the host cell
wall and protect itself from other bacteria, using a quorum sensing strategy, by which genes are
expressed when enough pseudomonad cells are present to produce effective quantities of said
molecules. It can facilitate frost injury by acting as ice nucleation, raising the temperature at
which water inside plant tissues, normally in a supercooled state, frosts (Lindow et al., 1978).
P. syringae is also interesting because it has one of the best characterised effector repertoire.
In summary, the plant-pathogen relation can be outlined by a  4-step model:  initially,  plants
recognise  pathogen (or  microbe)-associated molecular patterns (PAMPs/MAMPs)  (Zhang  et
al., 2007) – which include many different molecules, like lipopolysaccharides, flagellin, lipotei-
choic acid and peptidoglycan – and react with MAMP-triggered immunity (MTI, Figure 2.1); in
turn pathogens can develop strategies to hide their MAMPs, or suppress the host’s ability to
recognise them by delivering effectors through the type 3 secretion system (T3SS) encoded in
the hrp gene cluster; plants in turn recognise T3SS effectors through resistance (R) genes and
employ effector-triggered immunity (ETI) responses, which most often translates to a hypersen-
25
sitive response (HR), where the affected cells die in an attempt to immobilise and stop the
spread of the pathogen. Bacteria in turn can develop strategies to overcome ETI responses, e.g.
by losing or changing their T3SS effectors (Bent and Mackey, 2007; Newman et al., 2013).
Figure 2.1 – M/PAMP-triggered immunity (MTI), constituting the primary form of plant resis-
tance, vs. effector-triggered immunity (ETI), which is the plant’s response to the pathogen’s 
adaptation to MTI. [Source: (Henry et al., 2012)]
This model, in which both the pathogen and the plant change in response to new strategies de-
ployed by the other, has an interesting ramification, in that closely-related but less aggressive
bacterial strains could potentially thrive thanks to this ‘arms race’, because of their closeness,
instead of being cornered due to having a less optimised gene set, as it was generally assumed in
the past. Genomic research can intervene by helping plants develop new T3SS effectors detec-
tors (e.g. by breeding resistant cultivars), but also by altering the bacterial community in the
proximity of the plant, to create a less hospitable environment to pathogens by promoting a sta-
ble presence of non-pathogenic antagonists or closely related strains. Considering the classic re-
lationship between pathogen, host and environment, influencing the microbial community (be-
sides looking for plant resistances) could help managing pathogens by leveraging on various
26
tactics to slow its spread (Arneson, 2001): the initial inoculum could be reduced through dilu-
tion with closely-related non-pathogenic strains; the infection rate could be slowed by keeping
the pathogen busy with competing with other species or multiple biocontrol agents (Guetsky et
al., 2002); the duration of the epidemic could be shortened by inducing the need for more time-
consuming strategies to reach the plants.
The  papers  that  follow illustrate  a  few applications  of  genomic  analysis  on  Pseudomonas
strains. In the first one, the biocontrol activity of Pseudomonas sp. strain Pf-4 isolated from hy-
droponics was assessed and compared to the set of secondary metabolites-producing gene clus-
ters of the well-known soil biocontrol P. protegens strain Pf-5. Supplementary data is listed in
the Appendix, Chapter 6.1.
In the second paper, the inhibition strength of Pseudomonas sp. strain Pf-4 and its close relative
Pseudomonas sp. strain Pf-11 against fungal species were compared, to evaluate differences in
their genomic and biological (in terms of fungal inihibition capabilities) features.
In the third paper, two very close strains of P. s. pv. actinidiae (PSA) produced a markedly dif-
ferent response when inoculated in tobacco leaves; using a Third Generation sequencing, the
analysis showed that an insertion disrupted the functionality of the T3SS, suggesting that control
strategies that do not promote recombination might have a lesser chance of favouring more viru-
lent variant strains.
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 2.2  Genome sequence and antifungal activity in two niche-sharing 
Pseudomonas protegens strains isolated from hydroponics
Authors: Cesare Polano, Marta Martini, Francesco Savian, Serena Moruzzi, Paolo 
Ermacora, Giuseppe Firrao. Manuscript submitted to “Biological control”.
 2.2.1  Introduction
The rhizosphere environment hosts a complex of microorganisms that interact with plants in a
multitude of ways, such as the mutually beneficial relationship between nitrogen-fixing bacteria
and the radical apparatus; adverse interactions, such as the continuously evolving conflict be-
tween pathogens and their more-or-less specific hosts; and neutral interactions, in which neither
the microorganisms nor the plants derive any particular benefit, but also no significant detriment
(Raaijmakers et al., 2009). Vegetable crops are particularly sensitive to adverse interactions for
various reasons, to name a few: the intensity of cultivation can often push their physiological
capabilities, requiring a surge in the uptake of resources during the productive season, which
can leave the plants more susceptible to pathogen aggression; the use of a limited set of com-
mercially sought-after cultivars, which are often on the lower side of disease resistance, when
compared to more recently developed cultivars and breeds; and also the need for more environ-
mentally sound methods of pest and disease management (Colla et al., 2012), motivated both by
scientific and social reasons. The impact of pathogens can be reduced, sometimes significantly,
by employing various strategies, including the competition and antibiosis between microorgan-
isms, the induction of local or systemic resistance in hosts, and by influencing the chemical
characteristics of the soil itself (Mazzola, 2002). 
While not all root diseases can be avoided (Vallance et al., 2011), their impact can be decisively
limited by employing microorganisms as biocontrol agents  (Handelsman and Stabb, 1996). A
particularly  suited  genus  is  Pseudomonas,  common  in  all  agricultural  soils (Paulitz  and
Bélanger, 2001; Weller, 2007); P. fluorescens strains have been intensely studied as models for
rhizosphere ecological studies and analysis of secondary metabolism (Couillerot  et al., 2009),
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and Pseudomonas species have shown the ability of inhibiting the growth of fungal pathogens
in e.g. hydroponic cultures of  Valerianella locusta  (L.) Laterr.,  Pythium aphanidermatum and
Rhizoctonia solani in particular (Rankin, 1994) (Van Os, 1999)
Bacterial communities constitute a complex relation of interactions, driven by the necessity of
controlling limited resources (Hibbing et al., 2010; Stubbendieck and Straight, 2016). These in-
teractions can be competitive or mutualistic,  and can be between different species,  different
strains in the same species, or between members of the same species and strain. As a general
rule, interactions become more and more competitive the more distant the individuals are on a
genetic level.
Cooperation often involves quorum sensing (Hense et al., 2007): as small quantities of antimi-
crobial compounds can induce a physiologically tolerant state (bacteria that produce these com-
pounds are most likely tolerant themselves because of this mechanism), a common strategy is to
delay  production  of  antimicrobials  until  enough individuals  are  present  (Lyon and Novick,
2004), so that the release of these compounds will reach full inhibitory level of concentration.
Such antimicrobial compounds can have various level of specificity; organism with narrower
range of habitats will often have more specific targets.
Some degree of cooperation can however be present also between different species, such as be-
tween Pseudomonas putida strain R1 and Acinetobacter strain C6, where the former depends on
the benzoate produced by latter to grow on benzyl alcohol (Christensen et al., 2002).
Competition has been often compared to an arms race, with broadly two categories of strategies:
one involves direct interaction, where two or more individuals (or colonies) attempt to displace
the competition and get access to most of the resources; the other is indirect, and consists e.g. in
a faster uptake of limited resources, outgrowing the competition  (Nicholson, 1954). In large
enough communities, some individuals can take advantage of metabolites produced by other or-
ganisms and shift the cost of producing them, e.g. using heterologous siderophores (Khan et al.,
2006). This phenomenon is more frequent against different species, but has also been observed
intra-species.
Access to favourable locations involves colonising new niches or displacing existing competi-
tion. Long term persistence requires mechanisms for keeping hold of the position; some species
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produce receptors that bind to specific surfaces (Johnson-Henry et al., 2007), while others pro-
duce antimicrobials or molecules that facilitate dispersal of competing organisms  (Xavier and
Foster, 2007)
The diversity and composition of the microbial community can consequently change in time,
with some species prevailing over others while they compete for the same resources. If  the
‘weaker’ species happen to be those that are inoculated for biocontrol purposes, it becomes nec-
essary to reintroduce them periodically to keep them at an efficacious population level. Alterna-
tively, a better strategy would be attempting to facilitate a stable presence, or at least a slower
decline, of the species of economical interest to plant protection.
While the simplest form of biocontrol is one metabolite vs one antagonist, more complex pat-
terns can be identified: the same metabolites can affect more than one antagonist, while two or
more metabolites can act synergically on the same one, either acting on the same biochemical
mechanism or on multiple fronts (Kannan and Sureendar, 2009). 
In a previous work, a group of Pseudomonas protegens related strains were isolated from hydro-
ponic cultures of lamb’s lettuce, for their ability to inhibit selected fungal pathogens (Moruzzi et
al., 2017). The aim of this work was to investigate the biological activity of two of those strains
against a larger number of fungal strains, and correlate it with their genomic features, especially
those related to secondary metabolism.
 2.2.2  Materials and methods
Pseudomonas genomes: the Pseudomonas sp. Pf-4 and Pf-11 strains were isolated in 2009 from
the roots of healthy Valerianella locusta (L.) Laterr. plants grown in a hydroponic farm in Friuli
Venezia Giulia (FVG) region, north-eastern Italy. Genomic DNA was extracted from 1 ml of 24
hrs old cultures grown in Nutrient Broth with agitation using a Wizard DNA purification kit
(Promega Italia, Padova, Italy) following the manufacturer's instructions. DNA was measured
and checked for quality using a NanoDrop (NanoDrop products, Wilmington, DE, USA). Illu-
mina libraries were prepared as described previously (Scortichini et al., 2013) and sent to the Is-
tituto di Genomica Applicata (Udine, Italy) for sequencing on a Illumina Myseq with a 2x300
Reagent kit. Genomes were assembled using the A5-miseq pipeline (Tritt et al., 2012) and anno-
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tated using the NCBI Prokaryotic Genome Annotation Pipeline (http://www.ncbi.nlm.nih.gov/
genome/annotation_prok/) and the RAST server (Aziz et al., 2008). The BioSample accession
for Pf-4 is SAMN04554942; the BioSample accession for Pf-11 is SAMN04554943. A prelimi-
nary genome draft of Pf-4 has been published (Moruzzi et al., 2017), while no genomic infor-
mation about Pf-11 has been previously reported.
Orthologs and metabolic pathways: the NCBI-annotated sequences of Pf-11 and Pf-4 were
compared for orthologs using the standalone version of the  Orthologous Matrix tool (OMA;
http://omabrowser.org/standalone/). The output was converted into a comparison table, using a
custom Perl/Bash script.
Secondary metabolic pathways were investigated by verifying the presence of a selection of
genes and gene clusters typical of P. protegens strains (Mavrodi et al., 2010; Loper et al., 2012;
Blankenfeldt and Parsons, 2014) in the NCBI annotation. The two genomes were also submitted
to the antiSMASH 3.0 tool for rapid identification, annotation and analysis of secondary metabo-
lite biosynthesis gene clusters in bacterial and fungal genome sequences (Weber  et al., 2015),
for comparison with the hand-selected cluster findings. Structural and functional features of the
two genomes were compared using Mauve  (Darling, 2004), Busco  (Simão  et al., 2015), and
some ad hoc Perl scripts.
Fungal growth inhibition tests: to test the ability of both Pseudomonas strains to inhibit fungal
growth, a total of 18 fungal strains were assayed in four separate inhibition tests. Most strains
were freshly isolated identified by rDNA sequencing as belonging to the following species: Al-
ternaria alternata, Aspergillus flavus, A. niger, Fusarium oxysporum f. sp.  niveum, F. oxyspo-
rum f. sp. vasinfectum, F. verticillioides, Penicillium chrysogenum, P. griseofulvum, P. verruco-
sum;  Ilyonectria  europaea,  I.  robusta,  Epicoccum nigrum,  Neopestalotiopsis  rosae;  Phoma
betae, Botritis cinerea, Colletotrichum sp.  In addition,  Pythium aphanidermatum strain CBS
118745 and strain CBS 116664, obtained from the Centraal Bureau voor de Schimmelcultures
(CBS) and a two Rhizoctonia solani strains TR15 and TP20 isolated in 2009 from symptomatic
plants in the same hydroponic farm as the Pseudomonas strains, were used.
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Inhibition tests:  nine repetitions of each fungus were placed in the center of standard Petri
dishes (internal diameter 85 mm) containing PDA supplemented with 3 g/l peptone and 2 g/l
yeast estract, three of which were streaked at the sides, in a square shape, with Pf-4 and another
three with Pf-11; the last three were the control samples, with the fungus alone. The Petri dishes
were incubated at room temperature in a dim-lit environment. The dishes were photographed
about every 24 hours, for at least 10 days, and the diameter of each fungal colony was recorded
(for the early square shapes, an average diameter was noted). Statistical analysis was carried out
by comparing modeled growth curves using the “nlme” package (Pinheiro et al., 2017) of R (R
Development Core Team, 2007).
 2.2.3  Results
Genome sequencing: the ???????? Sequencing of strain Pf-11 DNA produced 3,727,137 reads,
300  nts  each,  for  a  total  of  1.1∙109 nucleotides,  while  sequencing  of  Pf-4  DNA produced
1,914,469 reads, 300 nts each, for a total of 0.6∙109 bp. The assembled Pf-11 draft genome se-
quence is 7,053,517 bp long in total, with a 62.0% G+C content, and consists of 125 contigs
ranging from 605 to 1,372,031 bp in size (N50: 1,036,338), with a coverage of 205.3×. The as-
sembled Pf-4 draft genome sequence is 6,832,152 bp long in total, with a 62.5% G+C content,
and consists of 36 contigs ranging from 605 to 1,018,138 bp in size (N50: 688,889), with a cov-
erage of 100.9×.
The genome sequence draft of Pf-11 contains 6154 predicted protein-coding sequences and 135
pseudogenes. In addition, 63 tRNA genes and 11 rRNA genes were identified. The genome se-
quence of Pf-4 contains 5907 predicted protein-coding sequences and 61 pseudogenes. In addi-
tion, 62 tRNA genes and 11 rRNA genes were identified.
Comparison of the Pf-4 and Pf-11 genomes: strains Pf-4 and Pf-11 are very similar to each
other. Their 16S rRNA gene sequences are almost identical (1 nt difference in the entire se-
quence). They are also very similar at the genome level, sharing a large number of orthologous
genes. OMA found 5534 orthologs, representing 89.9% of the Pf-11 genome and 93.7% of the
Pf-4 genome. We selected the predicted protein sequences of 437 orthologs that are highly con-
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served among the gammaproteobacteria according to the BUSCO data-set (Simão et al., 2015),
and estimated that the identical sequences were 261, while 100 had a single amino acid differ-
ence. In the total 153,633 amino acid residues resulting from concatenation of the 437 core pro-
tein sequences only 403 (0.26%) were different between Pf-4 and Pf-11. Differences among the
two genomes were mostly found in the accessory genome; the OMA program listed 427 addi-
tional genes exclusive to Pf-4 (Table 2.2.1 and 6.1.1) and 741 exclusive to Pf-11 (Table 2.2.2
and 6.1.2).
Table 2.2.1 – Highlights of OMA-isolated genes exclusive to Pf-4. An exhaustive list is present
in the supplemental data, Table 6.1.1.
Gene code Description
A1348_00295 iron dicitrate transport regulator FecR
A1348_01100, A1348_12715 antitoxin
A1348_01105 plasmid maintenance protein
A1348_05325 immunity protein
A1348_06835 organic radical-activating protein
A1348_07960 nitrilotriacetate monooxygenase
A1348_08840 RTX toxin
A1348_11565 ferredoxin
A1348_12720 addiction module toxin RelE
A1348_12950 pesticin immunity protein
A1348_15975 p-hydroxycinnamoyl CoA hydratase/lyase
A1348_16040 Vanillate O-demethylase oxidoreductase
A1348_16045 Rieske (2Fe-2S) protein
A1348_16275 nucleoid-associated protein YejK
A1348_17340 antibiotic ABC transporter permease
A1348_21675 nitric oxide synthase
A1348_22195 agmatine deiminase
A1348_25120 Holliday junction resolvase
A1348_25380 plasmid stabilization protein ParE
A1348_27055 flavin reductase
A1348_27075 monodechloroaminopyrrolnitrin synthase PrnB
A1348_29440 chemotaxis protein
A1348_30105, A1348_12615 large adhesive protein
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Table  2.2.2 –  Highlights  of  OMA-isolated  genes  exclusive  to  Pf-11.  An exhaustive  list  is
present in the supplemental data, Table 6.1.2.
Gene code Description
A1395_07930 methanobactin biosynthesis cassette protein MbnB
A1395_08725 acriflavin resistance protein
A1395_08815, A1395_21000 DNA repair protein RadC
A1395_09195 multidrug transporter
A1395_09200 multidrug efflux RND transporter permease subunit
A1395_16665 phenol degradation protein meta
A1395_17490, A1395_29460 addiction module toxin RelE
A1395_17495 toxin-antitoxin system protein
A1395_17640 cytotoxic translational repressor of toxin-antitoxin stability system
A1395_20785 coproporphyrinogen III oxidase
A1395_21095 nitrilase
A1395_22460 metal-chelation protein CHAD
A1395_25370 prevent-host-death protein
A1395_27990 host specificity protein
A1395_28685, A1395_28745 lysozyme
A1395_29380 large adhesive protein
A1395_29465 antitoxin of toxin-antitoxin stability system
A1395_31465 spermidine/putrescine ABC transporter substrate-binding protein
A1395_31485 nitrate reductase
A1395_31570 SfnB family sulfur acquisition oxidoreductase
nusA transcription termination/antitermination protein NusA
By using the complete sequence of Pf-5 as a reference (CP0000076.1; Paulsen et al., 2005), we
carried out the scaffolding of 16 contigs of Pf-4 (accounting for 6,802,786 nts, which corre-
spond to >99.5% of the Pf-4 estimated genome size) on one hand and, on the other, scaffolding
of 15 contigs of Pf-11 (accounting for 6,934,975 nts, which correspond to >98.3% of the Pf-11
estimated genome size). According to the genome alignment carried out with Mauve (shown in
Figure 2.2.1), the two genomes have a strong colinearity and conservation. However, the align-
ment highlighted 96 sequence regions (larger than 1,000 nts) in the genome of Pf-4 that were
missing in Pf-11 (460,862 nts total), and 68 in the genome of Pf-11 that were missing in Pf-4
(600,403 nts total). The 8 unique regions in Pf-4 and the 11 regions in Pf-11 that are larger than
10,000 nts are marked with a red dot in the genome alignment of Figure 2.2.1. Noticeably, in the
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Pf-4 genome, region 4 in scaffold 1 and region 5 in scaffold 2, as well as the region of poor sim-
ilarity and rearrangements located around and including region 3 in scaffold 4, contain many
genes involved in secondary metabolism. Moreover, several strain specific polyketide synthase
(PKS) could be located around and in region 1 in scaffold 8. Conversely, in the Pf-11 genome,
only the large region 1 in scaffold 1 was rich in genes involved in secondary metabolism.
On the whole, the genome of Pf-11 was about 200 kb (3%) larger than the genome of Pf-4, the
difference being related with a larger accessory genome. The count of genes annotated as con-
jugative protein and transposase sums 43 in Pf-11 and only 4 in Pf-4, suggests that the presence
of mobile elements is more extensive in Pf-11.
Genes involved in the production of secondary metabolites: in a comparison for their poten-
tial in the production of secondary metabolites, the two genomes resulted similar, yet with some
significant differences. A summary of the comparison of the secondary metabolite gene content
of the two strains is given in Table 2.2.3, and reported in full detail in Table 6.1.3.
Nine gene clusters for antibiotic metabolites typical of P. protegens were found in both Pf-4 and
Pf-11 strains, along with  gac/rsm homologues and small regulatory RNAs: hydrogen cyanide
(hcn), 2,4-diacetylphloroglucinol (phl), AprX protease (apr), pyoverdine (pvd), enantio-pyoche-
lin (pch), hemophore biosynthesis (has), ferric-enterobactin receptor (pfe), orfamide A (ofa), and
FitD toxin (fit). Three clusters, i.e. pyoluteorin (plt), pyrrolnitrin (prn), and rhizoxin (rzx), were
present only in Pf-4.
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Figure 2.2.1 – Mauve alignment of Pf-11 and Pf-4. The red dots mark unique regions larger 
than 10,000 nts.
Table 2.2.3 – Summary of the sequence analysis of gene clusters for the synthesis of antibiotics,
exoenzyme, cyclic lipopeptide, siderophores, and toxin, and of Gac/Rsm homologues in P. pro-
tegens Pf-11 and Pf-4 and similarities to those in P. protegens strains (Pf-5, PH1b) and other
closely related Pseudomonas sp. (CMAA1215, NFPP17, Os17). A more detailed list of genes is
present in Table 6.1.3.
Pf-11 NCBI Gene
ID
(A1395_)
Pf-4 NCBI Gene
ID
(A1348_)
Gene name
(Pf5 equiv.
PFL ID)
Pf-11 Locus Pf-4 Locus
hcn gene cluster (for hydrogen cyanide) – present in both
10425–10415 23065–23075 hcnA (2577)–hcnC(2579) 1: 991726–994695 (–)
6: 391003–393972
(+)
plt gene cluster (for pyoluteorin) – only in Pf-4
– 17270–17350 pltM (2784)–pltP(2800) – 4: 360091–390616
prn gene cluster (for pyrrolnitrin) – only in Pf-4
– 27080–27065 prnA (3604)–prnD(3607) – 8: 326813–332375
phl gene cluster (for 2,4-diacetylphloroglucinol) – present in both
18635–18670 10485–10520 phlH (5951)–phlE(5958) 3: 364619–372851 2: 363678–371910
apr gene cluster (for AprX protease) – present in both
08470–08450 26990–26970 aprA (3210)–aprF(3206) 1: 533253–539877 (–)
8: 303649–310279
(–)
Gac/Rsm homologues – present in both
13645 03275  gacS (4451) 2: 326117–328870 (+) 0: 690217–692970(–)
21170 25980 gacA (3563) 4: 104938–105522 (–) 7: 486282–486866(+)
13900 03020 rsmA (4504) 2: 377278–377466 (–) 0: 641626–641814(+)
17930 09780 rsmE (2095) 3: 220271–220990 (+) 2: 219078–219797(+)
24025 15270 retS (0664) 5: 78482–81268 (+) 3: 607391–610177(–)
26950 28385  ladS (5426) 6: 187267–189633 (–) 9: 172345–174711(+)
Small regulatory RNAs – present in both
N.A. N.A. rsmZ (6285) 0: 514076–513951 (–) 1: 506535–506661(+)
N.A. N.A. rsmY (6291) 3: 74313–74197 (–) 2: 73788–73906 (+)
N.A. N.A. rsmX (6289) 10: 33390–33506 (+) 10:86797–86915 (+)
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pvd gene cluster (for pyoverdine) – present in both
07080–07085 17855–17860 pvdQ (2902)–fpvR (2903) 1: 189376–192763 4: 506592–509979
30155–30060 29340–29435 pvdA (4079)–PFL_4097 10: 46820–92493 10: 26184–71830
12240–12290 04660–04610 PFL_4169–pvdH (4179) 2: 17612–26974 10: 56263–59334 (–)0: 990920–999310
12360–12370 04555–04545 pvdL (4189)–pvdY (4191) 2: 41461–55794 0: 962639–976972
pch cluster (for enantio-pyochelin) – present in both
30475–30520 15840–15885 pchR (3497)–pchA (3488) 11: 53981–72965 4: 49492–68476
has gene cluster (for hemophore biosynthesis) – present in both
26720–26690 28615–28645 hasI (5380)–hasF (5374) 6: 128190–138010(–)
9: 223960–233779
(+)
pfe gene cluster (for ferric-enterobactin receptor) – present in both
10085–10095 23430–23420 pfeR (2665)–pfeA (2663) 1: 916810–921183(+)
6: 470135–474508
(–)
ofa gene cluster (for orfamide A) – present in both
27845–27835 18430–18420 ofaA (2145)–ofaC (2147) 7: 7700–42217 (–) 5: 7709–42188 (–)
fit gene cluster (for FitD toxin) – present in both
08015–07980 26560–26525 fitA (2980)–fitH (2987) 1: 402656–424286 8: 180030–201661
rzx gene cluster (for rhizoxin) – only in Pf-4
– 26520–26475 PFL_2988–rzxA (2997) – 8: 99945–179906
Genes in the hcn cluster showed high similarity (between 91% and 98%) to those of P. prote-
gens strain Pf-5 in the case of Pf-11, while in the case of Pf-4 the best matches were to those of
strains P. sp. Os17 and St29 (95%–99%); similarly, the genes in the Pf-11 phl cluster have high
similarity (92%–98%) to those of P. protegens strain Pf-5 and to those of P. sp. Os17, and St29
and P. protegens strains in the case of Pf-4 (90%–99%). 
In both Pf-11 and Pf-4, high similarity to the PH1b, CMAA1215 and Os17 strains was found for
the apr cluster (92–99%) and to Pf-5 for the cluster associated with the gac/rsm signal transduc-
tion (91–100%).The pvd cluster for pyoverdine, whose product has been reported in Pf-5 (Gross
and Loper, 2009), is divided in four different loci, with varying levels of similarity; the largest
locus spans genes A1395_30060–A1395_30155, with similarity ranging between 31% and 96%,
in Pf-11, and (NCBI ID) A1348_29340–A1348_29435, with similarity ranging between 35%
and 100% in Pf-4. 
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Clusters  for  enantio-pyochelin,  fully  conserved  in  Pf-5  (Youard  et  al.,  2007),  hemophore
biosynthesis, ferric-enterobactin receptor and orfamide A were also found in both strains; the  fit
cluster  (Péchy-Tarr  et al., 2008), in the downstream region of the rzx cluster in Pf-5, has 88–
97% identity in both cases to P. protegens Pf-5 homologous, and appears inverted compared to
P. protegens strain Pf-5 and P. sp. Os17.
Differently from Pf-4, the plt cluster for pyoluteorin and the prn cluster for pyrrolnitrin, typical
antibiotic metabolites in P. protegens, as well as the rzx gene cluster encoding analogs of the an-
timitotic macrolide rhizoxin, are not present in Pf-11.
For comparison, the  antiSMASH tool found 6 metabolic pathways common to Pf-11 and Pf-4
(amychelin, arylpolyene, 2,4-diacetylphloroglucinol, mitomycin, orfamide, pyoverdine), 1 ex-
clusive to Pf-11 (alginate) and 3 exclusive to Pf-4 (pyoluteorin, pyrrolnitrin, rhizoxins), as re-
ported in Table 2.2.4 and Table 2.2.5. The enantio-pyochelin biosynthesis cluster, however, was
not detected. 
Fungal growth inhibition tests: strains of all fungal species but Pythium and Rhizoctonia took
at least 9 days to reach the plate border, therefore growth curves were constructed with data of 8
days of growth. The diameter of the fungal colonies grown for 10 days in the presence of strain
Pf-11 ranged from 22 mm (P. verrucosum) to 57 mm (E. nigrum), while those grown in the
presence of Pf-4 ranged from 15 mm (N. rosae) to 53 mm (A. niger).
Table 2.2.4 – Gene clusters in Pf-11 determined by antiSMASH 3.0 web tool. Under the “Most
similar known cluster” column, the percentage is the proportion of genes that show similarity.
Cluster Type From To Most similar known cluster MIBiG BGC-ID
scaffold 0
Cluster 1 T1pks 269602 315724 Alginate biosynthetic g.c.* (100%) BGC0000726 c1
Cluster 2 Bacteriocin 604419 615309 - -
Cluster 3 Bacteriocin 643914 655860 - -
scaffold 1
Cluster 4 Thiopeptide-Lantipep-
tide-Bacteriocin
60239 100470 - -
Cluster 5 Bacteriocin 387369 398181 - -
Cluster 6 Nrps 1101588 1153056 Mitomycin biosynthetic g.c.* (5%) BGC0000915 c1
scaffold 10
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Cluster 7 Nrps 28880 92959 Pyoverdine  biosynthetic  g.c.*
(31%)
BGC0000413 c1
scaffold 11
Cluster 8 Nrps 35259 89304 Amychelin biosynthetic g.c.* (12%) BGC0000300 c1
scaffold 2
Cluster 9 Nrps 21461 74477 Pyoverdine  biosynthetic  g.c.*
(16%)
BGC0000413 c1
Cluster 10 Nrps 503749 554778 - -
scaffold 3
Cluster 11 T3pks 350414 391463 2,4-Diacetylphloroglucinol  biosyn-
thetic g.c.* (87%)
BGC0000281 c1
Cluster 12 Bacteriocin 629699 640544 - -
scaffold 5
Cluster 13 Arylpolyene 294021 337638 APE Vf biosynthetic g.c.* (40%) BGC0000837 c1
scaffold 7
Cluster 14 Nrps 1 62217 Orfamide biosynthetic g.c.* (70%) BGC0000399 c1
*g.c.: “gene cluster”.
For all fungi except  A. niger and A. flavus, a statistically significant inhibition effect was ob-
served for both Pf4 and Pf11, starting from the 4th day post inoculum (DPI) (Figure 2.2.2).
In a first group of fungi (E. nigrum, Colletotrichum sp., A. alternata, I. robusta, P. betae, P. ver-
rucosum), the inhibition effect from Pf4 was more intense than Pf11 and both were more intense
than the controls. Significant difference from the controls was determined for all these fungi at
the 2nd DPI, while the effect difference between Pf4 and Pf11 ranged from the 2nd (E. nigrum)
to the 3rd (Collectricum sp., A. alternata), 5th (I. robusta) or 9th DPI (P. verrucosum). 
Table 2.2.5 – Gene clusters in Pf-4 determined by antiSMASH 3.0 web tool. Under the “Most
similar known cluster” column, the percentage is the proportion of genes that show similarity.
Cluster Type From To Most similar known cluster MIBiG BGC-ID
scaffold 0
Cluster 1 Nrps 464199 515228 - -
Cluster 2 Nrps 943956 996972 Pyoverdine biosynthetic g.c.* (17%) BGC0000413 c1
scaffold 1
Cluster 3 Bacteriocin 597423 608313 - -
Cluster 4 Bacteriocin 636903 648849 - -
scaffold 10
Cluster 5 Nrps 25701 89768 Pyoverdine biosynthetic g.c.* (27%) BGC0000413 c1
scaffold 2
Cluster 6 T3pks 349473 390522 2,4-Diacetylphloroglucinol  biosyn-
thetic g.c.* (87%)
BGC0000281 c1
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Cluster 7 Bacteriocin 644287 655132 - -
scaffold 3
Cluster 8 Arylpolyene 350533 394150 APE Vf biosynthetic g.c.* (40%) BGC0000837 c1
scaffold 4
Cluster 9 Nrps 30770 84815 Amychelin biosynthetic g.c.* (12%) BGC0000300 c1
Cluster 10 T1pks 344776 397525 Pyoluteorin biosynthetic g.c.* (100%) BGC0000127 c1
Cluster 11 Lantipeptide-Bacteriocin 396010 420165 - -
scaffold 5
Cluster 12 Nrps 1 62188 Orfamide biosynthetic g.c.* (70%) BGC0000399 c1
scaffold 6
Cluster 13 Nrps 230297 281765 Mitomycin biosynthetic g.c.* (3%) BGC0000915 c1
scaffold 8
Cluster 14 Transatpks 79945 198849 Rhizoxins biosynthetic g.c.* (12%) BGC0001112 c1
Cluster 15 Other 309674 350759 Pyrrolnitrin biosynthetic g.c.* (100%) BGC0000924 c1
*g.c.: “gene cluster”.
In a second group of fungi (F. verticillioides, F. oxysporum f. sp. vasinfectum, F. oxysporum f.
sp. niveum, N. rosae, B.cinerea, P. chrysogenum and I.europaea) Pf4 and Pf11 affect the growth
rate of the fungi if compared to the controls, but there was no difference in effect between Pf4
and Pf11 themselves.
In A. niger, the presence of Pf4 or Pf11 enhance, rather than inhibit, the fungus growth rate, the
difference becoming statistically different from the controls at the 7th DPI. No significant dif-
ference was observed between the Pf4 and Pf11 theses.
Finally, in  A. flavus, no statistical difference was found between Pf4 and Pf11, and between
these and the controls.
 2.2.4  Discussion
A full understanding of the dynamics and composition of the microbial communities in soil is of
paramount relevance for the establishment of biological control strategies against fungal patho-
gens. The conventional approach relies on in vitro screening of potential biocontrol agents by
evaluation of their ability to inhibit pathogen growth. As shown in this report, the bacteria selec-
ted for  the strongest  ability to  inhibit  pathogens are characterized by the production of the
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Figure 2.2.2 – Results of the statistical tests of the inhibition assays. The bars represent the dia-
meters means for Control, Pf11, Pf4 replicas observed at the last date relevant for statistical ana-
lysis (DPIend). Error bars are the standard deviation, while different letter indicate different 
means based on post hoc Tukey test at 0.01 level of significance. The number at the top right of 
each graph specify the DPIend. 
largest array of metabolite and a wider (broader) activity against a variety of fungal species: a
larger set of metabolites can allow a wider spectrum of biocontrol activity, and/or a stronger
control towards the same competitor, by exploiting different strategies simultaneously, possibly
resulting in a synergistic effect. 
Although the strains producing a wider range of secondary metabolites may result the most ef-
fective in restricting pathogen growth, it remain to be established whether or not their use is the
most profitable choice when aiming at a durable protection. The isolation from the same envir-
onment of strains that are taxonomically strictly related, yet significantly different in their inter-
action with other microorganisms, suggested that environmental demand for within species di-
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N. rosaeF. oxy. niveumF. oxy. vasinfectumF. verticillioidesP. verrucosum
B. cinerea P. chrysogenum I. europaea A. niger A. flavus
Pf11 Pf4
versity may grant to seemingly less fit bacterial strains, with narrower metabolite production
patterns, an opportunity to survive along with more competitive ones. It is tempting to speculate
that while the strong fungal growth inhibitory activity of Pf4 on one hand advocates a role of
deployment against fungal pathogens, on the other it has the potential of significantly alter the
equilibrium in the microorganism community, causing a comparably strong response that might
associate with a simplification of the community and eventual decline of the Pf4 population it-
self due to a lower ability to adapt to changing conditions. Under this view, a less impactful bac-
terium like Pf11, producing a more limited array of metabolites, might provide the conditions
for a more diverse microbial community.
The results of this work highlight the contrast  between a classification based on taxonomic
markers and one based on ecological roles; species that may appear homogeneous on a taxo-
nomical level might on the contrary present a high level of heterogeneity in terms of interactions
with other microorganisms. A dynamic equilibrium among different strains comprised in the
same species,  i.e. those that allow the maximum exploitation of competitive feature based on
secondary metabolites and those that preserve a more complex microbial community, may be
functional to the evolutionary success of the species.
An effective analysis of microbial diversity in ecological complex system needs to take into ac-
count the concepts outlined above. Although barcoding using taxonomically informative genes
such as ribosomal DNA is presently the most widely used approach to characterize complex mi-
crobial  communities,  it  severely underestimates the diversity  of  the communities.  Indeed,  it
would interesting to verify whether bacteria that are indistinguishable using rDNA and other
gene markers, but differ significantly in the genetic features that control interaction with other
microorganisms, can coexist in the same environment. When referring to P. protegens, a species
comprising strains that have a significant production of bio-active secondary metabolites, the in-
tra-species diversity and variability may play a major role in determining the composition of the
microbial community.
The cohabitation of different strains that are strictly taxonomically related and share a prevalent
fraction of their genomes, yet with significantly different secondary metabolite profiles, is func-
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tional to their continued coevolution. A continuous trade of horizontally transferred genetic ma-
terial needs to be fueled with new genetic information and, to this end, the intra-species di-
versity plays an instrumental role. According to the results presented in this paper, the produc-
tion of pyoluteorin, pyrrolnitrin, and rhizoxin, typical antibiotic metabolites in  P. protegens, is
relevant in determining the fungal growth inhibition pattern of competitive P. protegens strains.
Clusters prn, rzx and plt were found only in Pf4 scaffolds 8 and 4, along with two regions on
scaffolds 1 and 5 coding for secondary metabolites; therefore the difference between the two
strains can’t be attributed to a simple insertion event, but implies a relatively complex differenti-
ation focused on the accessory genomes. In contrast to the core genome, the evolution in the ac-
cessory genomes progresses exploiting primarily horizontal gene transfer consequent to mul-
tiple invasion of foreign DNA, that could be more or less stably integrated in the genome.  P.
protegens have the largest genomes among the bacteria of the fluorescens group and in general
among  Pseudomonas (whose genomes range from 4.17 to 8.6 Mb). Conceivably, larger gen-
omes allow to accommodate metabolic gene clusters conferring environmental fitness advant-
ages that compensate for the relax of an otherwise strict genome size constrains. In particular,
with 7.05 Mb, Pf11 stands at the high range of the genomes size allowed for the species. It can
be speculated that genome expansion (with horizontal acquisition of genes) and contraction is a
dynamic process that lead to a more stable genome. In this view, the Pf11 genome, with its lar-
ger size and the larger number of transposable elements appears to be in more dynamic evolu-
tionary stage as compared to Pf4 genome that already gained a richer pattern of secondary meta-
bolite production associated gene clusters.
 2.2.5  Acknowledgments
This research was supported by a grant (L. R. 26) from Friuli Venezia Giulia Region Adminis-
tration (Italy) and by “Ager – Agroalimentare e Ricerca” Foundation, project “Novel strategies
meeting the needs of the fresh-cut vegetable sector – ?????????”, nº 2370.
67
 2.2.6  References
Aziz, R. K. et al. (2008) ‘The RAST Server: Rapid Annotations using Subsystems Technology’, 
BMC Genomics, 9(1), p. 75. doi: 10.1186/1471-2164-9-75.
Blankenfeldt, W. and Parsons, J. F. (2014) ‘The structural biology of phenazine biosynthesis’, 
Current Opinion in Structural Biology. Elsevier Ltd, 29, pp. 26–33. doi: 
10.1016/j.sbi.2014.08.013.
Christensen, B. B. et al. (2002) ‘Metabolic Commensalism and Competition in a Two-Species 
Microbial Consortium’, Applied and Environmental Microbiology, 68(5), pp. 2495–2502.
doi: 10.1128/AEM.68.5.2495-2502.2002.
Colla, P., Gilardi, G. and Gullino, M. L. (2012) ‘A review and critical analysis of the European 
situation of soilborne disease management in the vegetable sector’, Phytoparasitica, 
40(5), pp. 515–523. doi: 10.1007/s12600-012-0252-2.
Couillerot, O. et al. (2009) ‘Pseudomonas fluorescens and closely-related fluorescent pseudo-
monads as biocontrol agents of soil-borne phytopathogens’, Letters in Applied Microbio-
logy, 48(5), pp. 505–512. doi: 10.1111/j.1472-765X.2009.02566.x.
Darling, A. C. E. (2004) ‘Mauve: Multiple Alignment of Conserved Genomic Sequence With 
Rearrangements’, Genome Research, 14(7), pp. 1394–1403. doi: 10.1101/gr.2289704.
Gross, H. and Loper, J. E. (2009) ‘Genomics of secondary metabolite production by Pseudomo-
nas spp.’, Natural Product Reports, 26(11), p. 1408. doi: 10.1039/b817075b.
Handelsman, J. and Stabb, E. V (1996) ‘Biocontrol of soilborne plant pathogens’, Plant Cell, 8, 
pp. 1855–1869.
Hense, B. A. et al. (2007) ‘Does efficiency sensing unify diffusion and quorum sensing?’, 
Nature reviews. Microbiology, 5(3), pp. 230–9. doi: 10.1038/nrmicro1600.
Hibbing, M. E. et al. (2010) ‘Bacterial competition: surviving and thriving in the microbial 
jungle.’, Nature reviews. Microbiology. NIH Public Access, 8(1), pp. 15–25. doi: 
10.1038/nrmicro2259.
Johnson-Henry, K. C. et al. (2007) ‘Surface-layer protein extracts from Lactobacillus helveticus
inhibit enterohaemorrhagic Escherichia coli O157:H7 adhesion to epithelial cells.’, Cellu-
lar microbiology, 9(2), pp. 356–67. doi: 10.1111/j.1462-5822.2006.00791.x.
Kannan, V. and Sureendar, R. (2009) ‘Synergistic effect of beneficial rhizosphere microflora in 
biocontrol and plant growth promotion’, Journal of Basic Microbiology. WILEY‐VCH 
Verlag, 49(2), pp. 158–164. doi: 10.1002/jobm.200800011.
68
Khan, A. et al. (2006) ‘Differential cross-utilization of heterologous siderophores by nodule 
bacteria of Cajanus cajan and its possible role in growth under iron-limited conditions’, 
Applied Soil Ecology, 34(1), pp. 19–26. doi: 10.1016/j.apsoil.2005.12.001.
Loper, J. E. et al. (2012) ‘Comparative Genomics of Plant-Associated Pseudomonas spp.: In-
sights into Diversity and Inheritance of Traits Involved in Multitrophic Interactions’, 
PLoS Genetics. Edited by D. S. Guttman, 8(7), p. e1002784. doi: 
10.1371/journal.pgen.1002784.
Lyon, G. J. and Novick, R. P. (2004) ‘Peptide signaling in Staphylococcus aureus and other 
Gram-positive bacteria.’, Peptides, 25(9), pp. 1389–403. doi: 
10.1016/j.peptides.2003.11.026.
Mavrodi, D. V. et al. (2010) ‘Diversity and Evolution of the Phenazine Biosynthesis Pathway’, 
Applied and Environmental Microbiology, 76(3), pp. 866–879. doi: 10.1128/AEM.02009-
09.
Mazzola, M. (2002) ‘Mechanisms of natural soil suppressiveness to soilborne diseases’, Antonie
van Leeuwenhoek, 81(1/4), pp. 557–564. doi: 10.1023/A:1020557523557.
Moruzzi, S. et al. (2017) ‘Genomic-assisted characterisation of Pseudomonas sp. strain Pf4, a 
potential biocontrol agent in hydroponics’, Biocontrol Science and Technology, 27(8), pp.
969–991. doi: 10.1080/09583157.2017.1368454.
Nicholson, A. (1954) ‘An outline of the dynamics of animal populations.’, Australian Journal 
of Zoology, 2(1), p. 9. doi: 10.1071/ZO9540009.
Van Os, E. A. (1999) ‘Closed soilless growing systems: A sustainable solution for Dutch green-
house horticulture’, Water Science and Technology, 39(5), pp. 105–112. doi: 
10.1016/S0273-1223(99)00091-8.
Paulitz, T. C. and Bélanger, R. R. (2001) ‘Biological control in greenhouse systems’, Annual 
Review of Phytopathology, 39(1), pp. 103–133. doi: 10.1146/annurev.phyto.39.1.103.
Paulsen, I. T. et al. (2005) ‘Complete genome sequence of the plant commensal Pseudomonas 
fluorescens Pf-5’, Nature Biotechnology, 23(7), pp. 873–878. doi: 10.1038/nbt1110.
Péchy-Tarr, M. et al. (2008) ‘Molecular analysis of a novel gene cluster encoding an insect 
toxin in plant-associated strains of Pseudomonas fluorescens’, Environmental Microbio-
logy, 10(9), pp. 2368–2386. doi: 10.1111/j.1462-2920.2008.01662.x.
Pinheiro, J. et al. (2017) ‘nlme: Linear and Nonlinear Mixed Effects Models’. Available at: ht-
tps://cran.r-project.org/package=nlme.
69
Raaijmakers, J. M. et al. (2009) ‘The rhizosphere: a playground and battlefield for soilborne 
pathogens and beneficial microorganisms’, Plant and Soil, 321(1–2), pp. 341–361. doi: 
10.1007/s11104-008-9568-6.
R Development Core Team (2007) ‘R: a Language and Environment for Statistical Computing’. 
Vienna, Austria: R Foundation for Statistical Computing. Available at: http://www.r-pro-
ject.org.
Rankin, L. (1994) ‘Evaluation of Rhizosphere Bacteria for Biological Control of Pythium Root 
Rot of Greenhouse Cucumbers in Hydroponic Culture’, Plant Disease, 78(5), p. 447. doi: 
10.1094/PD-78-0447.
Scortichini, M. et al. (2013) ‘A Genomic Redefinition of Pseudomonas avellanae species’, 
PLoS ONE. Edited by D. Arnold, 8(9), p. e75794. doi: 10.1371/journal.pone.0075794.
Simão, F. A. et al. (2015) ‘BUSCO: assessing genome assembly and annotation completeness 
with single-copy orthologs’, Bioinformatics, 31(19), pp. 3210–3212. doi: 10.1093/bioin-
formatics/btv351.
Stubbendieck, R. M. and Straight, P. D. (2016) ‘Multifaceted Interfaces of Bacterial Competi-
tion’, Journal of Bacteriology. Edited by W. Margolin. American Society for Microbio-
logy, 198(16), pp. 2145–2155. doi: 10.1128/JB.00275-16.
Tritt, A. et al. (2012) ‘An Integrated Pipeline for de Novo Assembly of Microbial Genomes’, 
PLoS ONE. Edited by D. Zhu, 7(9), p. e42304. doi: 10.1371/journal.pone.0042304.
Vallance, J. et al. (2011) ‘Pathogenic and beneficial microorganisms in soilless culture’, Agro-
nomy for Sustainable Development, 31, pp. 191–203.
Weber, T. et al. (2015) ‘antiSMASH 3.0—a comprehensive resource for the genome mining of 
biosynthetic gene clusters’, Nucleic Acids Research. Oxford University Press, 43(W1), 
pp. W237–W243. doi: 10.1093/nar/gkv437.
Weller, D. M. (2007) ‘Pseudomonas Biocontrol Agents of Soilborne Pathogens: Looking Back 
Over 30 Years’, Phytopathology, 97(2), pp. 250–256. doi: 10.1094/PHYTO-97-2-0250.
Xavier, J. B. and Foster, K. R. (2007) ‘Cooperation and conflict in microbial biofilms.’, Pro-
ceedings of the National Academy of Sciences of the United States of America, 104(3), pp.
876–81. doi: 10.1073/pnas.0607651104.
Youard, Z. A. et al. (2007) ‘Pseudomonas fluorescens CHA0 Produces Enantio-pyochelin, the 
Optical Antipode of the Pseudomonas aeruginosa Siderophore Pyochelin’, Journal of 
Biological Chemistry, 282(49), pp. 35546–35553. doi: 10.1074/jbc.M707039200.
70
 2.3  Genomic structural variations during clonal expansion of Pseudo-
monas syringae pv. actinidiae biovar 3 in Europe
Authors: Giuseppe Firrao1-2, Emanuela Torelli1, Cesare Polano1, Patrizia Ferrante3,
Francesca Ferrini1, Marta Martini1, Marco Scortichini3, Paolo Ermacora1.               
Manuscript submitted to “Frontiers in Microbiology”.
1 Dipartimento di Scienze Agroalimentari, Ambientali e Animali – Università di Udine – 33100
Udine, Italy
2 Istituto Nazionale Biostrutture e Biosistemi, Italy
3 Council for Agricultural Research and Analysis of Agricultural Economics (CREA), Research
Centre for Olive, Fruit Trees and Citrus; Via di Fioranello 52, I-00134 Roma, Italy.
 2.3.1  Summary
Pseudomonas syringae pv. actinidiae (Psa) biovar 3 has caused worldwide pandemic bacterial
canker of Actinidia chinensis and A. deliciosa since 2008. In Europe, the disease spread rapidly
in the kiwifruit cultivation areas from a single introduction from China. In this study, we invest-
igated the genomic diversity of Psa biovar 3 strains during the primary clonal expansion in
Europe using single molecule real-time (SMRT), Illumina and Sanger sequencing technologies.
By comparing the genome sequences obtained from strains isolated from symptomatic kiwifruit
tissue, we showed that despite the modest changes in terms of nucleotide polymorphysms, struc-
tural variations based on rearrangements of genetic elements occur frequently in the population
of Psa biovar 3 undergoing clonal expansion in Europe. We recorded evidences of frequent mo-
bilization and loss of transposon Tn6212, large chromosome inversions, and ectopic integration
of  IS sequences (remarkably ISPsy31 and ISPsy37) that,  at  least  in  one case,  interrupted a
pathogenesis related gene cluster and caused the loss in the ability to cause hypersensitivity re-
action (HR) on tobacco and eggplant leaves. The evidence of gene loss in variant strains with
reduced virulence in Europe is in streaking contrast with the emergence in New Zealand of cop-
per resistant variant strains characterized by gene gain.
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This divergence may be due to different environmental conditions or to the adoption of different
strategies in the management of the epidemics.
 2.3.2  Introduction
Pseudomonas syringae pv. actinidiae (Psa) is the causal  agent of bacterial  canker  of green-
fleshed  (Actinidia  deliciosa)  and  yellow-fleshed  kiwifruit  (A.  chinensis)  (Scortichini  et  al.,
2012). The pathogen was first isolated in Japan (Takikawa et al., 1989), where the disease was
reported since 1984 and, subsequently, in Italy (Scortichini, 1994) and South Korea (Koh et al.,
1994). In the years 2008–2011, sudden and repeated epidemics of bacterial canker developed
firstly in central Italy (Balestra et al., 2009; Ferrante and Scortichini, 2009; Ferrante and Scor-
tichini, 2010), and, subsequently, in all the other major areas of kiwifruit cultivation such as
New Zealand (Everett et al., 2011), and Chile (EPPO, 2016). In Europe, the epidemics spread to
Portugal, France, Spain, Switzerland, Germany, Slovenia and Greece (Abelleira  et al.,  2011;
Cunty et al., 2015b; Dreo et al., 2014; EPPO, 2016; Holeva et al., 2015).
Genomic and genetic analyses have soon revealed that the Psa strains causing the 2008–2011
epidemics differed significantly from those previously found in Italy (Marcelletti  et al., 2011)
and that the first outbreaks of kiwifruit bacterial canker in Italy were caused by a rapid and
clonal expansion of the pathogen in the cultivated areas (Marcelletti and Scortichini, 2011 ).
Then, the availability of strains isolated in China, the area of origin of many Actinidia spp., and
the intensive use of Illumina sequencing of bacterial genomes (Butler et al., 2013; Mazzaglia et
al., 2012; McCann et al., 2013; McCann et al., 2017) and VNTR analysis (Ciarroni et al., 2015;
Cunty et al., 2015a, Cesbron, et al., 2015) paved the way to the understanding of the epidemi-
ology of this important disease.
At present, Psa is subdivided into four biovars, three of which with distinct phylogeographic
structure. Biovar 1 produces phaseolotoxin and has been isolated in Japan and Italy before 2008.
Biovar 2 produces coronatine instead of  phaseolotoxin and has been isolated only in South
Korea. Biovar 3 produces neither phaseolotoxin nor coronatine and is responsible for the global
outbreak of bacterial canker of kiwifruit in recent years. Biovar 5 does not produce phaseolo-
toxin  nor  coronatine,  but  unlike  biovar  3  it  is  found only in  the Saga  Prefecture  of  Japan
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(Fujikawa and Sawada, 2016). A fifth clade, initially identified as Psa biovar 4, has been re-
cently described as a new pathovar, P.s. pv. actinidifoliorum (Cunty et al., 2015b; Ferrante and
Scortichini, 2015). Genome analysis performed so far is consistent with the hypothesis that all
Psa biovars originated independently from a single natural source population and established
subsequent  outbreaks  on  cultivated  kiwifruit.  McCann  et  al. (2013)  highlighted  the  overall
clonal population structure with signatures of within-pathovar, intra-biovar recombination. 
Psa biovar 3 is distinct from other biovars for the virulence and the sudden world-wide epidemic
spread, that has unveiled major weakness of our kiwifruit cultivation system, while calling for
efforts in the clarification of its dynamics in view of future prevention. Several genome-wide di-
versity studies revealed that epidemics in Europe, New Zealand and Chile of Psa biovar 3 ori-
ginated from independent introductions of a single founder variant from China (Butler  et al.,
2013; Mazzaglia et al., 2012; McCann et al., 2013) which, however, is not considered the center
of origin of the biovar 3 (McCann et al., 2016). 
In this work, we examined a sampling of the Psa population originated in Europe from the pu-
tative single introduction occurred in 2008. Through the analysis of Illumina sequence data-sets
of 11 European and one non-European Psa genomes, and through the reconstruction and com-
parison of two complete genomes, a picture emerged that accounts for the significant differ-
ences in the pathways of genome evolution of this bacterium before and after the clonal expan-
sion associated with the pandemic. DNA mobilization due to transposable elements was a major
cause of structural differences and, at least in one case, resulted in the disruption of genes relev-
ant in pathogen-host interaction, with a factual reduction of strain virulence on kiwifruit.
 2.3.3  Results and discussion
Differential HR response of Psa CRAFRU 12.29 is due to insertional inactivation of the
hrp gene cluster
Psa biovar 3 strains isolated in different regions of Europe were investigated to assess their
phytopathogenic and genomic diversity. While most strains, as expected, induced HR in egg-
plant and tobacco leaves when infiltrated at concentrations of 1–2∙108 cfu/ml, strains CRAFRU
12.50 and CRAFRU 12.29 failed in eliciting HR (not shown). Strains CRAFRU 12.50 and
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CRAFRU 12.29 were also compared with the reference strain CRAFRU 8.43 in their ability to
colonize  A. chinensis leaves. Visual observations clearly revealed differences between CRA-
FRU 8.43 (HR+), that caused leaf spots, on one hand, and CRAFRU 12.29 (HR–) and CRA-
FRU 12.50 (HR–), on the other, that failed in inciting foliar symptoms. The estimate of bacterial
concentration in leaves 22 days after inoculation, reported in Figure 2.3.1, showed that the pop-
ulation sizes of strain CRAFRU 12.29 and CRAFRU 12.50 did not increase during the assay
time, while those of the virulent strain CRAFRU 8.43 peaked up to 100 times the inoculum.
Thus, although the bacterial populations of HR– strains did not increase as much as the wild
type, the bacteria remained detectable after 22 days. Further experiments carried out on microp-
ropagated plantlets inoculated by dipping, revealed that the CRAFRU 12.29 cells move within
the stem and were detectable by PCR in the stem segments above the point of inoculation 10
days after the dipping (results not shown).
Furthermore, a preliminary SNPs analysis, based on Illumina sequencing data, suggested that
one of the HR– strains, namely CRAFRU 12.29, was highly similar, if not identical, to a HR+
strain, namely CRAFRU 14.08. Hence, the genome sequences of strains CRAFRU 14.08 and
CRAFRU 12.29 were completed by SMRT (Single Molecule, Real Time) and Sanger sequen-
cing. The resulting finished chromosomes, as shown in the alignment of Figure 2.3.2, differ for
several structural features.
Figure 2.3.1 – A. Symptoms on kiwifruit leaves 2 days (a, b, c) and 15 days (d, e, f) after inocu-
lation with CRAFRU 8.43 (a, d), CRAFRU 12.29 (b, e) and CRAFRU 12.50 (c, f). B. Popula-
tion dynamics of Psa strains CRAFRU 8.43 (HR+), CRAFRU 12.29 (HR–) and CRAFRU 12.50
(HR–) after inoculation of kiwifruit leaves.
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Figure 2.3.2 – Mauve alignment of the chromosomes of strains ICMP 18884, CRAFRU 14.08,
and CRAFRU 12.29.
First  of  all,  CRAFRU  14.08  displays  a  large  inversion  of  about  half  of  the  chromosome
(3,637,997 nts) as compared to CRAFRU 12.29. The inversion occurred by recombination of
the two identical copies of the gene encoding an integrating conjugative element protein of the
PFL_4705 family that are located, together with some other complete and incomplete copies, at
position  1850000-1858000  and  5488000-5500000  in  the  chromosome  of  CRAFRU  12.29.
Chromosome inversions  have  been  reported  to affect  gene  expression  and  occasionally  the
phenotype (Cui et al., 2012). However, whether or not the large genome inversion in CRAFRU
14.08 is associated with phenotype could not be determined in the present study. 
The second major difference in strain CRAFRU 12.29 concerns a 1700 bp integrative sequence,
encoding an integrase and an IS3/IS911 transposase. This small integrative unit was inserted in
the hrpS gene, within a transcriptional unit that spans several components of the type III secre-
tion system, including the gene encoding harpin,  hrpZ  (Figure 2.3.3). Since, according to an-
notation and Blast searches, there are no other copies of hrpZ in the genome of Psa CRAFRU
12.29, the lack of expression of hrpZ may conceivably be the reason for the reduced virulence
on kiwifruit and inability to elicit HR on eggplant and tobacco leaves. The phenotype is indeed
reminiscent of previously characterized hrpZ deletion mutants (He et al., 1993).
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Figure 2.3.3 – Drawing of part of the Hrp cluster of Psa, with the location of the insertion of
ISPsy31 in strain CRAFRU 12.29. 
The mobilization of IS3/IS911 elements has been already reported by Butler et al. (2013), who
found  that  in  the  comparison  of  Pac_ICE1  from four  New  Zealand  strains  (ICMP 18708,
ICMP18800, TP1 and 6.1) the presence of an IS element of the type IS3/IS911 in strain 6.1 was
the only difference. They designated this small transposable element ISPsy31 at the IS Finder
database (Siguier et al., 2016) and we will follow this nomenclature. Also, as remarked by But-
ler et al. (2013), ISPsy31 is predicted to have two, partially overlapping reading frames associ-
ated with a 21 frame shift (the typical pattern found in IS3/IS911 type elements). While this
shift encodes no functions other than those involved in its mobility, yet it may still significantly
impact the behavior of the pathogen in its interaction with the host. 
There are many copies of ISPsy31 in the Psa genome. In strain CRAFRU 12.29 we counted 52
completed and five incomplete copies in the chromosome, and two complete copies in the plas-
mid. With the notable exception of the one interrupting  hrpS, all other ISPsy31 copies are in
corresponding positions in the chromosomes of strains CRAFRU 12.29 and CRAFRU 14.08.
On the other hand, strain CRAFRU 14.08 genome displays (position 5223542-5224799) the in-
sertion of another IS element of the IS3/IS911 family, related to but well distinct from ISPsy31,
and designated as ISPsy37 at the ISFinder database (Siguier et al., 2016). There are two copies
of this transposon in CRAFRU 14.08, and only a single occurrence in CRAFRU 12.29. 
Finally, one variation associated with variable number tandem repeats (VNTR) was also scored
at positions 2787533-2786633 in CRAFRU 14.08, in additions to two unique SNPs (see below).
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Differences between the chromosomes of CRAFRU 14.08 and CRAFRU 12.29 are summarized
in supplementary Table 6.2.2.
Structural diversity in the chromosomes of the European population of Psa biovar 3
The availability of finished genomes of European Psa isolates allowed to precisely map SNPs in
additional 10 genomes (Table 2.3.1) of strains isolated in Europe, using Illumina data, as sum-
marized in Table 2.3.2. Accordingly, a single SNP between the chromosomes of strains CRA-
FRU 14.08 and CRAFRU 12.29 was scored, at position 39328331 in CRAFRU 14.08. Compar-
ison of the two finished chromosome sequences using MUMmer (Delcher et al., 2002) revealed
an additional SNP at position 2736260; that position corresponds to a transposase gene that is
present in several copies in the genome and therefore was not detectable by reads mapping (sup-
plementary Table 6.2.2). In summary, the SNP comparison of the 12 European Psa genomes re-
vealed that they differ from each other in 0 to 8 sites, on a total of 19 polymorphisms detected. 
The SNP analysis reported here supports the assertion of Butler et al. (2013) that the clonal pop-
ulations in New Zealand and Chile are undergoing divergence, but as yet the frequency of idio-
syncratic SNPs is less than one per Mb. A similar rate was determined in this work for European
strains, as it was also anticipated by Mazzaglia et al. (2012). However, these figures are signific-
antly lower than those reported by McCann et al. (2013) who identified 28-70 polymorphisms
among the four Italian strains included in their study. The explanation of this inconsistency may
lay in the fact that for three out of the four strains compared by those Authors, they used the
data from de novo draft assemblies deposited in the database by Marcelletti (Marcelletti et al.,
2011), Butler (Butler et al., 2013), and Mazzaglia (Mazzaglia et al., 2012), respectively, and de
novo assembly is much more error prone than the conservative read mapping method used in
this work. 
Mazzaglia and co-workers (2012) identified the presence, in the chromosome of Psa, of a diver-
gent genomic island  ∼100 kb long, similar to PPHGI-1, an integrative conjugative elements
(ICE) described earlier in P. syringae pv. phaseolicola (Pitman et al., 2005), and also similar to
PsyrGI-6, an ICE of P. syringae pv. syringae B728a (Feil et al., 2005). The genomic island was
analyzed in more detail  by  Butler  et  al. (2013),  who named Pac_ICE2 the type shared  by
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European strains of Psa (in contrast with Pac_ICE1, for New Zealand strains, Pac_ICE3, for
Chilean).
Butler et al. (2013) reported that the islands in ICMP 18708 (New Zealand), ICMP 18744 (Italy)
and ICMP 19455 (Chile) were broadly synthenic, although the sequences shared by the ICEs
were significantly divergent (∼85% identical). Two regions with high conservation were detec-
ted, corresponding to transposons named Tn6211 and Tn6212. While Tn6211 occupies distinct
positions in each of the three ICE types, the second conserved region (bases 55201–71516 in
Pac_ICE1 from ICMP 18708), designated Tn6212 and almost identical in all ICEs, was syn-
thenic in the three ICE types. 
Mapping of Illumina reads examined in this work revealed two distinct  types of  Pac_ICE2
among the 12 European Psa genomes. The Illumina reads from five strains (namely CRAFRU
12.50, CRAFRU 12.29, CRAFRU 14.21, CRAFRU 14.08, and CRAFRU 13.27) did not cover
the about 16.3 kbp of  Tn6212 (Figure 2.3.4).  “Split  reads” containing Tn6212 flanking se-
quences were also found suggesting that the transposon was excised. 
Figure 2.3.4 – Evidence of integration/excision of Tn6212. Left: Agarose gels of PCR amplific-
ation products  with primers that  amplify the upstream transposon junction,  the downstream
transposon junction, and the chromosome region resulting from excision (from left to right, as
indicated in the top scheme of PCR primers positions).  Right: density of reads mapping on
Tn6212 and flanking regions. The numbers indicate the CRAFRU strains. 
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PCR carried out with primers placed on the borders of Tn6212 (Figure 2.3.4) provided confirm-
ation of the excision and loss of Tn6212 in the named five strains: with their DNA extracts as
templates, both the PCRs with primers located on left end of Tn6212 and flanking region, and
the PCRs with primers located on right end of Tn6212 and flanking region, failed to amplify a
DNA fragment of the expected size. Conversely, PCRs with primers specific for the left and
right flanking regions amplified a DNA fragment that was 686 bp in length, i.e. lacking the
Tn6212 sequence. Unexpectedly, the DNA samples from the other strains were positive not only
to PCRs designed to amplify the ends of Tn6212 and flanking regions, but also primed amplific-
ation of the 686 bp DNA fragment with primers specific for the left and right flanking regions. 
Since the DNA samples were prepared from 24 hrs old liquid cultures started from single colon-
ies, we hypothesize that Tn6212 may occur with high frequency in vitro, so that at the time of
DNA extraction the sample contained a mixture of genomes with and without Tn6212 integra-
tion. A similar hypothesis may explain the incongruity of the results concerning strain CRAFRU
14.25, that showed reads coverage of the Tn6212 region but no amplification products with
primers located on its ends. Since the sequencing was carried out more than one year before
PCRs, we hypothesize that subculturing ultimately selected genomes missing Tn6212.
The evidence of optional and frequent excision of Tn6212 raised the question of its potential
role in the interaction with the plant host, that could warrant its maintenance in the pathogen
population over time and its detection in fresh isolates.
Tn6212 has been reported to be the Psa specific part that distinguished ICEs of Psa and Ps. syr-
ingae pv. phaseolicola (Psp). McCann et al. (2013) pointed out the presence within the Tn6212
region of genes that may be implicated in the interaction with the plant host, such as those en-
coding a predicted enolase and various transporters, including an ortholog of DctT (a putative
di- carboxylic acid transporter with N-terminus predicted to be targeted to the Type III Secretion
System) and a methyl-accepting chemotaxis protein predicted to be involved in taxis toward
malate. 
In an attempt to detect differences in virulence and within-plant movement of strains, we inocu-
lated plantlets with strain CRAFRU 8.43 and CRAFRU 14.08 and, after 10 days incubation, es-
timated by qPCR the bacterial population in the point of inoculation (“bottom” in Figure 2.3.5)
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and in the stem segment 3 cm above (“Top” in Figure 2.3.5). Although the bacterial cell number
estimated of CRAFRU 8.43 were higher, the detected difference was not statistically significant.
The optional excision of Tn6212 is the only significant variation in ICE2 among the 12 gen-
omes examined. In fact, ICE2 resulted identical in all strains except for a single polymorphism
in strain CRAFRU 10.29 at position 51525.
Furthermore, we examined the results of Illumina re-sequencing of all Psa strains with the aim
of discovering new genes possibly acquired during clonal expansion. Following read mapping
on the complete genome of strain CRAFRU 12.29, we selected and assembled the Illumina
reads that were not mapped. After filtering for Tn6212 (missing in the reference) sequences, we
obtained in total 175 contigs for a total of 105,000 nts.  The encoded aminoacids sequences
whose function could be recognized according to RAST annotation were exclusively phage as-
sociated proteins (Table 2.3.S4, see Supporting Information). Hence, we could find no evidence
of gene gain in our sample of 12 European genomes, reveling a picture divergent from that de-
scribed by Colombi et al. (2017) who showed the acquisition by strains isolated in New Zealand
of exogenous integrative conjugative elements carrying copper resistance genes during clonal
expansion. 
Figure 2.3.5 – Boxplot of the estimated bacterial population in the upper (“Top”) and lower
(“Bottom”) part of the stem 10 days after inoculation with strains CRAFRU 8.43 and CRAFRU
14.08.
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To confirm that genome diversity in the European strains is mostly due to rearrangement of ge-
netic elements, the Illumina dataset was used to investigate structural changes in the chromo-
somes of the collections of 10 European strains. The detection of structural changes, in most
cases associated with repetitive sequences, is challenging when using short Illumina reads data-
sets, hence we used different approaches to highlight clues of rearrangement events. 
We mapped the Illumina reads from all strains on both the CRAFRU 12.29 and CRAFRU 14.08
chromosomes and visualized the alignments in the regions covering the structural changes that
differentiate those chromosomes among themselves. As a result, we found that the ISPsy31 in-
sertion in CRAFRU 12.29, as well as the ISPsy37 insertion and the large inversion in CRAFRU
14.08 were unique in the respective strain chromosomes and not shared by any other of the re-
maining European strains. We therefore focused on the detection of specific structural changes
in the chromosomes of the other strains.
To this end, we prepared an inventory of the mobile elements that can be detected in the two
complete chromosomes of European Psa, CRAFRU 12.29 and CRAFRU 14.08 (supplementary
Table 6.2.5), then mapped their ends on the assemblies of other strains to detect traces of trans-
poson mobilization. By using this approach, we found contigs ending with sequences associated
with mobile element borders that were not present in the reference chromosome. In particular,
we found IS3 related sequences in unique positions in CRAFRU 12.64 and CRAFRU 8.43, and
an IS3 related sequence present in the same position in both CRAFRU 13.27 and CRAFRU
10.29.
The assemblies were also scaffolded using CRAFRU 12.29 genome as a reference and visual-
ized, allowing the detection of an inversion around position 5508000 (CRAFRU 12.29 number-
ing) in strain CRAFRU 8.43. 
Comparison of chromosomes of European vs. New Zealand Psa biovar 3 strains
The comparison of the European strain CRAFRU 12.29 and the two complete genomes of New
Zealand isolates that were available from NCBI in October 2016, i.e. strains ICMP 18708 and
ICMP 18884, showed substantial syntheny of the chromosomes (Figure 2.3.2). 
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As previously noticed the sequences diverged largely in the ICE region, and much less in the
rest of the genome. As it has already been reported for other strains (Butler et al., 2013) the ICE
is inserted in a different lysine tRNA site in the genomes of European Psa strain CRAFRU
12.29 and in the New Zealand strain ICMP 18708.
Apart from the ICE region, the chromosomes of the two New Zealand strains were identical ex-
cept for seven SNPs (including single nucleotide indels), according to the results of direct com-
parison using MUMmer (Delcher et al., 2002) and Mauve (Darling et al., 2004). Two of the in-
dels  occurred  in  homopolynucleotide  stretches  and  were  not  confirmed  by  our  Illumina
sequencing and reads mapping of strain ICMP 18884. Thus, the number of single nucleotide
variations  between the  two  New Zealand  strains  were  similar  to  that  occurring  among  the
European strains. Conversely, 27 SNPs (including indels) and three sequence variations affect-
ing multiple nucleotides were detected between the European Psa strain CRAFRU 12.29 and the
New Zealand strain ICMP 18884 in the remaining (after exclusion of ICE) about 6 Mb of the
chromosome (pos 1-5410820 and 5511674-6555571, strain ICMP 18708 numbering). This find-
ing is in substantial agreement with the hypothesis that Psa strains originating the epidemics in
Chile, New Zealand and Europe were independently invaded by Pac_ICE1/3, supporting the no-
tion that this ICE may contain genetic elements that significantly affect the virulence of the
pathogen. 
In addition to SNPs, several  genome rearrangement events distinguished the genome of the
European  Psa  strain  CRAFRU 12.29  and  the  New Zealand  strains  ICMP 18708/18884,  as
presented in supplementary Table 6.2.3. Major events include the insertion of a copy of a mobile
selfish genetic element of the group named bacterial group II intron reverse transcriptase/mat-
urase in CRAFRU 12.29 at positions 1023375-1025252. Proteins in this group have an N-ter-
minal reverse transcriptase (RNA-directed DNA polymerase) domain (pfam00078) followed by
an RNA-binding maturase domain (pfam08388). This mobile element is present in 14 copies in
CRAFRU 12.29 and 13 copies in ICMP 18708/18884 genomes. 
On the other hand, ICMP 18708 and ICMP 18884 are characterized by a similar event, the inser-
tion of another distinct bacterial group II intron reverse transcriptase/maturase starting at posi-
tion 5715260 and ending at position 5717133. Also this transcriptase/maturase is present in sev-
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eral identical copies in the Psa genomes, namely 14 copies in ICMP 18708 and 13 copies in
CRAFRU 12.29, respectively. There are, in total, 54 proteins annotated as bacterial group II in-
tron reverse transcriptase/maturase in each of the two genomes in comparison. Another major
difference between the two genomes concerns an insertion of two transposase genes at positions
3287490-3288700 in a DNA region that  includes sequences encoding IS630 transposases,  a
phage  invertase  and  related  proteins  that  are  associated  with  a  316  kb  inversion  in  ICMP
18708/18884. Another IS630 insertion that is specific of ICMP 18708/18884 occurs in those
genomes at  position 6522179 – 6523356 (ICMP 18708 numbering).  In ICMP 18708/18884
there are 61 complete and five incomplete IS630 transposases, while CRAFRU 12.29 displayed
59 complete and five incomplete copies of this gene. Two minor variation associated to repeats
of variable lengths were also scored, one of which corresponding to the same repeat region that
differentiated CRAFRU 14.08 from CRAFRU 12.29. 
 2.3.4  Conclusions
Mobile DNA elements contribute to bacterial evolution, as their ability to mobilize themselves
and unrelated DNA in their proximity can lead to genome rearrangements that affect the mi-
croorganism phenotype (Bardaji  et al., 2011). Their role in improving fitness and, potentially,
pathogenicity  and  virulence of  phytopathogenic  bacteria  is  well  established  (Jackson  et  al.,
2011). Many studies stressed the role of mobile DNA dependent gene gain in pathogen popula-
tions during epidemics, leading to the differentiation and development of more adapted clones
(Holden  et al., 2009; Mutreja  et al., 2011; Petrovska  et al., 2016; Santagati  et al., 2012). Psa
biovar 3 represents a relevant example of such a process, considering the primary role of mobile
DNA mediated horizontal genetic transfer (particularly the gain of ICE) in its emergence as a
pandemic pathogen of kiwifruit, according to several studies (Butler et al., 2013; Marcelletti et
al., 2011; McCann et al., 2013; McCann et al., 2017).
However, Mobile DNA-induced mutations are often deleterious (Wu et al., 2015), and transpos-
able elements have been regarded as a sort of genomic disease (Wagner, 2009). Loss of fitness
due to the accumulation of deleterious mutations has been reported for small, obligate asexual
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populations, as these are incapable of reconstituting highly fit genotypes by recombination or
back mutation (Lynch et al., 1993; Moran, 1996). 
According to the results of a pangenomic study by Bolotin and Hershberg (2015), while non-
clonal species diversify through a combination of changes to gene sequences (gene loss and
gene gain), gene loss completely dominates as a source of genetic variation among clonal spe-
cies, for which it needs to be taken into account as a potential dominant source of phenotypic
variation. In the case of Psa biovar 3, we report here a relevant number (considering the small
sample) of transposon mediated structural variations, occasionally impairing relevant pheno-
typic aspects of the interaction with the host,  as occurred in the genome of strain CRAFRU
12.29 where a ISPsy31 insertion in the hrpS gene disrupted the functionality of the TTSS. In all
cases, structural variations implied rearrangement of genetic elements and not incorporation of
external DNA. 
There is a growing body of evidence supporting the hypothesis of two phases in the recent evol-
ution of Psa biovar 3, with a landmark in the initiation of the worldwide pandemic in 2008. The
SNP based comparisons (this work, McCann et al., 2017), as well as the evidence of independ-
ent invasions of ICE (Butler et al., 2013), suggest the conservation of within-biovar diversity in
the natural environment of the region of origin and during initial spread in China, before pan-
demic initiation. In this phase, acquisition of exogenous DNA through mobile DNA and selec-
tion for increased fitness were drivers of the evolution, promoting the emergence of adapted in-
dividuals. Also in this phase, recombination (intra- and inter-pathovar; McCann  et al.,  2013;
McCann et al., 2017) and selection limited the proliferation of transposons and the deleterious
mutations associated to DNA mobilization.
A new phase begun with the introduction of adapted highly virulent strains from China into the
kiwifruit cultivated areas in Europe, Chile and New Zealand. In Europe, Psa biovar 3 estab-
lished and spread clonally in an ecological niche lacking competitive selection, such as that rep-
resented by the highly sensitive A. chinensis cv. Hort 16A. The results of this study show that
the new phase was associated to an increase in the number of small transposons in the bacterial
genome, with rearrangements leading to gene loss rather than to gain of functions by horizontal
transfer. The data collected herein would suggest that clonal spread of the pathogen in a free
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ecological niche occurred with no access to the environmental gene pool,  with diversification
through rearrangement of genetic elements, and in the absence of the recombination-selection
process that mitigates genome degeneration associated with transposon mobilization (Bast et al.,
2016). 
While evidence of gene gain associated with the emergence of copper-resistant strains was re-
cently reported by Colombi et al. (2017) for Psa in New Zealand, in this study we report evid-
ence of gene loss and the isolation of some low virulence variant Psa biovar 3 strains. The dif-
ferent outcomes of the surveys may be related with differences in the environmental conditions
or in epidemic dynamics or disease management, such as timing of the disease spread on the ter-
ritory, introduction of tolerant cultivars, use of containment measures directed to the reduction
of the inoculum size (particularly copper treatments) or to the reduction of pathogen dispersal
and the establishment of conducive conditions for the epidemics (pruning, girdling, cultivation
under cover), prevalence of the crop in the region (Vanneste, 2017).
Modern strategies for the management of destructive epidemics, such as that caused by Psa bio-
var 3 on kiwifruit, may benefit from the awareness of their effect on short-term genome evolu-
tion and population structure of the pathogen. The results presented in this paper would suggest
that strategies that do not promote recombination and preserve the clonal structure of the invas-
ive microorganism may be associated with lower risk of developing variant strains with en-
hanced fitness or virulence.
 2.3.5  Experimental procedures
Strains and sequencing
The strains investigated in this work and their genome data accessions are listed in Table 2.3.1. 
Genomic DNA was extracted from 1 ml of 24 hrs old cultures grown in Nutrient Broth with
agitation using a Wizard DNA purification kit  (Promega Italia,  Padova, Italy)  following the
manufacturer's  instructions.  DNA was measured and checked for quality  using a NanoDrop
spectrophotometer (NanoDrop products, Wilmington, DE, USA). Illumina libraries were pre-
pared as described previously (Scortichini et al., 2013) and sent to the Istituto di Genomica Ap-
plicata (Udine, Italy) for sequencing on a Illumina Genome Analyser IIx (Illumina, USA). An
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average of 14 million single (50 nts) reads were obtained, filtered for quality using Prinseq
(Schmieder and Edwards, 2011) and further processed. The sequence reads of strain 7286, ob-
tained by Mazzaglia et al. (2012) were downloaded from the Sequence Read Archive (SRA ac-
cession  SRX105337;  https://www.ncbi.nlm.nih.gov/sra).  The  complete  genome  sequence  of
strain ICMP ICMP 18884 (Templeton et al., 2015) and ICMP 18708 (yet unpublished but made
available by Poulter, R.T.M., Poulter, G.T.M., Stockwell, P.A., Lamont, I.L. and Butler, M.I.)
were obtained from the NCBI nucleotide database and used as comparative reference for non-
European strains.
Genomic DNA extracted from strains CRAFRU 12.29 and CRAFRU 14.08 was also sent for
single molecule real-time (SMRT) sequencing to the University of Washington PacBio Sequen-
cing Services. The genomes were then completed with Sanger sequencing using a primer walk-
ing approach on PCR fragments amplified from putatively adjacent contigs ends, as resulted by
scaffolding using ICMP 18708 as a reference; fragments were sent for sequencing to Genelab,
Casaccia, Italy. Sequences were edited and manipulated using Seaview (Gouy et al., 2010) and
Ugene (Okonechnikov et al., 2012).
Sequence analysis
Preliminary reads alignments and alignments manipulation were carried out using widely used
tools such as BWA 0.5.5 (Li and Durbin, 2009), SAMtools 0.1.16 (Li et al., 2009) and PICARD
tools  (http://picard.sourceforge.net).  SNP calling  was  carried  out  with  the  GATK  package
(McKenna et al., 2010); SNPs call was supported by a depth of coverage of at least 5 and a con-
sensus of at least 95% of the aligned reads. Tablet (Milne et al., 2010) and IGV (Robinson et al.,
2011) were used for the visualization of the alignments.
Assemblies of small DNA regions were carried out with Edena (Hernandez et al., 2008). Gen-
ome reconstructed from Illumina reads were assembled with SPAdes (Bankevich  et al., 2012)
and  scaffolded  with  Ragout  (Kolmogorov  et  al.,  2014).  Alignments  were  carried  out  with
Mauve (Darling et al., 2004) and MUMmer (Delcher et al., 2002). The above listed tools were
integrated  with  several  ad-hoc Perl  scripts  into  Bash  scripts  and  run  on  Linux  instances
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launched on the infrastructures of the DIAG (http://www.igs.umaryland.edu/resources/irc/) and
CyVerse (Merchant et al., 2016) projects.
Annotation of Insertion Sequences (IS) in the complete genomes was carried out at the ISsaga
(Insertion Sequence semi-automatic genome annotation) engine (Varani et al., 2011).
Plantlet inoculations
To investigate whether or not Psa strains were impaired in their within plant spread capabilities,
micropropagated kiwifruit  plantlets  Actinidia chinensis (cv. Soreli)  at  the stage of  6 leaves,
provided by Az. Agr. Fanna Giampaolo (Moimacco, Italy) were used for plantlet inoculation.
Bacterial strains grown for 24 hrs in Nutrient Broth with agitation were washed twice and resus-
pended in 0.9% saline solution in concentration of 1–2·109 cfu/ml. Plantlets were cut from cal-
lus, dipped in the inoculum and transferred to a fresh medium. Control plants were dipped in
sterile saline. After 10 days the plantlets were collected, cut into two halves (about 3 cm from
inoculation point), and DNA was extracted from each subsample according to standard proto-
cols (Doyle and Doyle, 1990). The bacterial populations were quantified by qPCR according to
published protocol  (Gallelli  et al., 2014). For statistical analysis, carried out with R  (R Core
Team, 2013), the medians of three PCR reactions for each of five repetitions per strain was
used.
Leaves inoculations
To compare the capability of strains to induce disease symptoms and to determine their growth
in planta,  Actinidia chinensis (cv. Dorì®) leaves were inoculated with the method described
previously (Marcelletti et al., 2011). Leaf areas of approximately 1 cm in diameter were inocu-
lated at the concentrations of 1–2∙106 cfu/ml. For each thesis, 10 leaves were inoculated in four
sites. Control plants were treated using solely sterile solution (0.85 % NaCl). Two, 6, 15 and 22
days after inoculation, leaf disks of about 0.5 cm of diameter were sampled and ground in 1 ml
of sterile saline, then serial ten-fold dilutions were counted by colony growth onto nutrient agar
supplemented with 3% of sucrose (NSA).
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Hypersensitive reactions were tested by infiltrating aqueous bacterial suspensions at 1–2 x 10E8
cfu/ml on fully expanded tobacco and eggplant leaves using a needless syringe. The develop-
ment of typical hypersensitivity reaction was checked within 48 hrs after infiltration. Assays
were repeated three times.
Other wet lab methods
To determine the excised/integrated state of Tn6212, primers (supplementary Table 6.2.1) were
designed on the inner and outer borders of the transposon. PCRs with primer pairs fX1/rX2;
fX1/rX4 and fX3/rX4 were performed with the automated One Advanced thermocycler (Euro-
Clone, Celbio, Milan, Italy) in 25 μl reactions containing 200 μM of each of the four dNTPs, 0.4
μM of each primer, 1.5 mM MgCl2, 0.625 units of GoTaq Flexi DNA Polymerase (Promega,
Madison, WI, USA) and 1 μl of diluted bacterial DNA (5 ng/μl). The PCR program consisted of
initial denaturation for 2 min at 94 °C; 35 cycles of 1 min at 94 °C, 45 sec at 58 °C, 1 min at 72
°C; and a final extension for 8 min at 72 °C.
PCR products were separated by electrophoresis in a 1% agarose gel, stained with ethidium
bromide, and captured with a DigiDoc-It imaging system (UVP, Cambridge, United Kingdom).
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 3  Metagenomic approaches for the characterization of 
fastidious prokaryotes
In an ideal situation, a pathogen is isolated and cultivated for further studies and for sequencing.
Unfortunately, some microorganisms cannot be reliably cultivated in vitro, which in turns makes
it difficult to amplify them to the amount required for analyses. A typical example of fastidious
pathogens are phytoplasmas, wall-less obligate parasites of phloematic tissues, transmitted by
insect vectors; belonging to the class  Mollicutes (thus related to mycoplasmas and spiropla-
smas), they were originally identified in 1967 and named mycoplasma-like organisms (MLOs)
(Doi et al., 1967). Because of the inability to cultivate them, a step that is required by the Inter-
national Code for the Nomenclature of the Bacteria, phytoplasmas are presently classified under
the ‘Candidatus Phytoplasma’ genus (IRPCM Phytoplasma/Spiroplasma Working Team–Phyto-
plasma Taxonomy Group, 2004)
Currently, only for four phytoplasmas the finished genome sequence is available: the onion yel-
lows (Oshima et al., 2004) and the aster yellows witches’ broom phytoplasmas (both belonging
to ‘Candidatus Phytoplasma asteris’)  (Bai  et al., 2006), ‘Ca. P. australiense’ (Tran-Nguyen et
al., 2008) and ‘Ca. P. mali’ (Kube et al., 2008). Phytoplasmas genomes are among the smallest
known genomes, 600–1300 kbp long, and often lack genes encoding essential metabolic func-
tions, and cannot therefore survive outside vectors or plant phloem. Phytoplasmas have resisted
most attempts to culture them in vitro, although there are reports of successful cultivation (Con-
taldo et al., 2012). 
In the following papers, a new WGS-based in vitro pipeline to derive a Phytoplasma sequence
directly from infected samples is presented, followed by two works that employ this strategy: in
one not only was the phytoplasma isolated, but a spiroplasma was additionally identified, while
in the other it is shown that the pipeline can employ a combined reference genome to screen the
pathogen.
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 3.1.1 Abstract
A pipeline  for  the  genome assembly of  pathogens  that  cannot  be axenically  cultivated,  with  particular
reference to the plant pathogenic phytoplasmas, is presented. The  Phytoassembly pipeline uses  ????????
sequencing data produced from DNA isolated from an infected plant, using a healthy host genome reference
as a filter and exploiting the difference in coverage between the sequences of the pathogen and those of the
host.  For  phytoplasma infected  samples  containing >2-4% of  pathogen DNA and an isogenic  reference
sequence  the  resulting  assemblies  can  be  next  to  complete.  The  pipeline  has  been  benchmarked using
simulated and real ???????? runs.
Using this pipeline, high quality draft assemblies were obtained for ‘Ca. Phytoplasma aurantifolia’ strain
2034 causing Lime Witches’ Broom of Lime, the phytoplasma strain associated to Cassava Frogskin Disease
(CFSD) and that associated to Chicory Phyllody (ChiP). 
 3.1.2 Introduction
Phytoplasmas are bacterial plant pathogens that cause disease in over 100 plant families (Lee et al., 2000);
they belong to the class  Mollicutes, bacteria characterized by the absence of a cell wall, and are typically
about 200–300 nm in size, with a genome of 0.5–1.2·106 nts (Zhao et al., 2005). They live in the host phloem
cells and propagate by vectors such as insects (mainly Cicadellidae, Fulgoroidea and Psyllidae; (Weintraub
and Beanland, 2006)) and parasitic plants (Marcone et al., 1997).
Genomics of fastidious prokaryotes is made challenging by the fact that they are difficult to cultivate in vitro
(Tran-Nguyen and Gibb, 2007). For the phytoplasmas, protocols typically involve time consuming isolation
and purification of DNA from plant or insect infected tissue using CsCl equilibrium buoyant density gradient
in the presence of bisbenzimide (Saeed et al., 1994), or physical isolation by pulsed-field gel electrophoresis
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(PFGE) of entire chromosomes (Oshima et al., 2004). Currently, only for four phytoplasmas the
genomes  have  been  sequenced  to  completion:  ‘Ca. Phytoplasma  asteris’  Onion  Yellows
phytoplasma strain M (Oshima et al., 2004), ‘Ca. P. asteris’ Aster Yellows phytoplasma strain
Witches’ Broom ph. (Bai et al., 2006), ‘Ca. P. mali’ strain AT (Kube et al., 2008) and ‘Ca. P.
australiense’ strains Paa and SLY (Tran-Nguyen et al., 2008; Andersen et al., 2013). 
Genomic surveys have also been published for multiple phytoplasmas (Liefting and Kirkpatrick,
2003; Garcia-Chapa  et al., 2004; Cimerman, Arnaud and Foissac, 2006; Kawar  et al., 2010).
With the introduction of New Generation Sequencing (NGS) methods, an emerging alternative,
made possible by informatics tools, is to random sequence a large library of DNA extracted
from diseased plants and then select the sequences of the pathogen. However,  the pathogen
sequence selection is not trivial and therefore many genome drafts obtained with this approach
so far are incomplete (Casati et al., 2011; Saccardo et al., 2012; Chung et al., 2013; Davis et al.,
2013; Quaglino et al., 2013, 2015; Chen et al., 2014).
The pipeline developed here, named Phytoassembly, is an evolution of the procedure described
in  (Saccardo  et  al.,  2012) and exploits  on one hand the differential  coverage of  sequences
originating  from  the  pathogen  and  those  from the  host,  due  to  the  relative  abundance  of
pathogen genome units even in samples with less than 10% pathogen DNA, and on the other
hand the filtration of reads that map on a reference healthy plant genome assembly.
 3.1.3 Materials and methods
Design and implementation of the pipeline
A major point in the procedure presented here is that plant sequences are separated first by
setting a cutoff point based on the differential coverage of the plant (host) and the phytoplasma
(pathogen) sequence contigs resulting from a pre-assembly. Indeed, in samples collected from
phytoplasma infected plants, despite the prevalence of host DNA, the number of phytoplasma
genome copies exceed the number of host genome copies. Phytoplasma genomes sizes range
around 106 bp, while plant genomes are about 3 orders of magnitude larger (Zonneveld, Leitch
and Bennett, 2005); therefore when counting the reads in an ???????? data-set obtained from a
diseased plant sample containing 1% phytoplasma DNA, the coverage of phytoplasma DNA is
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expected  to be 10 times greater  than  the  coverage  of  the  plant  DNA.  As  the  sequence  of
phytoplasma DNA are over-represented, it would be possible to select phytoplasma reads in an
???????? data-set  from infected samples  assuming a  cutoff  in  a coverage graph;  with  data
obtained by phytoplasma enriched samples from well infected plants the peaks are distinct, but
in  many  other  cases  there  is  overlap  between  the  phytoplasma  and  the  host  peaks,  hence
determining the optimal cutoff requires an estimation, that is carried out by the program, to
ensure that all phytoplasma reads are retained during the selection.
Thus,  the first  steps  of  the pipeline consist  in  a  preassembly,  the estimation of  pre-contigs
coverage and calculation of the optimal cutoff. Then the  ???????? reads belonging to contigs
above the cutoff are selected and aligned against the healthy plant genome reference, so that
those pertaining to the plant  can be discarded and the non-plant reads can be assembled in
preliminary phytoplasma assembly.  Further  polishing is  carried  out  to  filter  out  ambiguous
contigs, originating from low-quality reads from the plant. This is based on the percentage of
indentity of  BLAST matches against the healthy plant reference, the threshold being any match
greater than 95%.
The standard procedure requires a reference genome from an uninfected plant in FASTA format
and the sequence reads from an ???????? MiSeq in ????? format. If necessary, the pipeline can
also assemble reference genome reads in  ????? format,  and it  is  possible  to also  input  the
already assembled sequence reads in ????? format. For best results, the healthy plant should be
isogenic to, and grown in the same environment as the diseased specimen, so as to match the
plant  genome  and  include  the  same  contaminants.  The  aforementioned  ????? verification
becomes a necessity if  the reference does not meet these qualities. On the other hand, it  is
possible to input a collection of reference genomes (simply by joining the relative ????? files),
e.g. to filter out known pathogens.
The pipeline is written in the Bash and Perl languages and requires  a working installation of
BioPerl (http://bioperl.org/),  NCBI Blast+ (https://blast.ncbi.nlm.nih.gov/Blast.cgi) and the A5
pipeline (Tritt  et al., 2012).  Phytoassembly has been tested on Linux Ubuntu 16.04 LTS and
Mac OS X 10.11.6.
In detail, the pipeline includes the following steps:
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Stage 0: data preparation. Phytoassembly calls the A5 pipeline to assemble the healthy plant
sequence reads (producing the file Healthy.contigs.fasta), unless an already assembled sequence
is  provided.  Next,  the  diseased  plant  reads  are  assembled  (producing  the  file
Diseased.contigs.fasta).  A  step  in  the  A5  pipeline  produces  error  corrected  reads
(Diseased.ec.fastq),  which  are  used  in  all  the  subsequent  steps.  The  assembled  reference
sequence file is then indexed and aligned with the error corrected reads using the BWA tool (Li
and Durbin, 2009). The resulting file is converted to the  bam format (Diseased.mapped.bam)
and,  using  samtools (http://www.htslib.org/doc/samtools.html), a  summary  of  statics  is
produced (Diseased.sorted.csv),  consisting of the reference sequence name, sequence length,
number of mapped and unmapped reads.
Stage 1: cutoff. The pipeline estimates the optimal cutoff value by running once with cutoff 0,
then using a fraction of the ratio between the sum of the lengths of the non-mapping reads at
cutoff 0 (Stage2.0.nonmatch.fastq, see below) and the sum of the lengths of the error corrected
reads (Diseased.ec.fastq)  of the diseased plant,  multiplied by 100.  Alternatively,  if  the user
wants to supply a range of specifies fixed cutoff values, then the pipeline repeats the following
steps from the lowest to the highest values provided (represented here as $cutoffval). From the
summary of statistical data (Diseased.sorted.csv), per-contig coverages are calculated (as the
ratio  between  the  sum  of  the  lengths  of  the  mapped  reads  and  the  length  of  the  contig,
multiplied  by  100),  and  saved  in  a  text  file  (Diseased.sorted.cov.csv).  The  contigs  with  a
coverage higher than  $cutoffval are exported to a  ????? file (Diseased.cutoff.$cutoffval.fasta,
where  $cutoffval is  e.g. “10”).  The  error-corrected  reads  from  the  diseased  plant
(Assembly.ec.fastq)  are  then  aligned  to  the  contigs  in  that  last  file  using  BWA.  From the
alignment  file  (Stage1.$cutoffval.match.sam)  the  reads  above  the  cutoff are  extracted  and
exported in a ????? file (Stage1.$cutoffval.match.fastq).
Stage 2: re-alignment and filtering.  The reads from the cutoff (Stage1.$cutoffval.match.fastq)
are now aligned with  BWA against the healthy plant reference (Healthy.contigs.fasta)  and a
????? file with the reads that do not align is exported (Stage2.$cutoffval.nonmatch.fastq). These
non-aligned reads are assembled with the A5 pipeline (Stage3.$cutoffval.contigs.fasta).
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Stage 3: Blast. A  Blast nucleotide database is  created from the reference healthy plant file
(Healthy.contigs.fasta, which could also be a combination of different references) and used to
query the contigs outputted by the previous stage (Stage3.$cutoffval.contigs.fasta) using tblastx
(translated nucleotide query vs. translated nucleotide database Blast). The results are saved in a
text  file  (Stage3.$cutoffval.contigs.csv),  which  is  then  filtered  according  to  the  identity
percentage  (IP):  entries  with  an  IP  greater  than  95%  are  attributed  to  the  plant
(Stage3.$cutoffval.contigs.plant.csv),  while  those  with  a  lower  IP  are  attributed  to  the
phytoplasma (Stage3.$cutoffval.contigs.phyto.csv). Using this last file the contigs pertaining to
the  phytoplasma  are  extracted  from  the  query  and  saved  in  a  ????? file
(Stage3.$cutoffval.phyto.fasta).
Stage 4: clean-up. Lastly, the main outputs are compressed in the gzip format, moved to a folder
(Results_$timestamp), statistical data such as contigs size and number are calculated, while the
intermediate files are moved to a sub-folder (Other_files), which also contains the assembly of
the reference and/or the diseased plant reads, unless skipped in Stage 0. If the user did not input
a cutoff value, the Results folder will contain files for cutoff 0, the calculated maximum value
and half of the maximum.
A flow chart of the Phytoassembly pipeline is provided as supplementary Figure 6.3.1.
Source of data
Genome  assemblies  of  ‘Ca. Phytoplasma  asteris’,  strain  Aster  Yellows  Witches’-Broom
(AYWB;  Bai  et  al., 2006;  accession  number  CP000061),  Milkweed  Yellows  phytoplasma
(MW1;  (Saccardo  et  al.,  2012);  accession number  AKIL00000000), Italian Clover Phyllody
phytoplasma (MA1;  (Saccardo  et al.,  2012); accession number AKIM00000000), Vaccinium
Witches’  Broom  phytoplasma  (VAC;  (Saccardo  et  al.,  2012);  accession  number
AKIN00000000) and Poinsettia branch-inducing phytoplasma strain JR1 (JR1; (Saccardo et al.,
2012);  accession  number  AKIK00000000)  were  downloaded from the  NCBI  database.  The
???????? reads data-sets of MW1 and MA1, and from ‘Ca. Phytoplasma aurantifolia’ strain
Witches’ Broom of Lime 2034 (WBDL; Siqueira Alves  et al., submitted), Cassava Frogskin
Disease associated phytoplasma (CFSD; Neves  et al., manuscript in preparation) and Chicory
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Phyllody associated phytoplasma (ChiP2; Martini  et al., in preparation) were provided by the
authors of the cited papers. 
Simulations and further data analysis
Comparisons of the assemblies were carried out using BUSCO (Simão et al., 2015), MUMmer
(Delcher  et  al.,  2002), and  OMA  (Altenhoff  et  al.,  2015).  To  benchmark  the  pipeline,  a
sequencing  experiment  was  simulated  from  an  existing  complete  phytoplasma  genome.
Artificial sequence reads were generated from a complete sequencing of AYWB, using an ad-
hoc Perl script that introduces reading errors and combines the phytoplasma and the plant reads.
Reads obtained from a healthy periwinkle in a previous work ((Saccardo  et al.,  2012); SRA
accession number  SRS356159)  were combined with the artificially  generated reads,  so that
phytoplasma reads resulted in adding 5%, 10% and 15% proportions to the plant reads.
 3.1.4 Results
Validation
As presented in the introduction, the procedure described here exploits the different coverages
of pathogen and host contigs resulting for a preliminary assembly of the ???????? reads. Figure
3.1.1 shows a coverage graphs of the contigs resulting from a preassembly of an  ‘artificial’
dataset generated from the genome of AYWB, and mixed in proportion of 15% to real ????????
reads  from  a  healthy  periwinkle.  Although  the  two  peaks  corresponding  to  the  host  and
pathogen  contigs  are  clearly  distinguishable  in  the  graph,  maximizing  the  recovery  of  the
pathogen  data  in  order  to  obtain  the  most  complete  genome  reconstruction  requires  the
estimation and use of an inclusive, cautious cutoff value. We found that an optimal cutoff value
can be estimated as 0.3 times the ratio between the sum of the lengths of the non-mapping reads
at cutoff 0 and the sum of the lengths of the error corrected reads, multiplied by 100. To test the
robustness of the pipeline with this estimate, we performed a number of tests using artificial and
real datasets.
First, the pipeline was run for cutoff values between 0 and 15 with various simulated datasets
and the size of the resulting final assemblies evaluated (Figure 3.1.2). With optimized cutoff the
pipeline recovered 88.1% (with 5% of phytoplasma reads and cutoff 2), 94.2% (with 10% of
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phytoplasma reads and cutoff 4) and 93.9% (with 15% of phytoplasma reads and cutoff 5) of the
original AYWB sequence. The number of reconstructed genes (including partials) was 711, 666
and 666, respectively, compared to 534 in the actual AYWB genome. The higher value of the
gene number in the assemblies generated by the pipeline was due to the fragmentation of genes
located at contigs ends. 
Figure 3.1.1 – Coverage graph of the artificial aster yellows phytoplasma strain witches’
broom sample  pre-assembly.  The graph,  from a  dataset  with  15% of  phytoplasma reads,
illustrates the position of the plant (left) and the phytoplasma (right) peaks. The optimal cutoff
site determined by Phytoassembly falls between the two peaks. On the x-axis is the per-contig
coverage, calculated as the ratio between the sum of the lengths of the reads aligned on the
contig and the length of the contig, multiplied by 100. On the y-axis is the number of contigs
with similar coverage. The plant peak has 111 contigs at coverage 4, the phytoplasma peak has
98 contigs at coverage 15.
As a quality evaluation, we compared the genes found in the complete AYWB genome with
those in the assembly generated by the pipeline from the dataset with 10% of phytoplasma reads
and cutoff 4 using OMA. According to the results, 59 genes of AYWB did not have an identical
counterpart in the  Phytoassembly reconstructed genome. However, 20 of those genes showed
>95% identity with a gene in the AYWB genome, the differences being due to misassembly of
genes that are present in multiple, non identical, copies. The remaining 39 genes (7%) were all
annotated as hypothetical proteins or phage associated proteins, and were characterized by low
complexity in  sequence.  In conclusion the pipeline provided suitable  data  for  the complete
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reconstruction of the genetic features of the AYWB phytoplasma, failing only in areas of the
genome with low complexity likely associated with phage integrations. 
Figure  3.1.2 – Size (in knts) of the artificial  aster yellows phytoplasma strain witches’
broom (AYWB) sequences resulting from the use of different cutoff values. Datasets have
phytoplasma/plant reads ratio of 5% (top), 10% (middle), or 15% (bottom). The vertical line
shows the optimal  cutoff  determined by  Pythoassembly.  blast  filtering did not  remove any
sequence from the output.
A second test used actual  ???????? reads of MW1 and MA1, and the results were compared
with the previously obtained assemblies  (Saccardo  et al., 2012). The reference genome used
was  a  Velvet (https://www.ebi.ac.uk/~zerbino/velvet/) assembly  from  ???????? reads  of
periwinkle.  The  reconstructed  assembly  of  MW1 was  632,844 nts  long  without  cutoff  and
631,878 nts long with a 10 cutoff (222 contigs), while the 2012 assembly comprised 583,806 nts
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(158  contigs)  (Table  3.1.1); the  minimum  size  of  the  contigs  in  the  Phytoassembly
reconstructions is 307 nts (N50 6,099 nts), while in the 2012 one is 231 nts (N50 7,972 nts). The
reconstructed assembly of MA1 was 710,075 nts long without cutoff and 708,886 nts long with
a 10 cutoff (299 contigs), while the previously obtained assembly comprised 597,245 nts (197
contigs); the minimum size of the contigs in the Phytoassembly assembly is 188 nts and 184 nts
(N50 10,390 nts and 10,407 nts), while in the 2012 one is 230 nts (N50 12,309 nts). The MW1
assemblies differ on 128 contigs, 308–5477 nts in size; MA1 assemblies differ on 35 contigs,
299–1227 nts in size. 
Table 3.1.1 – Data relative to draft phytoplasma assemblies obtained with Phytoassembly.
Nucleotides Contigs Min. size Max. size N50size
N50
contigs G+C
AYWB reference 706,569 1 706,569 706,569 706,569 1 27%
AYWB 5% cutoff 0 624,492 242 398 21,808 3,987 47 27%
AYWB 5% cutoff 2 622,737 243 398 21,808 3,845 47 27%
AYWB 10% cutoff 0 673,019 111 407 137,058 30,483 7 27%
AYWB 10% cutoff 4 665,375 95 559 137,058 30,472 7 27%
AYWB 15% cutoff 0 664,899 95 512 90,316 28,048 8 27%
AYWB 15% cutoff 5 663,628 97 500 87,545 25,058 9 27%
Milkweed Yellows ph. 
(MW1) reference 583,806 158 231 22,485 7,972 26 27%
Phytoassembly MW1, 
cutoff 0 632,844 224 308 22,483 6,099 32 28%
Phytoassembly MW1, 
cutoff 10 631,878 222 307 22,483 6,099 32 28%
Italian Clover Phyllody 
ph. (MA1) reference 597,245 197 230 40,778 12,309 16 27%
Phytoassembly MA1, 
cutoff 0 710,075 296 188 39,685 10,390 20 27%
Phytoassembly MA1, 
cutoff 10 708,886 299 184 39,685 10,407 20 27%
Cassava Frogskin Disease 
(CFSD) 818,980 293 311 35,791 7,796 28 29%
‘Ca. Phytoplasma 
Aurantifolia’ (WBDL) 794,372 182 602 56,244 13,769 17 28%
Chicory Phyllody (ChiP2) 
raw 1,931,149 370 605 83,360 11,391 35 26%
Chicory Phyllody (ChiP2) 547,918 138 605 25,180 4,832 30 25%
To assess the completeness of the MA1 and MW1 genome reconstructions by Phytoassembly,
the assemblies were checked for missing conserved genes, using BUSCO. Running the program
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with the set of 14 phytoplasma genome drafts used in (Firrao et al., 2013), we generated an ad
hoc list  comprising  a  subset  of  77  BUSCOs  (conserved  genes)  that  are  common  to  all
phytoplasma genomes. As shown in Table 3.1.2, one gene was missing in the assembly of MW1
and  two  genes  were  missing  in  the  assembly  of  MA1.  It  was  therefore  estimated  that
Phytoassembly can recover >95% of the coding information of the sampled genomes. 
Table 3.1.2 – Conserved genes missing from new genome drafts built by Phytoassembly.
Assembly Missing BUSCOs Description
MA1 POG090A00A0 tRNA uridine 5-carboxymethylaminomethyl modification protein
POG090A001V ribosomal protein S15
MW1 POG090A019O signal recognition particle protein Srp54
CSFD None
CHIP2 POG090A00VB transcription termination/antitermination factor NusG
POG090A012Q ribosomal protein L35
WBDL POG090A00FL Elongation factor G
Novel drafts
Using  this  pipeline,  high  quality  draft  assemblies  of  the  WBDL,  CFSD,  and  ChiP2  were
obtained. The size of the assemblies varied from about 550,000 to about 800,000 nts (Table
3.1.1).
Each of the phytoplasma genomes reconstructed by Phytoassembly was analyzed along with the
four complete phytoplasma genomes available (Oshima et al., 2004; Bai et al., 2006; Kube et
al.,  2008;  Tran-Nguyen  et  al.,  2008) using  standalone  OMA,  in  order  to  identify  shared
orthologs. 274 ‘shared’ orthologs are present in all of the four phytoplasma genomes.
The CFSD sample was processed using a healthy cassava sample, obtaining a phytoplasma
genome assembly of 818,980 nts in 293 contigs, ranging from 311 to 35,791 nts in length (see
Table 3.1.1 for a full comparison between the samples). This sample shares 457 orthologs with
at least one of the four phytoplasmas, and 247 with all of them.
The WBDL sample was processed with an ensemble of Citrus sinensis and Citrus clementina,
because an isogenic reference was not available.  After annotation, the phytoplasma genome
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assembly was 794,372 nts long divided in 182 contigs, ranging from 602 to 56,244 nts. This
sample shares 479 orthologs with at least one of the four phytoplasmas, and 220 with all of
them. An additional about 1,000,000 nts long set of small contigs could not be attributed to the
phytoplasma nor to the plant, as they were not represented in the available Citrus genomes, but
are assumed to be specific lime repeated sequences.
The ChiP2 sample was processed using the healthy periwinkle specimen (see MW1 and MA1
above), obtaining an assembly of 1,931,149 nts. The output of the pipeline was consistently
oversized for a phytoplasma, which rarely exceeds 106 nts. It was therefore annotated using
RAST (Aziz et al., 2008), and the result showed that 1,338,982 nts (69.3%) actually belonged to
a spiroplasma, while the true phytoplasma genome was 547,918 nts (28.4%), assembled in 138
contigs, ranging from 605 to 25,180 nts. 
The check for draft completeness, carried out with BUSCO and the ad hoc conserved gene list
revealed, as shown in Table 3.1.2, that no conserved genes were missing in the CSFD assembly,
one gene was missing in the assembly of WBDL, and two genes were missing in the assembly
of Chip2.
 3.1.5 Discussion
The  Phytoassembly pipeline  successfully  addresses  the  problem  of  obtaining  the  genomic
sequences of phytoplasmas, by selectively excluding the reads of the host plant from a infected
plant  ???????? sequence data-set. It does so by first by filtering out reads with low coverage,
which can be assumed to belong to the plant, because of the vast disparity in coverage between
the plant and the pathogen genome; then by removing the reads that  can be aligned on the
healthy plant genome.
As an improvement of the procedure developed in (Saccardo et al., 2012), which required ad
hoc tuning and various manual or external steps for the de novo assembly, Phytoassembly can
carry out autonomously the complete analysis,  and relies on an assembler (the A5 pipeline)
which doesn’t require additional input from the user. The assembler is tailored for  ????????
reads, and works with paired-ends.
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The sequences that pass the re-alignment step are those that do not map on the healthy plant
reference, therefore they can only belong to genes not attributable to the plant host. While the
main aim of the Phytoassembly procedure is the isolation of phytoplasma genes, by virtue of the
mechanism  employed  it  can  also  isolate  other  non-culturable  pathogens,  or  mask  specific
pathogens by adding their genomes to the healthy plant reference. 
The pipeline attempts to determine a cutoff value using the ratio between the total length of the
non-mapping reads at cutoff 0 and the error corrected reads of the diseased plant. This ratio was
chosen because the error corrected reads exclude any ambiguous or unreliable data from the
estimation, and the non-mapping reads represent a fraction roughly proportional to the pathogen
quota in the sequencing. Using the value as is, however, leads to an excessive cutoff. Plotting
the nucleotide count  of  the phytoplasma reconstructions at  various cutoffs  (Figure  3.1.2),  a
common feature is a significant drop after a value that appears correlated to the percentage of
pathogen genome in the diseased plant specimen. Based on the results of the artificial reads test,
a more conservative estimation is obtained by using 1/3 of the aforementioned ratio.
An alternative method to determine the optimal value would be to run the pipeline at cutoff 0,
increasing the value until the last estimation has a significant drop (in the order of more than
1000 nts) in the reconstructed genome size. This however can increase the computation time
significantly, while the chosen method repeats the procedure only once. Testing different values
is  still  allowed,  simply  by  inputting  the  minimum and  maximum values  and  the  distance
between the cutoffs (e.g. from 3 to 12, with step 3, produces cutoffs 3, 6, 9, 12). 
In  conclusion,  Phytoassembly is  a  focused  tools  that  allows  a  user-frendly  and  performant
processing of  ???????? sequence data from a pair  of samples, a phytoplasma infected plant
sample  and its  uninfected  reference  sample,  outputting  a  high  quality  genome draft  of  the
pathogen. Given the increasing availability of access to ???????? technology, Phytoassembly is
expected to be a valuable help in the characterization of the genomes of the large, diverse and
economically relevant group of plant pathogens that belong to the genus ‘Ca. Phytoplasma’.
The  Phytoassembly source  code  is  available  on  GitHub  at  https://github.com/cpolano/
/phytoassembly .
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 3.2  Metagenomics highlighted mixed infection of spiroplasma and 
phytoplasma in chicory
Authors: Polano C., Moruzzi S., Ermacora P., Ferrini F., Martini M., Firrao G.
Manuscript in preparation
 3.2.1  Summary
Phytoplasma disease symptoms were  observed on chicory  in a  restricted  area  near  Carlino
(North East Italy). Preliminary analyses demonstrated the presence of a phytoplasma belonging
to pigeon pea witches’ broom (16SrIX) group. Using ???????? sequencing, we obtained a high
quality draft of the genome of the phytoplasma associated with chicory phyllody (ChiP), con-
sisting in an assembly of 126 contigs for a total length of 547,918 nucleotides. The assembly al-
lowed a clearer look to the genome-wide phylogeny of the 16SrIX group and to the secreted
protein potential and diversity of the genome. While carrying out the assembly of the phyto-
plasma it became evident that the sample used for the analysis was mixed infected by a phyto-
plasma and a spiroplasma. Preliminary field sampling actually confirmed that the two organisms
occur frequently in mixed natural infections of chicory.
 3.2.2  Introduction
In 2011 a severe outbreak of chicory phyllody has been reported in the Carlino area (Udine
province) in Friuli Venezia Giulia region (FVG, North-eastern Italy). Plants of Cichorium inty-
bus L., (chicory, family Asteraceae) showed symptoms of phyllody, virescence and proliferation
of  axillary buds. Molecular  characterization of chicory phyllody (ChiP)  phytoplasma strains
(Martini et al., 2012; Ermacora et al., 2013) based on the three genes 16S rDNA, ribosomal pro-
tein (rp, rpl22 and  rps3) and  secY showed that all the strains were nearly identical and were
closely related to strains PEY (Picris echioides yellows) and  NaxY (Naxos periwinkle vires-
cence), belonging to 16SrIX-C, rp(IX)-C1 and secY(IX) C1 subgroups (Lee et al., 2012). 
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Since the genome of the 16SrIX group phytoplasma is poorly known, in this paper we report on
our  use  of  a  metagenomic  approach  to  obtain  a  genome draft  of  the  phytoplasma causing
chicory phyllody (ChiP).
 3.2.3  Materials and methods
PCR amplification. Chicory phyllody phytoplasma (16SrIX-C) specific primers based on rp
(rpl22-rps3) and secY gene sequence alignments of 16SrIX phytoplasma strains have been used
for the diagnostic direct and nested PCR amplification of chicory phyllody phytoplasma DNA
as reported by (Martini et al., 2012), according to the published method. Spiroplasmas infection
in field chicory plants was assessed using a set of primers for spiral in gene PCR amplification
developed by Martini et al. (manuscript in preparation).
Illumina sequencing. A total of 10 mg DNA from each sample was fragmented by incubation
for 70 min with 5 µl dsDNA Fragmentase (New England Biolabs). The following steps in lib-
rary preparation were carried out as described elsewhere (Marcelletti et al., 2011). The samples
were run on an ???????? MySeq that provided paired reads of 300 nt in length, at the Istituto di
Genomica Applicata (Udine, Italy).
Phylogenetic analysis. In order to provide a solid alignment of DNA sequence a multistep pro-
cedure was set up with the development of a set of ad hoc PERL scripts. To assess the complete-
ness of the MA1 and MW1 genome reconstructions by  Phytoassembly,  the assemblies were
checked for missing conserved genes using BUSCO (Simão et al., 2015), which was run with a
set of 8 phytoplasma genome drafts used to generate an ad hoc list comprising a subset BUS-
COs (conserved genes) that are common to all phytoplasma genomes investigated. Orthologous
groups  that contained more than one protein for at least one genome (paralogs) were not dis-
carded. Then the alignments in each othologous group were split, sorted and re-merged in order
to identify and exclude alignment regions that contained a number of gaps higher than a cutoff
(10 gaps/50 aa. positions) and that could therefore be of uncertain alignment. The protein align-
ments were analyzed individually and as a concatenated sequence. Alignment inspection and
preliminary analyses were carried out with SEAVIEW (Gouy et al., 2010).
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Maximum likelihood analysis was carried out with PHYML (Guindon and Gascuel, 2003), using
LC as a substitution model for protein sequence analysis, respectively. Tree topologies were es-
timated using the better topology obtained using Nearest Neighbor Interchange (NNI) or Sub-
tree Pruning and Regrafting (SPR). A most parsimonious tree was used as input tree. The sup-
port of the data for each internal branch of the phylogeny was estimated using non-parametric
bootstrap with 100 replicates. 
Concatenated gene sequence data were also analyzed using split networks with the aid of the
software SPLITTREE4 (Huson and Bryant, 2006). Split networks are used to represent incompat-
ible and ambiguous signals in a data set. The median network of all most parsimonious trees
used here, is depicted as a tree with additional edges, so that the distance between two taxa is
equal to the length of the shortest path connecting them (Bandelt  et al., 1995). It is therefore
capable of highlighting taxa relationships that are not tree-like, taking in account polytomy at
branching points, i.e. the fact that one sequence may share identities with a sequence that is
more distant in the tree in positions where its neighbour sequence(s) differ(s).
For the construction of a consensus network, trees from individual protein sequence alignments
were obtained by recursively running PHYML using NNI, then processed with SPLITTREE4 us-
ing a median network construction (Holland et al., 2004). In these split networks, the lengths of
the edges are proportional to the number of gene trees in which a particular edge occurs. Thus,
the presence of boxes in the networks indicates contradictory evidence for grouping.
 3.2.4  Results and discussion
DNA sequence analysis of the Chicory with Phyllody symptoms
Field collected samples displaying phyllody symptoms were preliminary analyzed by PCR and
qPCR using phytoplasma specific primers as reported elsewhere  (Martini  et  al.,  2012).  One
sample that, according to qPCR, resulted to contain >2% phytoplasma DNA was further pro-
cessed,  as  described in methods,  for  ???????? genome sequencing.  As a results,  3,360,210
paired reads, for 1,009,810,635 nucleotides overall, were obtained. 
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The reads were assembled with the A5 pipeline (Tritt et al., 2012) and the sequences belonging
to  the  plant  (SRA accession  number  SRS356159)  were  separated  with  the  Phytoassembly
pipeline (Polano and Firrao, submitted). The pipeline produced a genome draft fragmented into
390 contigs, accounting for 1,931,149 bp. overall, that was anomalously large for the expected
phytoplasma genome. RAST annotation  (Aziz  et al., 2008) clarified that the pipeline selected
the sequences of two mollicutes, due to the presence in the annotation of a large number of se-
quences with similarity to Spiroplasma spp. genes, in addition to sequences encoding phytoplas-
mal typical proteins. Using an ad hoc Perl script, the RAST annotation result was used to sort
the contigs in three batches: one with contigs that are unambiguously assigned to phytoplasmas,
one with contigs that are unambiguously assigned to spiroplasmas, and one with contigs that
were spurious or did not allow to differentiate the sequences as belonging to the phytoplasma
(Table 3.2.1). After sorting the assemblies were separately re-submitted to RAST annotation,
since the spiroplasma have a different genetic code.
Table 3.2.1 – Assemblies data for the ChiP sample, as it was obtained from Phytoassembly and
further separated in phytoplasma and other microorganisms. Row 1 is not the sum of rows 2 and
3 because the Illumina reads were re-mapped and re-assembled after the first split.
Nucleotides Contigs Min. size Max. size G+C
Chicory Phyllody, raw 1,931,149 370 605 83,360 26%
Chicory Phyllody, phytoplasma 541,091 134 605 25,180 25%
Chicory Phyllody, spiroplasma 1,560,885 334 621 83,360 27%
 
Characterization of the phytoplasma genome
The phytoplasma genome resulting after the exclusion of non-phytoplasma sequences from the
assembly resulted 541,091 nucleotides, with the predicted encoding potential of 583 proteins.
This size is significantly larger than the recently reported genome of ‘Ca. P. phoenicium’ strain
AlmWB (Almond Witches’ Broom), another phytoplasma of the 16SrIX group. The Venn dia-
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gram in Figure 3.2.2 shows a comparison. However, comparing the predicted proteins of strains
AlmWB and ChiP (Table 3.2.2) it became apparent that the AlmWB genome draft misses a rel-
atively large number of proteins that are common to ChiP and all other phytoplasmas, hence the
difference in size between ChiP and AlmWB genome draft sequences is due to the large incom-
pleteness of the latter. Therefore the AlmWB genome draft was not used for further analyses.
Table 3.2.2 – Protein coding potential of the genome drafts of strains AlmWB and their compar-
ison with that of other ‘Ca. Phytoplasma’ species. Values with an asterisk include duplicates.
Total number of predicted proteins for ChiP 583*
Total number of predicted proteins for AlmWB 286*
Proteins shared among AlmWB and ChiP 167
Proteins shared among AlmWB, ChiP, ‘Ca. P. asteris’, ‘Ca. P. mali’
and ‘Ca. P. pruni’ 104
Proteins shared among ChiP, PWB, ‘Ca. P. asteris’, and ‘Ca. P. pruni’ 65
Proteins shared among AlmWB, PWB, ‘Ca. P. asteris’, and ‘Ca. P. pruni’ 10
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The comparison of the orthologous gene content of ChiP with three phytoplasmas as represent-
atives of other major clades, that is presented in the Venn diagram of Figure 3.2.2, shows that
there is a well conserved set of 169 core genes shared by this set of four very diverse phytoplas-
mas. The similar number of genes shared between three out of four genomes is likely a balance
between the process of individual reductive evolution of the phytoplasma from a centre of radi-
ation and the result of the intense horizontal gene trafficking. It can also be observed a relatively
high number of strain specific genes in all genomes but PWB. 
For the analysis of the genome wide phylogeny of the strain ChiP, we selected 23 gene frag-
ments from 16 genes of the core genome that were present and well conserved among the “Can-
didatus Phytoplasma” species compared (5285 aa with less than 100 indels), in order to con-
struct  a  robust  alignment  despite  the  relevant  differences  in  the  gene  sequence  of  the
phytoplasmas. According to the analyses carried out on single or a few genes that have been re-
ported widely in the literature, in the Maximum Likelihood phylogram of core genome concat-
enated gene sequences (Error: Reference source not found) ChiP phytoplasma resulted well dis-
tinct from other phytoplasmas. Strain ChiP, and thus ‘Ca. P. phoenicium’, belongs to a branch of
the phytoplasma evolutionary tree that includes ‘Ca. P. pruni’ and PWB, although is not related
to those species (strain MA1, that is related to ‘Ca. P. pruni’ is included in the trees for reference
and comparison). The evolution of the core genome of ChiP has been limitedly influenced by
exchanges and genome hybridisation with other phytoplasmas, as shown by the phylogenetic
split network of Figure 3.2.3, that has substantially a tree/like structure. The consensus analysis
of 16 trees presented in Figure 3.2.4 shows the presence of some contrasting phylogenetic in-
formation at the basis of the major branch separating PRU-PHE-PWB from other phytoplasmas,
but a substantial independent evolution.
A different picture emerges from the analysis of accessory gene content. In particular, a closer
look to the secreted proteins as predicted by SignalP provides some hints about the extensive
gene exchange among ChiP phytoplasma and other phytoplasmas.  Table 3.2.3 reports the 35
proteins predicted as secreted in the ChiP phytoplasma genome and their similarities and identit-
ies with the secreted proteins that have been found in the genomes in other phytoplasmas. As
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Figure 3.2.2 – Maximum likelihood phylogram of concatenated gene sequences.
Figure 3.2.3 – Neighbor phylogenetic network calculated on gene concatenation alignment
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Aster Yellows Witches Broom ph. (‘ Ca.  P. asteris’)
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Peanut witches broom ph.
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Figure 3.2.4 – Consensus of 16 trees.
Table 3.2.3 – Results of blast searches of ChiP proteins predicted as secreted by SignalP against
a database of phytoplasma putatively secreted proteins.
Chicory Phyllody Phytoplasma Best matching phytoplasma %similarity %identity
orf00012CHP1contig19 orf04485AP1contig1 44.26 27.87
orf00010CHP1contig19 orf00010MA1contig108 51.47 23.53
orf00001CHP1contig40 orf98840AUScontig1 56.25 28.12
orf00013CHP1contig59 orf00001VACcontig1461 94.12 88.24
orf00005CHP1contig69 orf56218AY1contig1 64.84 43.96
orf00005CHP1contig78 orf98965AUScontig1 58.33 33.33
orf00002CHP1contig80 orf04091AP1contig1 80.63 66.14
orf00005CHP1contig86 orf56572AY1contig1 83.72 71.51
orf00002CHP1contig90 orf99298AUScontig1 95.71 87.14
orf00007CHP1contig90 orf50623OYMcontig1 96.15 91.03
orf00009CHP1contig90 orf50621OYMcontig1 96.05 88.16
orf00001CHP1contig101 orf00009JR1contig524 60.98 41.46
orf00007CHP1contig118 orf98797AUScontig1 45.00 32.50
orf00001CHP1contig139 orf00002MA1contig512 97.14 91.43
orf00006CHP1contig139 orf50770OYMcontig1 94.17 87.38
orf00011CHP1contig139 orf00002VACcontig1552 79.38 61.48
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orf00009CHP1contig179 orf00002MA1contig512 97.14 91.43
orf00003CHP1contig185 orf00001MA1contig172 66.28 46.51
orf00001CHP1contig202 orf00002MA1contig512 97.14 91.43
orf00003CHP1contig223 orf00001JR1contig3782 51.06 38.30
orf00002CHP1contig223 orf98938AUScontig1 80.87 67.83
orf00002CHP1contig247 orf04489AP1contig1 50.00 31.48
orf00008CHP1contig265 orf00001VACcontig1461 94.12 88.24
orf00003CHP1contig321 orf99065AUScontig1 84.25 70.08
orf00002CHP1contig349 orf50301OYMcontig1 95.60 93.41
orf00002CHP1contig350 orf50645OYMcontig1 93.51 89.23
orf00008CHP1contig354 orf00002VACcontig1552 93.33 76.19
orf00004CHP1contig445 orf00002JR1contig142 45.14 29.86
orf00001CHP1contig509 orf00001JR1contig2836 47.25 28.57
orf00003CHP1contig635 orf00001VACcontig1461 97.69 94.10
orf00003CHP1contig851 orf50608OYMcontig1 48.84 37.21
orf00001CHP1contig891 orf00002VACcontig1552 87.85 73.83
orf00002CHP1contig1867 orf00002VACcontig1552 81.01 69.38
orf00003CHP1contig2350 orf50443OYMcontig1 64.71 35.29
orf00001CHP1contig5435 orf00002VACcontig1552 85.98 71.96
 
shown, similarities are very high, and in some cases the proteins are nearly identical to those of
phytoplasmas of the 16SrIII or 16SrII clades that, as shown above, are very distantly related
phylogenetically and genomically.
Characterization of the spiroplasma genome
The second genome draft obtained and annotated in this work resulted 1,560,885 bp in size, as-
sembled into 334 contigs, with an N50 of 13807 bp. According to a preliminary analysis based
on 16S rDNA sequence (not shown), the genome belonged to a Spiroplasma sp. that is part of
the Citri-Chrysopicola-Mirum phylogentic clade, as defined by Lo and coworkers  (Lo  et al.,
2013). Most of the plant pathogenic Spiroplasma species were assigned to this clade, including
S. citri, that causes the Citrus Stubborn Disease (Saglio et al., 1973) and S. kunkelii, that causes
the Corn Stunt Disease (Whitcomb et al., 1986). 
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The drafted genome was compared with the 8 genomes presently available for the Citri-Chryso-
picola-Mirum phylogentic  clade,  in  order to precisely determine its  taxonomic position and
highlight any peculiarity in the genome content of of the strain in comparation with its relatives.
Orthologous  search using OMA resulted in  the  identification  of  442 genes  shared  by  all  8
strains; a concatenated alignment, construced with 261 partial protein sequences including a
total of 73,856 aa with less than 365 prot indels, was used to build a Maximum Likelihood
phylogram and a Neighbor phylogenetic network (Figure 3.2.5 and  3.2.6).  According to the
phylogram based on the conserved gene sequences, the Chicory hosted Spiroplasma sp. strain
whose genome was drafted in this work (ChiSsp) is a close relative of  Spiroplasma citri. The
phylogenetic network has a tree-like structure, indicating indipendent evolution of the genomes,
with minor, if any, within clade gene exchanges.
Figure 3.2.5 – Maximum Likelihood phylogram of concatenated sequences from genomes be-
longing to the Citri-Chrysopicola-Mirum phylogentic clade.
The consensus network (Figure 3.2.7), shows the complete congruence of the phylogenetic sig-
nal and absence of any contradictory evidence for grouping.
According to the phylogenetic analysis presented above, the genomes of our ChiSsp and re-
cently sequenced (Davis et al., 2017) genome of Spiroplasma citri strain R8-A2 are closely re-
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lated.  The  alignment  of  the  genomes  (Figure  3.2.8),  obtained  with  Mauve  (Darling  et  al.,
2004) shows several genome rearrangements, despite the fragmentation of the ChiS draft into 
Figure 3.2.6 – Neighbor phylogenetic network of concatenated sequences from genomes be-
longing to the Citri-Chrysopicola-Mirum phylogentic clade.
345 contigs, that is expected to hide rearrangements occurring at contig ends, the most numer-
ous as most often the assembly stops when a repetitive sequence occours.
Moreover, in striking contraddiction with the the results from OMA just presented, a relevant
fraction of the genomes does not align: coincevaibly, an unusually large fraction of the genomes
consists in virus associated sequences that are distinct in the two genomes. Indeed, the unusu-
ally, extremely abundant presence of sequences of viruses, particularly plectoviruses, in the gen-
ome of  Spiroplasma citri has been reported and it is a well known obstacle that delayed the
completion  of  the  organism  genome  sequence  determination  for  a  long  time  (Carle  et  al.,
2010) until the availability of the SMRT sequencing technology (Davis et al., 2017).
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To understand the functional differences in the two genomes we compared the predicted pro-
teome of the two strains. The S. citri R8-A2 genome encodes 1812 proteins, among which 1061
are annotated as hypothetical  proteins.  In the remaining 751 proteins,  118 are  annotated as
preudogenes. Conversely, the ChiSsp genome encodes 1994 proteins, among which 1027 are  
Figure 3.2.7 – Consensus network, showing the complete congruence of the phylogenetic signal
and absence of any contradictory evidence for grouping.
Figure 3.2.8 – Mauve alignment between Spiroplasma citri strain R8-A2 and Chicory Spiro-
plasma sp. (ChiS).
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annotated as hypothetical proteins. In the remaining 967 proteins, we estimated that at least 159
are preudogenes. 
A preliminary orthologous search using OMA of annotated proteins found 485 pairs of ortholog-
ous proteins, suggesting that the number of functions that are not shared by the two strains could
be relevant. However, a closer look to the putatively strain-specific gene sequences revealed that
they were mostly composed by complete and (most often) incomplete copies of genes already
used by OMA. We therefore used a collection of perl scripts (that we named “Comparator”; Fir-
rao & Marcelletti,  unpublished) developed for  this  task in previous works  (Saccardo  et  al.,
2012; Scortichini et al., 2013; Torelli et al., 2015) to identify gene families by homology. While
OMA identifies pairs of orthologous genes, one in each genome in comparison,  Comparator
identifies groups of homologous genes that includes orthologs and paralogs, i.e. including one
or more genes from each genome.
Comparator found 1031 homologous gene families containing at least one gene in each genome
in comparison, comprehensive of 1258 genes in S. citri R8-A2 and 1445 in ChiSsp. The number
of genes not included in common families was 454 in S. citri R8-A2 and 549 in ChiSsp.
Among the 454 S. citri R8-A2 specific putative proteins 9 were phage/plasmid associated pro-
teins, 369 were unannotated as hypothetical proteins (most likely of viral origin), 21 were mo-
bile element associated proteins. The remaining only 4 S. citri R8-A2 specific putative proteins
included 2 methyltransferases and 1 HAD family hydrolase and one incomplete copy of the
same gene.
Among the 549 ChiSsp specific putative proteins 114 were phage/plasmid associated proteins,
364 were unannotated hypothetical proteins, 31 were mobile elements associated proteins. The
remaining 36 ChiSsp specific putative proteins include genes and gene fragments that are annot-
ates as methylases/methyltransferases (21 among genes and fragments), as adhesins (3 genes
and 1 fragment), or as genes implicated in sugar transport and metabolism (8 genes), and two
other additional genes as detailed in Table 3.2.4. Adhesins and transporters may play a role in
insect host specificity (Dénes et al., 2003; Boutareaud et al., 2004; Bové et al., 2003).
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In summary, the second Mollicute genome characterized from our chicory samples resulted to
belong to a strain of Spiroplasma citri that have a functional content very similar to S. citri R8-
A2, despite the divergent structure, the different viral content and the divergent distribution of
gene fragments and repetitive sequences. Similarly to the other S. citri genomes investigated so
Table  3.2.4 – ChiSsp putative proteins found by  Comparator (Firrao & Marcelletti,  unpub-
lished), classified by their functions.
Context Name Number of 
genes/frag-
ments
Similar to:
Adhesion orf00596CHScontig16 1 Putative adhesin P89 
orf00633CHScontig169 1 Putative adhesin P89 
orf02110CHScontig82 1 Putative adhesin P89 
orf00663CHScontig171 1 Streptococcal hemagglutinin protein 
Methilases orf00400CHScontig127 1 Site-specific DNA methylase 
orf00630CHScontig168 9 Adenine-specific methyltransferase
orf00502CHScontig141 8 DNA-cytosine methyltransferase 
orf00156CHScontig1 3 tRNA:m(5)U-54 MTase gid 
Sugar metabolism 
and transport
orf00708CHScontig18 1 PTS system, diacetylchitobiose-spe-
cific IIC component
orf02096CHScontig8 1 PTS system, fructose-specific IIA/ 
IIB/IIC component
orf02094CHScontig8 1 PTS system, galactose-inducible IIA 
component 
orf00921CHScontig22 1 PTS system, IIA component 
orf01804CHScontig58 1 PTS system, N-acetylglucosamine-spe-
cific IIB/IIC component
orf00145CHScontig1 1 ABC transporter ATP-binding protein 
orf00697CHScontig18 1 Outer surface protein of unknown func-
tion - cellobiose operon 
orf02170CHScontig9 1 D-lactate dehydrogenase (EC 1.1.1.28) 
Other genes orf02100CHScontig8 1 Bona fide RidA/YjgF/TdcF/RutC sub-
group 
orf00162CHScontig1 1 Nucleoside-diphosphate-sugar epi-
merases 
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 far, a large fraction of the genome of the chicory strain is the result of plectovirus invasion.
Comparative analysis of S. melliferum IPMB4A (Lo et al., 2013) showed that these phages have
facilitated extensive genome rearrangements in these bacteria, and our result provide confirming
evidence for this notion as far as S. citri is concerned. The Authors also suggest that this feature
contribute to horizontal gene transfers that led to species-specific adaptation to different euka-
ryotic hosts, a contribution that we did not evidence through the analysis of our samples.
Presence of the phytoplasma and the spiroplasma in the environment
The evidence of double infection in the sample used for the ???????? sequencing prompted us
to the investigation of field samples in order to ascertain whether or not mixed infections were a
common occurrence and may have epidemiological significance.
As reported in  Table 3.2.5, we found out that as much as two third of spiroplasma positive
samples and nearly the same for phytoplasma positive samples were in mixed infections, a
strong indication of vector preferential behaviour.
Table 3.2.5 – Result of the field sample analysis by direct (d:) and nested (n:) PCR.
Total samples Phytoplasma Spiroplasma Mixed infections
45 31 (direct:24 + nested:7) 27 (direct:11 + nested:16) 18
It has been reported in the literature that phytoplasma may manipulate the host gene expression
making plants more actractive for the insects, by altering volatile profiles  (Bertaccini  et al.,
2011; Tan  et  al.,  2016; Janik  et  al.,  2017),  hormonal patterns and other physiological  traits
(Cettul and Firrao, 2011; MacLean et al., 2011; Sugio et al., 2011; Sugio and Hogenhout, 2012).
A similar effector-based interaction, that results in a more favorable environment for the insect
vector on one hand, and in the typical symptoms such as phyllody and witches’ broom on the
other, has not been reported for the spiroplasmas. On the basis of mutant analysis, spiroplasma
associated symptoms, such as yellowing, have been related with selective sugar uptake of the
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pathogen cells in the plant host phloem (Gaurivaud et al., 2000). It is therefore conceivable that
phytoplasma infection results in plants that are more attractive for several insect species, includ-
ing those vectoring spiroplasmas. Epidemiological studies are presently ongoing in our laborat-
ory to further elucidate this complex interactive network.
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 3.3  Molecular characterization of organisms associated with cassava 
plants showing cassava frogskin disease
Abstract; manuscript draft to be prepared by the first Author.
Authors: Neves de Souza A.1, Polano C.2 , Martini M.2 , Firrao G.2, Carvalho C.1
1 Department of Plant Pathology, Universitad Federal de Viçosa, Brazil
2 Dipartimento di Scienze AgroAlimentari, Ambientali e Animali, Università di Udine
Cassava Frogskin Disease (CFSD) is a disease of great concern to the cultivation of cassava,
mainly affecting their primary product, the tubers. Efforts have been made with the aim of better
understanding the infectious process and the appearance of CFSD symptoms, but due to its eti-
ology still controversial, these studies are challenging. 
The identification and complete characterization of organisms associated with cassava plants
showing CFSD are important to allow a better understanding of the disease, a more detailed
studies on its etiology and on host-pathogen interaction. Therefore, the main aim of this study
was the utilization of next-generation sequencing to identify and characterize potential organ-
isms involved on the development of this disease. A deep sequencing of DNA and RNA from
cassava plants showing symptoms of CFSD was performed. 
In the DNA sequencing, the emphasis was on sequencing of a phytoplasma previously associ-
ated with this disease. The phytoplasma belonging to the ribosomal group 16SrIII had its gen-
ome sequenced, and we obtained its draft genome. This phytoplasma was compared with other
phytoplasma from the same ribosomal group and it seemed to be slightly different from the
other representatives of the group. 
In the RNA deep sequencing, a new RNA subviral agent of 1228 bp in length was identified,
and it shows two putative ORFs in its genome. One of the ORFs shows 156 aa in length and a
common conserved domain from Potexvirus coat protein, and the second ORF, a putative 90 aa
protein of unknown function. This was the first report of an RNA subviral agent associated with
cassava plants. The presence of this subviral agent does not appear to be related to the occur-
rence of CFSD in cassava plants.
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 4  Metagenomic characterisation of communities
Until the 2000s, microbiology, microbial genome sequencing and genomics were conducted us-
ing cultivated clonal cultures and specific genes to simulate natural diversity, with the limitation
of losing a large part of microbial biodiversity (Hugenholtz, Goebel and Pace, 1998). Used first
in 1998, the term metagenomics indicates a set of research techniques, mainly including the use
of shotgun sequencing, and a research field, the study of genetic material obtained directly from
environmental samples (Handelsman et al., 1998; Board on Life Sciences, 2007). By analysing
microorganisms as an aggregate and focusing on how genes might influence each other’s activ-
ities in serving collective functions, metagenomics tries to circumvents the unculturability and
genomic diversity of most microbes, and employs computational methods designed to interpret
the genetic composition and activities of communities that cannot be characterized at the indi-
vidual level. With the advent of next-generation sequencing technologies, it became possible to
obtain datasets where the sequences belong to a wide range and number of individuals, as op-
posed to one or few. The data used in metagenomic derives from high-throughput sequencing,
but unlike genomic sequencing the coverage is generally low, as each read may come from a
different individual. These reads can be attributed to the respective taxons using metabarcoding,
which uses genetic markers (typically, 16S rRNA for bacteria and ITS for fungi) for identifica-
tion.
Most of the tools and methods used to characterise isolates can be used in metabarcoding, but
additional tools have become necessary to further characterise and perform statistical analyses
on the datasets (Thomas, Gilbert and Meyer, 2012). First, low-quality sequences are filtered; du-
plicates are noted and represented only once to lower the computational requirements. Then the
sequences are binned, grouped according to similarity, either by aligning them to a database of
known sequences, attributing to each a taxonomic position, or by determining operational taxo-
nomic unit  (OTUs)  that  not  necessarily  correspond to known taxons  (Blaxter  et  al.,  2005).
OTUs can be used with distance-matrix methods to determine phylogenetic trees. While an in-
depth exposition of the methods for calculating phylogenetic trees is beyond the scope of this
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thesis, it is worth mentioning a few methods, like UPGMA and neighour-joining, along with
maximum parsimony, maximum likelihood, and Bayesian methods  (Lemey, Salemi and Van-
damme, 2009).
Additional tools from statistics can be employed to further explore metagenomic datasets, most
notably multidimensional scaling, in which the distances between the OTUs are represented in
an n-dimensional space (usually 2 dimensional scatterplots,  Figure 4.1) with arbitrary x and y
axes (Borg, and Groenen, 2005). The most commonly used are Principal Coordinate Analysis
(PCoA) and non-metric multidimensional scaling (nMDS) (Ramette, 2007).
Figure 4.1 – An example of a multidimensional scaling (MDS) scatterplot. [Source: (Galimanas 
et al., 2014)]
Statistical indices such as the Simpson and the Shannon estimators, and tools such as the ana-
lysis of molecular variance (AMOVA) (Excoffier, Smouse and Quattro, 1992), can of course be
applied to assess the significativity of the elaborated data results. Commonly used tools to per-
form all of these analyses are MEGAN (Huson et al., 2007), Mothur (Schloss et al., 2009) and
QIIME (Caporaso et al., 2010).
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In the following paper, a metagenomic approach is used in attempt to understand, and possibly
take advantage of, the relations between the kiwifruit endophytes and  Pseudomonas syringae
pv. actinidiae, causal agent of the kiwifruit canker.
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 4.1  Multivariate analysis of endophytes diversity in kiwifruit in 
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 4.1.1  Introduction
Pseudomonas syringae is a Gram-negative bacterium whose pathovars can infect a variety of
plant  species;  some pathovars target  specific species,  while others  can infect  a spectrum of
hosts; In particular, P. syringae pv. actinidiae (Psa) targets Actinidia deliciosa and A. chinensis
plants as the causal agent of bacterial canker. This disease was identified as early as 1989 in Ja-
pan  (Takikawa  et  al.,  1989) and  1994 in Italy  (Scortichini,  1994).  Yellow and red  fleshed
kiwifruits are generally more susceptible than green ones; Psa3 was in fact first detected on yel-
low cultivars (Koh et al., 2012). Symptoms include leaf spots and necrosis, extensive twig die-
back, reddening of the lenticels, bleeding cankers on the trunk and leader with whitish to orange
ooze, and in the worse cases can lead to the death of the host (Agrios, 2005).
However, the impact of the disease worldwide has not been as severe as in Japan and Korea un-
til an outbreak occurred a decade later, which has caused grave damage to kiwifruit culture par-
ticularly in southern Europe, New Zealand and Korea (Vanneste, 2012; Kim et al., 2016). Psa
from these outbreaks has been divided into 3 biovars: Psa1 and Psa2 caused the cankers in Ja-
pan and Korea in 1980s and produce phaseolotoxin (Psa1) and coronatine (Psa2), while Psa3
caused the cankers in Italy and worldwide in 2008 (Scortichini et al., 2012). It was determined
that the new strain emerged as a result of horizontal transfers events from asian strains (Marcel-
letti et al., 2011), including the incorporation of Integrative Conjugative Elements (ICEs) (Mar-
celletti et al., 2011; Butler et al., 2013). 
Strategies for controlling the spread of  Psa are limited and consist in eliminating the affected
plants and protecting the healthy ones in spring and fall using copper formulations (Vanneste et
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al., 2011) and avoiding excess humidity, e.g. by covering the plant with nets. Excessive recourse
of copper treatments however led to the differentiation of resistant subclones, by acquisition of
another ICE (Colombi et al., 2017). It was recently observed that some plants do not seem to get
infected, even after a few years of exposure. The hypothesis tested in this work is whether this
resilience could be influenced by the interaction between the pathogen and the endophyte popu-
lation (Reinhold-Hurek and Hurek, 2011); the testing was conducted using a metagenomic ana-
lysis of 16S and ITS sequences sampled in 3 consecutive years.
 4.1.2  Materials and methods
Two sets of data were sampled: a preliminary set (“alpha”) of 16S sequences included data from
12 samplings of kiwifruit bark and leaves obtained between 2014 and 2015 (Table 4.1.1), from
an experimental  field in  Dandolo di  Sopra, Friuli-Venezia Giulia,  Italy,  using the 926F and
1392R primers. Samples 16S-1/2, 16S-3/4/5/6/7 and 16S-8/9/10/11/12 were sampled each from
a single plant.
A second, more complete set (“beta”) of 16S (V6–V8) and ITS2 sequences included data from
24 samplings of kiwifruit  bark obtained in July 2016,  from the same field, using the 926F,
1392R (Engelbrektson  et al., 2010), ITS3_KYO2, ITS4 (Toju  et al., 2012) primers. The ITS2
primers are not specific, in order to amplify as many fungi as possible, though they can fail to
pick up a few Orders (Asemaninejad et al., 2016). Symptoms from the plants used in the beta
set were recorded during three years, from 2015 to 2017.
Genomic DNA was extracted from 24 bark samples with various levels of PSA symptoms, using
modified version of the Doyle and Doyle method  (Doyle and Doyle, 1990). Amplicons were
amplified using a PCR method described in (Martini et al., 2009), with a KAPA HiFi HotStart
PCR kit; primers used were 799F/1492R for bacteria (Goodfellow and Stackebrandt, 1991) and
ITS1F-KYO1/ITS4 for fungi  (Toju  et al., 2012). To avoid possible plant contaminations, the
amplicons were run in an electrophoretic apparatus, and the excised bands purified with an RBC
Real  Biotech  kit.  The  purified  amplicons  were  then  amplified  with  the  aforementioned
926F/1392R primers for bacteria and ITS3_KYO2/ITS4 for fungi, and purified with an RBC
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Real Biotech kit. The samples were then sent to were sent to the Institute of Applied Genomics
(IGA, Udine, Italy) to be sequenced with Illumina MiSeq 2×300.
Because of the limitations of phylotype-based methods, such as ambiguously-defined taxons
(particularly below the order level) and, consequently, the limited completeness of available
taxonomical databases  (Schloss and Westcott, 2011), an Operational Taxonomic Unit (OTU)-
based strategy for sequence clustering was chosen, in order to verify whether the microbial
community in the samples can be correlated to the severity of the symptoms and time of infec-
tion. The correlation between the samples was assessed using a multivariate analysis, which has
increasingly become an essential tool in exploring and understanding large data sets (Ramette,
2007). Non-metric multidimensional scaling analysis (nMDS) was chosen over principal com-
ponent analysis (PCoA) because it does not require data preprocessing and is generally regarded
as a more robust method (Taguchi and Oono, 2005), while the distances were calculated using
the Canberra method, as it is known to perform especially well for detecting clusters (Kuczynski
et al., 2010).
The OTUs were determined and clustered using the LotuS processing pipeline  (Hildebrand et
al., 2014); the nMDS spatialisation was carried out using the software suite Mothur (Schloss et
al., 2009) and graphed using the R statistical language (R Core Team, 2017).
 4.1.3  Results
In the alpha set each sample had on average 48,729 reads, ranging from 14,994 to 87,988, for a
total of 584,752 reads (Table 4.1.1); in the beta set, each 16S sample had on average 519,800
reads, ranging from 199,492 to 1,085,258, for a total of 24,950,422 reads (Figure 4.1.4), while
each ITS sample had on average 291,075 reads, ranging from 121,877 to 582,370, for a total of
13,971,610 reads (Figure 4.1.5).
The preliminary analysis on the alpha set was done to assess the variability resulting from the
sampling method. Comparing replicas showed that there is some variability between replicas: in
Figure 4.1.1, for example, Enterobacteriales are present in less than 5% of sample 16S-1 reads
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and over 25% of sample 16S-2, while Burkholderiales are present in over 15% of sample 16S-1
reads and slightly over 5% of sample 16S-2 reads.
There are also some differences between the populations in the bark and the leaves (Figure
4.1.2): Burkholderiales are twice as numerous in bark as they are in leaves, while in half of the
leaves samples  Rhizobiales and  Sphingomonadales represent 25% of the reads, as opposed to
15% of the rest of the samples. As for the changes over time (Figure 4.1.3), Sphingobacteriales
and Actimomycetales are almost absent in June but have a significant presence in September,
then decline again, while  Bacillales are absent in September and October but moderately pre-
sent in June and March.
Table 4.1.1 – Preliminary samples (“alpha set”) used to calibrate the analysis. The sampling was
done to include samples from autumn and spring and from bark and leaves.
Sample ID Source Date of sampling Reads Sample ID Source Date of sampling Reads
16S-3 bark June 2014 29.648 16S-8 bark June 2014 76.100
16S-4 bark September 2014 34.893 16S-9 bark September 2014 44.493
16S-5 bark October 2014 77.521 16S-10 bark October 2014 69.072
16S-6 leaf October 2014 87.899 16S-11 leaf October 2014 19.985
16S-7 bark March 2015 34.777 16S-12 bark March 2015 14.994
16S-1 bark April 2015 26.041 16S-2 bark April 2015 69.329
Figure 4.1.1 – Orders distribution for samples 16S-1 and 16S-2 of the alpha set, repetitions 
made at the same time (April 2015) from the same location (bark) of the same plant.
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Figure 4.1.2 – Orders distribution differences between bark (samples #5 and #10 of the alpha 
set) and leaves (samples #6 and #11); pairs come from different plants.
For the complete analysis on the beta set, the samples were divided in 4 groups, based on the
time of the first occurrence of the symptoms (Table 4.1.2): group A has no observed symptoms,
group B had symptoms since 2017, group C since 2016 and group D since 2015. For the 16S
clusters, the spatialisation (Figure 4.1.6) shows a fairly good segregation, as the samples from
group C or D are completely on the left side, while the samples from group A or B are on the
right side, although not separated. Similarly, most of the ITS samples from group C or D are se-
gregated to the  lower-left  side  (Figure 4.1.7)  with a  few outliers  on  the upper-right,  while
samples from group A and B are on the right side, in this case without intermixing.
From  Table  4.1.3 it  can  be noted  that  16S24 and 16S03 differ  by  the  proportion  of  Cyto-
phagaceae, Oxalobacteriaceae, Microbacteriaceae, and of most notably,  Pseudomonadaceae.
Similarly, ITS22 and ITS03 differ by the proportion of Phaeosphaeriaceae, Leptosphaeriaceae,
Taphrinaceae, Montagnulaceae and Mycosphaerellaceae.
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Figure 4.1.3 – Orders distribution differences between months: June (samples #3 and #8), 
September (samples #4 and #9), October (samples #5 and #10), March (samples #7 and #12); 
pairs come from different plants.
Figure 4.1.4 – Read size and distribution of the kiwifruit samples in the 16S region.
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Figure 4.1.5 – Read size and distribution of the kiwifruit samples in the ITS region.
 4.1.4  Discussion
In the last decade,  Pseudomonas syrigae pt.  syringae (Psa) has become a gravely damaging
causal agent of disease in kiwifruits. Attempts to contain it with copper formulations produced
the undesired effect of selecting resistant strains. Psa has proven to have a rather complex set of
elicitors and T3SS effectors, and a dynamic system of transposable elements.
With the introduction of metagenomic analyses made possible by Whole Genome Sequencing, a
more comprehensive scope of investigating the relation between pathogens, plants and the rest
of the microbial community has been made possible. The complexity of the pathogenic mecha-
nisms of Psa, along with the experimental observation that some plants appear less affected than
others while not being more resistant themselves, suggested to investigate the microbial popula-
tion as a whole, in order to verify whether this form of ‘resistance’ is influenced by differences
in the diversity of the endophyte population of kiwifruit samples. At the time of this writing, it
was not possible to include data from unculturable microorganisms, therefore their role in this
analysis could not be assessed.
With this ongoing 4-year project, we have shown that such a metagenomic analysis has found a
correlation with the severity of the symptoms and the time of infection of the plants. While fur-
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ther analyses will be required to elucidate whether the differences in Order distributions in 16S
and ITS samples are linked, and whether these differences could be used as predictors for Psa
spread, the graphical spatialisation of the OTUs did reflect fairly well the preexistent data relati-
ve to the symptomatological classes derived from visual and real-time PCR observations.
Table 4.1.2 – Samples taken in three consecutive years (“beta set”), with real-time PCR results
on the same DNA extracted from kiwi vines, used for categorising the samples of the microbial
community. Symptomatological classes are: 0 – no exudates; 1 – few exudates without cankers
or dryings; 2 – exudates, cankers and dryings of young parts of the plant; 3 – abundance of ex-
udates, wide presence of cankers and dryings of older parts of the plant. Real-time PCR was
done on PSA using DNA extracted from vines in July 2016.
Label Group
Symptomatological classes
Real-time PCR
2015-04-24 2016-03-21 2017-04-20
#1 B 0 0 1 –
#2 A 0 0 0 –
#3 A 0 0 0 –
#4 B 0 0 2 –
#5 B 0 0 1 –
#6 A 0 0 0 –
#7 B 0 0 2 –
#8 B 0 0 1 –
#9 C 0 1 0 + (ct 19.40)
#10 C 0 1 3 –
#11 C 0 1 2 –
#12 C 0 1 0 –
#13 C 0 1 1 –
#14 C 0 1 1 –
#15 C 0 1 (pollarded) 0 –
#16 C 0 1 2 –
#17 D 2 (pollarded) 0 3 + (ct 23.73)
#18 D 2 1 1 –
#19 D 2 1 2 + (ct 23.33)
#20 D 2 1 (pollarded) 1 + (ct 23.89)
#21 D 2 2 1 + (ct 23.14)
#22 D 2 1 2 + (ct 23.57)
#23 D 2 1 2 + (ct 23.13)
#24 D 1 1 (pollarded) 1 + (ct 22.74)
143
Table 4.1.3 – Distribution of the most represented families in the most distant samples (group D
16S24 vs. group A 16S03 and group D ITS22 vs. group A ITS03) from the 16S and the ITS clus-
terings.
                   Families Reads
16S24
Bacteria;Proteobacteria;Betaproteobacteria;Burkholderiales;Comamonadaceae 55,570
Bacteria;Proteobacteria;Betaproteobacteria;Burkholderiales;Oxalobacteraceae 22,011
Bacteria;Proteobacteria;Gammaproteobacteria;Pseudomonadales;Pseudomonadaceae 19,997
Bacteria;Actinobacteria;Actinobacteria;Actinomycetales;Propionibacteriaceae 15,261
Bacteria;Firmicutes;Bacilli;Bacillales;Staphylococcaceae 10,905
Bacteria;Firmicutes;Clostridia;Clostridiales;Clostridiales_Incertae Sedis XI 8,166
Bacteria;Proteobacteria;Alphaproteobacteria;Rhizobiales;Methylobacteriaceae 2,883
16S03
Bacteria;Proteobacteria;Betaproteobacteria;Burkholderiales;Comamonadaceae 46,557
Bacteria;Bacteroidetes;Cytophagia;Cytophagales;Cytophagaceae 13,790
Bacteria;Actinobacteria;Actinobacteria;Actinomycetales;Microbacteriaceae 9,443
Bacteria;Proteobacteria;Betaproteobacteria;Burkholderiales;Oxalobacteraceae 8,954
Bacteria;Proteobacteria;Alphaproteobacteria;Rhizobiales;Methylobacteriaceae 8,103
Bacteria;Proteobacteria;Alphaproteobacteria;Sphingomonadales;Sphingomonadaceae 7,483
Bacteria;Proteobacteria;Gammaproteobacteria;Pseudomonadales;Pseudomonadaceae 4,402
ITS22
Fungi;Ascomycota;Dothideomycetes;Pleosporales;Pleosporaceae 54,069
Fungi;Ascomycota;Dothideomycetes;Pleosporales;Phaeosphaeriaceae 15,046
Fungi;Basidiomycota;Tremellomycetes;Tremellales;Incertae sedis 10,669
Fungi;Ascomycota;Dothideomycetes;Pleosporales;Leptosphaeriaceae 10,133
Fungi;Ascomycota;Dothideomycetes;Pleosporales;Incertae sedis 4,068
Fungi;Ascomycota;Taphrinomycetes;Taphrinales;Taphrinaceae 2,923
Fungi;Ascomycota;Dothideomycetes;Incertae sedis;? 2,215
ITS03
Fungi;Ascomycota;Dothideomycetes;Pleosporales;Pleosporaceae 33,200
Fungi;Basidiomycota;Tremellomycetes;Tremellales;Incertae sedis 9,683
Fungi;Ascomycota;Dothideomycetes;Pleosporales;Montagnulaceae 8,844
Fungi;Ascomycota;Dothideomycetes;Capnodiales;Mycosphaerellaceae 6,946
Fungi;Ascomycota;Dothideomycetes;Pleosporales;Incertae sedis 5,155
Fungi;Basidiomycota;Tremellomycetes;Tremellales;unidentified 3,184
Fungi;Ascomycota;Dothideomycetes;Incertae sedis;Incertae sedis 2,455
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 5  General conclusions and perspectives
Whole genome sequencing in the last decade has seen a sharp increase in the amount and qual-
ity of data that can be made available, at a fraction of the cost and the labour it used to have.
This promped the need for more complex strategies and tools aimed at ‘making sense’ of such
data, but also opened the doors to an unprecedented scope of enquiries. On a phytopathological
perspective, this technological improvement has the potential for a deeper understanding of the
relation between pathogens and their hosts and between pathogens and the rest of the microbial
community (Stubbendieck and Straight, 2016), and ultimately the potential for better (less-im-
pacting) preventive defence strategies against current, but also future plant diseases.
WGS has great potential in many aspects of phytopathology; in characterising bacterial strains,
it allows a comparison between known (and occasionally unknown) availabilities of secondary
metabolites (Gross and Loper, 2009): in the case of the Pseudomonas sp. strain Pf-4, comparing
sequences of clusters pertaining to previously-identified secondary metabolite production, it was
possible to prove that the genome of Pf-4 includes an ‘arsenal’ of metabolites quite similar to
that  of  already  well-characterised  biocontrol  agents,  P.  protegens strain  Pf-5  in  particular
(Takeuchi et al., 2014). This is significant, because Pf-5 is a biocontrol agent employed in soil
cultures, while Pf-4 was isolated from a hydroponic system, suggesting that the mechanisms in-
volved in the biocontrol activity of these strains are very similar,  regardless of the environ-
mental conditions in which they developed. Comparing clusters has become a common strategy
to characterise and understand the internal relations of strains (Takeuchi et al., 2015; Garrido-
Sanz et al., 2016; Loper et al., 2016)
A more comprehensive approach also suggests that a more careful understanding of the dynam-
ics and composition of the microbial communities is necessary, in order to formulate more at-
tentive biological control strategies against fungal pathogens (Colla et al., 2012). While select-
ing biocontrol  agents for the strongest ability to inhibit pathogens through a wider range of
secondary metabolites may be the most effective, it might not be the preferable choice for a dur-
able protection.
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It could be hypothesised that a too strong inhibitory activity might potentially alter the equilib-
rium in the microorganism community, leading to a comparable response and a simplification of
the community itself, eventually causing a decline of the strong biocontrol agent population it-
self, if it is less capable of adapting to changing conditions. If that is the case, a less impactful
bacterium (such as Pf-11), with a more limited array of metabolites, might allow for a more di-
verse microbial community. For sure, it has become more and more evident that plant disease
management cannot overlook the impact of the complex relations between pathogen strains,
other competing microorganisms, the various types on environment (soil, hydroponics,  root,
etc.) and the plants themselves (Hibbing et al., 2010; Stubbendieck and Straight, 2016; Tollen-
aere et al., 2016).
Sequencing Pf-11 allowed me to prove that its genome includes a large array of secondary meta-
bolite clusters with a broader activity against a variety of fungal species, even larger than Pf-4,
yet lacking many of those available to the latter. A larger set of metabolites allows for a wider
spectrum of biocontrol activity, or a stronger control towards the same competitor, by exploiting
different strategies, possibly in a synergistic combination (Kannan and Sureendar, 2009).
Comparing Pf-4 and Pf-11 also pointed out an issue related to metabarcoding,  i.e. the use of
conserved sequences such as the 16S rRNA: while being the most commonly used method to
characterise complex communities, it potentially underestimates the diversity of said communit-
ies (Hengstmann et al., 1999; Vrålstad, 2011); in fact, Pf-4 and Pf-11 are indistinguishable using
these markers, yet they significantly differ in their inhibitory activity. Nevertheless, they coexist
in the same environment, suggesting the necessity of a within-species diversity, which allows
for seemingly less fit bacterial strains to survive along with more competitive ones.
A possible explanation might lie in the role of the horizontal transfer of genetic material that is
favoured by intra-specific diversity. In the simplest cases, this is caused by insertion events, but
the more relevant situation is that of a complex differentiation of accessory genomes (Jackson et
al., 2011), due to multiple invasions of foreign DNA that are then integrated in the genome. It
could be argued that an expanding/contracting genome is in a more dynamic evolutionary stage,
and might eventually result in a stabler genome.
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Genomic diversity is often caused by rearrangement of genetic elements; it has become increas-
ingly evident that detecting structural changes, especially those associated with repetitive se-
quences,  can require Third Generation sequencing strategies  that  produce longer reads than
those usually provided by Second Generation sequencers  (Stapley  et al., 2010).  Mobile DNA
elements contribute to bacterial evolution, as they can lead to genome rearrangements that can
influence their fitness, and possibly their pathogenicity and virulence, in some cases suggesting
‘two speed’ mechanisms that help pathogens adapting to quickly changing environmental condi-
tions (Faino et al., 2016; Seidl and Thomma, 2017)
Psa biovar 3 is a typical example of this process, as its emergence as a pandemic pathogen of
kiwifruit was influenced by horizontal transfer (ICE sequences, in particular). By comparing
PacBio sequencings of the CRAFRU 12.29, CRAFRU 14.08 and ICMP 18708 strains, whose
longer uninterrupted reads allowed to pinpoint the structural variations between them, using
multiple alignment tools, it was possible to note that those structural variations (an insertion in
the hrpS gene that disrupted the functionality of the T3SS) were caused by a rearrangement of
genetic elements, and not by incorporating external DNA, without the recombination-selection
process that mitigates genome degeneration associated with transposon mobilization.
In turn, this suggest that more attentive strategies for managing destructive epidemics might
want to keep in mind their effect on the short-term genome evolution and population structure
of the pathogen, as strategies that do not promote recombination might be at a lesser risk of de-
veloping variant, more virulent strains.
Considering the metagenomic approach to pathogen control, another significant difficulty in
drawing a complete picture of the relations between pathogens and the larger microbial com-
munity is caused by unculturable pathogens, such as phytoplasmas (Lee et al., 2000). As in the
case of using barcodes, the difficulties in obtaining reliable in vitro cultures of these organisms
can lead to an underestimation of the diversity in the community they live in.
While various isolation and purification protocols have been developed, they are generally time-
consuming and occasionally specific to single species or even strains. With  Phytoassembly, it
was possible to develop a pipeline that employ a WGS-based strategy to indirectly derive fairly
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complete genomes from infected plant samples, by using a (preferably isogenic) reference gen-
ome of a healthy plant as a filter and exploiting the differential coverage of sequences from the
host and the (more abundant) ones from pathogen; this in silico approach is an additional evid-
ence of the growing importance of WGS and its potentials in overcoming the difficulties in un-
derstanding the more elusive pathogens (Barba et al., 2014; Kakizawa and Yoneda, 2015).
Phytoassembly not only worked well to derive single phytoplasma genomes, but as in the case
of the Chicory Phyllody-associated phytoplasma (Martini et al., 2012), it allowed the discovery
of a double infection of phytoplasma and spiroplasma, due to the unusal size of the output. By
filtering the RAST-annotated genome set with a custom Perl script, it was possible to recon-
struct both the phytoplasma and the spiroplasma sequences. In the light of the results of recent
investigations it may be speculated that the manipulation of the host gene expression by the
phytoplasma is advantageous for and affect the epidemic behaviour of other pathogens, another
example of a diveristy-influencing factor that might be underestimated with traditional analysis
methods.
As mentioned, the reference genome used with  Phytoassembly should preferably be isogenic
with the infected sample, but if not available a combination of reference genomes can also be
used, as with the CFSD-associated phytoplasma (Alvarez et al., 2009).
Expanding the scope to a fully metagenomic approach, WGS is the technology that made possi-
ble such perspective, which as mentioned elsewhere can provide a better understanding of the
relations between pathogens and the other microorganisms present in the environment, by in-
cluding all the species (Flynn et al., 2015). While possibly not covering the differences deriving
from intra-specific diversity, metabarcoding is still a comprehensive method of surveying a mi-
crobial population.
In the case of the kiwifruit endophyte populations, the attempt was to correlate their spatial and
temporal variation to the physiological state of the plant related to the severity of the symptoms
and time of Psa infection. While further elaborations will be required to fully explore the differ-
ences between the samples as resulting from the spatialisation of the OTUs, it was still possible
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to infer a relation between the observed state of the plants, the composition of the communities
from each sample and how these could interact with the pathogen (Brader et al., 2017).
The results from each paper included in this thesis, each from a slightly different perspective,
showed how a deep understanding of the data provided by Whole Genome Sequencing requires
the use of rigorous bioinformatic analyses and modern computing techniques. Complex, virulent
pathogens like Psa requires a level of understanding of their dynamics that, as suggested by the
works  presented  here,  benefits  from including their  relation  with  the other  microorganisms
(Tringe et al., 2005), and designing better strategies to contain them could rely on non-patho-
genic strains, or on apparently less efficient biocontrol agents, which in the past would have oth-
erwise been overlooked.
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 6  Appendix: Supplementary data
 6.1  Genome sequence and antifungal activity in two niche-sharing 
Pseudomonas protegens strains isolated from hydroponics
Table 6.1.1 – OMA-isolated genes exclusive to Pf-4.
Gene code Description Position
A1348_00125 hypothetical protein 29948:30160 F
A1348_00215 lysine transporter LysE 48045:48686 F
A1348_00270 transcriptional regulator 55172:55489 R
A1348_00290 RNA polymerase subunit sigma 59893:60405 F
A1348_00295 iron dicitrate transport regulator FecR 60381:61349 F
A1348_00300 ligand-gated channel 61469:63949 F
A1348_00305 acid phosphatase 64010:64849 R
A1348_00465 lipid A 3-O-deacylase 97975:98493 F
A1348_00985 7-cyano-7-deazaguanine synthase 203207:203905 F
A1348_01010 hypothetical protein 208353:208850 R
A1348_01100 antitoxin 225842:226075 F
A1348_01105 plasmid maintenance protein 226075:226473 F
A1348_01575 cupin 330307:330603 R
A1348_01980 hypothetical protein 415988:416218 R
A1348_02040 hypothetical protein 426717:427472 F
A1348_03470 cupin 733169:733480 F
A1348_03835 hypothetical protein 804067:804255 R
A1348_04005 GDP-fucose synthetase 846573:847550 F
A1348_04010 transferase 847681:848172 F
A1348_04460
mannose-1-phosphate guanylyltransferase/mannose-6-phosphate
isomerase 943809:945266 R
A1348_04580 hypothetical protein 981628:984981 R
A1348_05010 hypothetical protein 54372:54707 F
A1348_05320 hypothetical protein 123702:123884 R
A1348_05325 immunity protein 126358:126621 F
A1348_05875 SAM-dependent methyltransferase 243409:244230 R
156
A1348_06830 AAA family ATPase 462393:464003 R
A1348_06835 organic radical-activating protein 464000:464557 R
A1348_06840 hypothetical protein 464558:465190 R
A1348_06845 hypothetical protein 465192:466175 R
A1348_07190 hypothetical protein 535974:537785 F
A1348_07815 hypothetical protein 669710:670660 F
A1348_07835 transporter 673474:674388 R
A1348_07875 sulfurtransferase 681625:683208 R
A1348_07880 cysteine dioxygenase 683205:683834 R
A1348_07885 LysR family transcriptional regulator 683941:684828 F
A1348_07890 ABC transporter permease 685097:685894 F
A1348_07895 sulfonate ABC transporter ATP-binding protein 685897:686676 F
A1348_07900 acyl-CoA dehydrogenase 686673:687878 F
A1348_07905 dihydrofolate reductase 687875:688813 F
A1348_07910 hypothetical protein 689149:689958 F
A1348_07915 aliphatic sulfonate ABC transporter substrate-binding protein 689971:690933 F
A1348_07920 peptidase M19 691062:692273 F
A1348_07925 monoamine oxidase 692488:694065 F
A1348_07930 hypothetical protein 694154:694651 F
A1348_07935 TonB-dependent receptor 694677:697145 F
A1348_07940 ABC transporter substrate-binding protein 697221:698135 F
A1348_07945 proline hydroxylase 698429:699205 F
A1348_07950 tRNA-dependent cyclodipeptide synthase 699210:699959 F
A1348_07955 MFS transporter 700072:701499 F
A1348_07960 nitrilotriacetate monooxygenase 701492:702844 F
A1348_08035 restriction endonuclease 714963:716048 F
A1348_08735 transposase 875906:876886 F
A1348_08795 hypothetical protein 887576:887758 R
A1348_08840 RTX toxin 898144:900932 F
A1348_29255 type IV secretion protein Rhs 1:572 F
A1348_29440 chemotaxis protein 71986:73602 R
A1348_29515 hypothetical protein 88414:89601 F
A1348_29755 hypothetical protein 21764:22006 R
A1348_29760 hypothetical protein 22632:22916 F
A1348_29780 hypothetical protein 29349:29705 F
A1348_29785 hypothetical protein 29754:30008 R
A1348_29790 AraC family transcriptional regulator 30077:30946 R
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A1348_29805 hypothetical protein 32224:32499 R
A1348_30105 large adhesive protein 7799:12114 R
A1348_30115 hypothetical protein 1989:2201 F
A1348_30120 hypothetical protein 1:713 R
A1348_30125 hypothetical protein 710:1210 R
A1348_10605 hypothetical protein 388292:388588 R
A1348_10725 hypothetical protein 414063:414335 F
A1348_10770 hypothetical protein 421772:422425 F
A1348_11280 hypothetical protein 535747:536175 F
A1348_11290 hypothetical protein 536466:537725 R
A1348_11495 ABC transporter ATP-binding protein 577020:577856 F
A1348_11500 nitrate ABC transporter substrate-binding protein 577894:578895 F
A1348_11505 ABC transporter permease 578925:579701 F
A1348_11515 cupin 580478:581014 F
A1348_11520 hydrolase 581019:581897 F
A1348_11535 hypothetical protein 583519:585201 F
A1348_11540 aspartate dehydrogenase 585212:586015 F
A1348_11545 aldehyde dehydrogenase 586129:587625 F
A1348_11550 glyoxalase 587622:588587 F
A1348_11555 hypothetical protein 588615:588842 F
A1348_11560 3-phenylpropionate dioxygenase 588864:589898 F
A1348_11565 ferredoxin 589957:590916 F
A1348_11570 hypothetical protein 591241:592470 F
A1348_11585 hypothetical protein 595537:596082 R
A1348_11695 transporter 624286:624726 F
A1348_12040 histidine kinase 696144:696548 F
A1348_12045 hypothetical protein 696571:696867 F
A1348_30155 type IV secretion protein Rhs 915:1621 F
A1348_30165 type I secretion protein 1:899 F
A1348_30170 hypothetical protein 1:899 F
A1348_30175 hypothetical protein 1:812 R
A1348_12615 large adhesive protein 1:4801 R
A1348_12635 taurine dioxygenase 10395:11282 F
A1348_12640 nitrate ABC transporter substrate-binding protein 11309:12346 F
A1348_12645 sulfonate ABC transporter ATP-binding protein 12352:13212 F
A1348_12650 ABC transporter permease 13246:14112 F
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A1348_12715 antitoxin 29384:29629 F
A1348_12720 addiction module toxin RelE 29619:29900 F
A1348_12930 phosphatidylinositol kinase 66585:67805 R
A1348_12935 transcriptional regulator 67798:68046 R
A1348_12945 fatty acid desaturase 69321:70394 F
A1348_12950 pesticin immunity protein 70547:70954 F
A1348_12955 arylsulfatase 71015:72625 R
A1348_12960 ABC transporter ATP-binding protein 72640:73455 R
A1348_12965 ABC transporter permease 73452:75047 R
A1348_12970 nitrate ABC transporter substrate-binding protein 75434:76456 F
A1348_12975 transcriptional regulator 76723:77643 R
A1348_12980 taurine dioxygenase 77827:78732 F
A1348_12985 phosphonate monoester hydrolase 78974:80590 R
A1348_12990 transcriptional regulator 80865:81809 R
A1348_12995 TonB-dependent receptor 81964:84336 F
A1348_13000 ArsR family transcriptional regulator 84403:85752 F
A1348_13030 transcriptional regulator 88576:88827 F
A1348_13035 phosphatidylinositol kinase 88827:89759 F
A1348_13065 hypothetical protein 94041:94364 F
A1348_13070 energy transducer TonB 94784:95599 F
A1348_13075 biopolymer transporter ExbB 95655:96380 F
A1348_13080 biopolymer transporter ExbD 96382:96783 F
A1348_13180 hypothetical protein 119210:119596 R
A1348_13540 hypothetical protein 201586:203268 F
A1348_13545 hypothetical protein 203432:205084 R
A1348_13550 hypothetical protein 205483:206022 F
A1348_13555 transcriptional regulator 206345:206680 F
A1348_13560 hypothetical protein 208517:208879 F
A1348_13565 hypothetical protein 211448:211723 R
A1348_13570 integrase 211716:212700 R
A1348_13585 amidase 215393:216037 F
A1348_13710 hypothetical protein 244712:245041 R
A1348_13730 hypothetical protein 246892:247968 R
A1348_14105 hypothetical protein 331346:331726 R
flgK flagellar biosynthesis protein FlgK 1:735 F
A1348_30190 terminase 1:727 R
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A1348_15630 hypothetical protein 1:642 F
A1348_15635 hypothetical protein 1434:2237 F
A1348_15910 MarR family transcriptional regulator 73975:74934 F
A1348_15920 GntR family transcriptional regulator 76426:77094 F
A1348_15925 ABC transporter substrate-binding protein 77170:77976 F
A1348_15930 polar amino acid ABC transporter permease 77989:78762 F
A1348_15935
ectoine/hydroxyectoine  ABC  transporter  ATP-binding  protein
EhuA 78765:79544 F
A1348_15940 gamma-glutamyltransferase 79581:81191 F
A1348_15950 sugar ABC transporter substrate-binding protein 81884:82831 F
A1348_15955 TonB-dependent receptor 82899:85298 F
A1348_15960 3-(3-hydroxy-phenyl)propionate transporter MhpT 85381:86592 R
A1348_15965 porin 86925:88244 F
A1348_15970 MarR family transcriptional regulator 88266:88787 R
A1348_15975 p-hydroxycinnamoyl CoA hydratase/lyase 88995:89825 F
A1348_15980 salicylaldehyde dehydrogenase 89931:91379 F
A1348_15985 feruloyl-CoA synthase 91606:93489 F
A1348_15990 acetyl-CoA acetyltransferase 93486:94727 F
A1348_15995 acyl-CoA dehydrogenase 94787:96541 F
A1348_16000 MFS transporter 97060:98385 F
A1348_16035 GntR family transcriptional regulator 106692:107405 F
A1348_16040 Vanillate O-demethylase oxidoreductase 107582:108532 R
A1348_16045 Rieske (2Fe-2S) protein 108592:109650 R
A1348_16095 hypothetical protein 121097:121291 F
A1348_16110 hypothetical protein 123365:123565 F
A1348_16215 hypothetical protein 138378:138758 R
A1348_16230 hypothetical protein 141682:141933 R
A1348_16235 hypothetical protein 142040:142429 F
A1348_16240 hypothetical protein 142430:142720 R
A1348_16245 hypothetical protein 142999:143271 R
A1348_16250 hypothetical protein 143940:144680 R
A1348_16255 hypothetical protein 144791:144997 F
A1348_16260 hypothetical protein 145009:145411 R
A1348_16265 hypothetical protein 145510:145737 F
A1348_16270 hypothetical protein 145877:146554 F
A1348_16275 nucleoid-associated protein YejK 146687:147694 R
A1348_16280 hypothetical protein 148111:148437 R
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A1348_16300 hypothetical protein 150519:150725 F
A1348_16320 hypothetical protein 152288:152560 R
A1348_16325 hypothetical protein 152618:152836 R
A1348_16330 hypothetical protein 152913:153113 R
A1348_16335 hypothetical protein 153865:154740 R
A1348_16340 transposase 154980:155420 F
A1348_16345 hypothetical protein 155706:155999 F
A1348_16350 hypothetical protein 156217:156426 R
A1348_16355 hypothetical protein 156452:157222 R
A1348_16360 hypothetical protein 157322:157534 F
A1348_16365 hypothetical protein 157588:158202 F
A1348_16375 hypothetical protein 159125:159469 F
A1348_16380 phage replication protein 159471:160436 F
A1348_16390 hypothetical protein 161205:161711 F
A1348_16395 hypothetical protein 161708:161995 F
A1348_16405 hypothetical protein 162572:162838 F
A1348_16410 hypothetical protein 162835:163065 F
A1348_16425 hypothetical protein 165241:165558 F
A1348_16435 hypothetical protein 166334:166693 R
A1348_16450 terminase 168161:169483 F
A1348_16465 hypothetical protein 172478:173206 F
A1348_16475 hypothetical protein 174228:174812 F
A1348_16580 integrase 193933:194325 R
A1348_16595 hypothetical protein 195955:196605 R
A1348_16600 hypothetical protein 197225:197467 R
A1348_16605 hypothetical protein 198425:198790 F
A1348_16610 hypothetical protein 199046:199399 R
A1348_16615 acetyltransferase 200642:201172 R
A1348_16635 hypothetical protein 205076:205375 F
A1348_16640 aminoglycoside phosphotransferase 205405:206181 F
A1348_16890 hypothetical protein 253936:255027 F
A1348_16950 hypothetical protein 267554:268399 F
A1348_16955 hypothetical protein 268483:268833 F
A1348_17170 alkaline phosphatase 324812:325972 F
A1348_17270 halogenase 360091:361599 R
A1348_17275 transcriptional regulator 361596:362627 R
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A1348_17280 peptidyl carrier protein PltL 363114:363380 F
A1348_17285 FADH2-dependent halogenase PltA 363394:364743 F
A1348_17290 polyketide synthase 364776:372152 F
A1348_17300 halogenase 377576:379210 F
A1348_17305 acyl-CoA dehydrogenase 379212:380354 F
A1348_17310 D-alanine--poly(phosphoribitol) ligase 380351:381844 F
A1348_17315 thioesterase 381848:382630 F
A1348_17320 transcriptional regulator 382636:383307 R
A1348_17325 hypothetical protein 383383:384396 F
A1348_17330 ABC transporter ATP-binding protein 384393:386162 F
A1348_17335 hypothetical protein 386172:387314 F
A1348_17340 antibiotic ABC transporter permease 387331:388437 F
A1348_17345 RND transporter 388449:389945 F
A1348_17350 transporter 390011:390616 F
A1348_17365 alpha/beta hydrolase 392399:393268 R
A1348_17375 alkene reductase 394187:395287 R
A1348_17475 hypothetical protein 414065:414451 R
A1348_17480 hypothetical protein 414521:414805 R
A1348_17485 hypothetical protein 414923:415360 F
A1348_17495 amidase 416352:417638 F
A1348_17510 hypothetical protein 419490:420233 F
A1348_17515 hypothetical protein 422227:423993 F
A1348_17525 hypothetical protein 425271:425900 F
A1348_17750 glycosyl transferase 481588:482241 R
A1348_17755 methyltransferase 482238:482837 R
A1348_17760 acetylglucosaminylphosphatidylinositol deacetylase 482834:483592 R
A1348_17765 acyl-CoA dehydrogenase 483589:484602 R
A1348_18380 hypothetical protein 622032:622726 F
A1348_30205 hypothetical protein 1:189 R
A1348_18495 hypothetical protein 57784:58044 F
A1348_18665 type B chloramphenicol O-acetyltransferase 85320:85955 F
A1348_18950 hypothetical protein 142049:143482 F
A1348_18955 hypothetical protein 143872:144651 F
A1348_18960 DNA polymerase V subunit UmuC 144768:146045 R
A1348_18965 peptidase S24 146038:146463 R
A1348_18970 hypothetical protein 146560:146769 R
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A1348_18975 hypothetical protein 147004:148581 R
A1348_19010 phage tail protein 152627:155185 R
A1348_19015 hypothetical protein 155327:155632 R
A1348_19020 phage tail protein 155645:156154 R
A1348_19025 phage tail protein 156167:157333 R
A1348_19035 phage tail protein 157869:159773 R
A1348_19040 phage tail protein 159770:160375 R
A1348_19045 baseplate assembly protein 160377:161258 R
A1348_19050 phage baseplate protein 161255:161581 R
A1348_19055 hypothetical protein 161586:161789 R
A1348_19060 phage baseplate protein 161854:162447 R
A1348_19065 hypothetical protein 162444:162956 R
A1348_19070 hypothetical protein 162949:163602 R
A1348_19075 hypothetical protein 163599:163913 R
A1348_19080 major capsid protein E 163916:164911 R
A1348_19085 hypothetical protein 164975:165319 R
A1348_19090 Clp protease ClpP 165316:166458 R
A1348_19095 portal protein 166455:167936 R
A1348_19100 hypothetical protein 167936:168142 R
A1348_19105 terminase 168144:170156 R
A1348_19110 terminase small subunit 170161:170733 R
A1348_19140 peptidase S24 175807:176520 F
A1348_19170 hypothetical protein 178601:178822 F
A1348_19175 hypothetical protein 178864:179160 F
A1348_19180 DNA methyltransferase 179150:180883 F
A1348_19185 hypothetical protein 181407:181880 F
A1348_19950 hypothetical protein 361445:361741 F
A1348_30220 conjugal transfer protein 1:615 R
A1348_30225 mammalian cell entry protein 1:608 R
A1348_21245 permease 9187:10101 R
A1348_21250 transcriptional regulator 10202:10978 R
A1348_21420 IclR family transcriptional regulator 44127:44903 R
A1348_21425 ABC transporter substrate-binding protein 45074:45838 F
A1348_21430 amino acid ABC transporter permease 45899:46555 F
glnQ glutamine ABC transporter ATP-binding protein 46552:47298 F
A1348_21440 FAD-dependent oxidoreductase 47295:48584 F
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A1348_21480 LysR family transcriptional regulator 57715:58622 R
A1348_21485 short-chain dehydrogenase 58821:59678 F
A1348_21505 hypothetical protein 63792:64385 F
A1348_21605 hypothetical protein 87826:88128 F
A1348_21610 hypothetical protein 88354:89010 R
A1348_21615 hypothetical protein 89122:89529 R
A1348_21645 AraC family transcriptional regulator 94388:95353 R
A1348_21650 MFS transporter 95513:96724 F
A1348_21665 hypothetical protein 101116:101817 R
A1348_21670 thiamine biosynthesis protein ApbE 101873:102847 R
A1348_21675 nitric oxide synthase 102837:105026 R
A1348_21680 Tat pathway signal protein 105053:105523 R
A1348_21685 DNA-binding response regulator 105758:106417 F
A1348_21690 two-component sensor histidine kinase 106414:107757 F
A1348_21755 hypothetical protein 121340:122269 F
A1348_21760 hypothetical protein 122419:122943 F
A1348_21765 hypothetical protein 123174:123527 F
A1348_21775 hypothetical protein 125735:126490 R
A1348_21780 colicin transporter 126737:126991 R
A1348_21805 hypothetical protein 131316:132215 R
A1348_21815 MerR family transcriptional regulator 133791:134180 F
A1348_21825 hypothetical protein 134871:135530 R
A1348_21910 hypothetical protein 152325:152837 R
A1348_21930 GNAT family acetyltransferase 156912:157487 F
A1348_21935 hypothetical protein 157524:157958 R
A1348_21955 hypothetical protein 160070:161089 F
A1348_21960 hypothetical protein 161086:161421 F
A1348_21965 hypothetical protein 161411:161599 F
A1348_22020 ABC transporter permease 168325:169284 R
A1348_22025 transcriptional regulator 169438:170334 F
A1348_22035 riboflavin-specific deaminase 170816:171253 F
A1348_22040 hypothetical protein 171316:171846 F
A1348_22090 hypothetical protein 181168:181653 R
A1348_22100 hypothetical protein 182448:182999 R
A1348_22105 hypothetical protein 183068:183829 R
A1348_22125 ligand-gated channel protein 186693:189131 R
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A1348_22135 RNA polymerase subunit sigma 190196:190702 R
A1348_22175 LysR family transcriptional regulator 199277:200152 R
A1348_22180 peptidyl-arginine deiminase 200290:201348 F
A1348_22185 N-carbamoylputrescine amidase 201345:202253 F
A1348_22190 ABC transporter substrate-binding protein 202255:203376 F
A1348_22195 agmatine deiminase 203524:204651 F
A1348_22265 hypothetical protein 216898:219108 R
A1348_22270 hypothetical protein 219099:219299 R
A1348_22275 hypothetical protein 219706:220326 R
A1348_22370 hypothetical protein 238369:238836 R
A1348_22820 hypothetical protein 335526:336224 F
A1348_22870 diaminopimelate epimerase 347954:348748 R
A1348_22940 ABC transporter permease 365055:366068 F
A1348_22960 hypothetical protein 369107:369514 R
A1348_23055 hypothetical protein 389106:389492 F
A1348_23060 hypothetical protein 389682:390623 F
A1348_23265 acyl-CoA synthetase 435248:436237 F
A1348_23270 ABC transporter ATP-binding protein 436234:437010 F
A1348_23275 ABC transporter permease 437010:437888 F
A1348_23280 ABC transporter permease 437893:438942 F
A1348_23285 ABC transporter permease 438971:440305 F
A1348_23290 ABC transporter ATP-binding protein 440309:441076 F
A1348_23405 hypothetical protein 467911:468312 F
A1348_23445 hypothetical protein 476273:476920 F
A1348_23450 hypothetical protein 476917:477387 F
A1348_23480 hypothetical protein 480392:481999 F
A1348_23485 hypothetical protein 482058:482744 R
A1348_23500 RNA polymerase subunit sigma-24 484024:484623 F
A1348_23580 ATP-dependent endonuclease 499198:500982 F
A1348_23585 DNA/RNA helicase 500964:502865 F
A1348_23590 hypothetical protein 503249:503974 F
A1348_23745 hypothetical protein 542601:544184 R
A1348_23750 hypothetical protein 544181:546673 R
A1348_23875 hypothetical protein 573885:574388 R
A1348_23965 DNA-binding protein 17387:17962 R
A1348_24010 transcriptional regulator 27036:27233 R
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A1348_24015 hypothetical protein 27230:27604 R
A1348_24285 cytochrome B 85173:85727 R
A1348_24330 amine oxidase 95481:96866 F
A1348_24335 cupin 96882:97226 F
A1348_24340 regulator 97216:98721 R
A1348_24345 spermidine/putrescine ABC transporter substrate-binding protein 98930:99946 F
A1348_24895 CopG family transcriptional regulator 215279:215551 F
A1348_24905 restriction endonuclease 216530:217441 R
A1348_24910 restriction endonuclease subunit R 217451:220648 R
A1348_24915 hypothetical protein 220648:221868 R
A1348_24920 restriction endonuclease subunit M 222045:224027 R
A1348_24925 fructose-bisphosphate aldolase 224343:224624 R
A1348_25115 hypothetical protein 262102:262341 F
A1348_25120 Holliday junction resolvase 262462:262785 R
A1348_25125 hypothetical protein 262903:263616 R
A1348_25135 hypothetical protein 264171:264452 F
A1348_25140 hypothetical protein 264459:264728 F
A1348_25225 hypothetical protein 280126:281694 R
A1348_25230 hypothetical protein 281875:283428 R
A1348_25380 plasmid stabilization protein ParE 318168:318524 R
A1348_25440 hypothetical protein 335315:337831 R
A1348_25445 hypothetical protein 337898:339991 R
A1348_25485 hypothetical protein 359473:359823 F
A1348_25490 fimbrial protein 360488:361036 F
A1348_25500 fimbrial protein 361911:364373 F
A1348_25505 hypothetical protein 364461:368051 R
A1348_25510 DNA-binding response regulator 368062:368685 R
A1348_25515 hypothetical protein 369021:369980 F
A1348_25560 hypothetical protein 379276:379551 R
A1348_25565 glucosidase 379748:382381 F
A1348_25725 hypothetical protein 424620:425150 F
A1348_25775 hypothetical protein 435725:435970 R
A1348_25780 serine hydrolase 436222:437841 F
A1348_25795 hypothetical protein 444938:445366 R
A1348_25800 hypothetical protein 445348:446046 R
A1348_25855 hypothetical protein 457880:458704 F
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A1348_25860 hypothetical protein 458856:459623 F
A1348_25875 transcriptional regulator 462042:462467 R
A1348_25880 mRNA interferase 462518:462697 R
A1348_25885 hypothetical protein 462787:463053 R
A1348_26080 type IV secretion protein Rhs 511853:512559 F
A1348_26085 hypothetical protein 1:651 F
A1348_26230 hypothetical protein 30283:31623 F
A1348_26240 hypothetical protein 32325:33269 R
A1348_26245 hypothetical protein 33256:34881 R
A1348_26320 hypothetical protein 60100:60516 R
A1348_26325 hypothetical protein 61124:62077 F
A1348_26330 ATP-dependent exonuclease 62151:63221 R
A1348_26335 ATP-dependent endonuclease 63214:64818 R
A1348_26380 NAD-dependent dehydratase 79396:80252 R
A1348_26445 hypothetical protein 92020:93603 R
A1348_26450 hypothetical protein 94157:94720 F
A1348_26455 hypothetical protein 94743:96380 R
A1348_26460 hypothetical protein 96380:97372 R
A1348_26465 hypothetical protein 97378:97959 R
A1348_26470 hypothetical protein 98131:99558 R
A1348_26475 polyketide synthase 99945:107012 R
A1348_26480 acyl transferase 106937:108964 R
A1348_26485 SAM-dependent methyltransferase 109125:109991 F
A1348_26490 polyketide synthase 110029:117654 R
A1348_26495 polyketide synthase 117720:130220 R
A1348_26500 cytochrome P450 130286:131695 R
A1348_26505 polyketide synthase 131692:143814 R
A1348_26510 polyketide synthase 143811:158636 R
A1348_26515 polyketide synthase 158807:178849 R
A1348_26520 hypothetical protein 179502:179906 F
A1348_27055 flavin reductase 324880:325440 R
A1348_27060 potassium transporter 325465:326700 R
A1348_27065 2Fe-2S ferredoxin 326813:327904 R
A1348_27070 FAD-dependent oxidoreductase 327929:329632 R
A1348_27075 monodechloroaminopyrrolnitrin synthase PrnB 329674:330759 R
A1348_27080 tryptophan halogenase 330759:332375 R
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A1348_27135 hypothetical protein 345390:345572 R
A1348_27540 hypothetical protein 447277:449721 F
A1348_28115 hypothetical protein 114675:115046 R
A1348_28605 hypothetical protein 222974:223395 F
A1348_29000 diguanylate phosphodiesterase 307568:308742 R
Table 6.1.2 – OMA-isolated genes exclusive to Pf-11.
Gene code Description Position
A1395_00130 hypothetical protein 31786:32013 F
A1395_00295 hypothetical protein 63051:63428 R
A1395_00300 GCN5 family acetyltransferase 64070:64507 R
A1395_00305 GNAT family acetyltransferase 64805:65353 R
A1395_00310 AraC family transcriptional regulator 65511:66359 F
A1395_00460 hypothetical protein 99323:99508 R
A1395_00575 hypothetical protein 125921:126262 F
A1395_00680 hypothetical protein 153783:154220 R
A1395_01315 hypothetical protein 283126:284442 R
A1395_01320 hypothetical protein 284476:285237 R
A1395_01325 hypothetical protein 285284:286510 R
A1395_01330 hypothetical protein 286498:287235 R
A1395_01335 hypothetical protein 287228:288253 R
A1395_01340 hypothetical protein 288250:289605 R
A1395_02460 phage tail protein 543394:544479 F
A1395_02465 hypothetical protein 544476:544856 F
A1395_02645 hypothetical protein 578866:579078 F
A1395_03120 GntR family transcriptional regulator 681101:682102 R
A1395_03125 amidase 682469:683827 F
A1395_03130 polysaccharide deacetylase 683875:684756 F
A1395_03135 MFS transporter 684785:686125 F
A1395_03150 hypothetical protein 687791:688090 F
A1395_03155 cobalamin biosynthesis protein CobW 688087:689094 F
A1395_03160 signal peptide prediction 689094:690302 F
A1395_03190 hypothetical protein 695707:696003 F
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A1395_03470 hypothetical protein 751292:751510 F
A1395_03520 hypothetical protein 758156:758347 F
A1395_03780 hypothetical protein 811187:812647 F
A1395_03785 hypothetical protein 812664:813638 R
A1395_03790 hypothetical protein 813681:813905 R
A1395_03795 hypothetical protein 813902:814240 R
A1395_03800 hypothetical protein 814345:814644 R
A1395_03805 hypothetical protein 814659:815354 R
A1395_03810 hypothetical protein 815503:815898 R
A1395_03815 serine recombinase 816281:816916 R
A1395_03820 hypothetical protein 817443:818366 F
A1395_03850 LysR family transcriptional regulator 823835:824779 R
A1395_03855 tricarboxylate transporter 824850:826379 R
A1395_03860 tripartite tricarboxylate transporter TctB 826376:826909 R
A1395_03865 tricarboxylate transporter 826985:827983 R
A1395_03870 4-hydroxythreonine-4-phosphate dehydrogenase 828481:829485 F
A1395_03875 MFS transporter 829829:831154 F
A1395_03880 L-rhamnonate dehydratase 831188:832363 F
A1395_03885 FAH family protein 832416:833411 F
A1395_03890 ketoglutarate semialdehyde dehydrogenase 833454:835034 F
A1395_04065 transposase 887179:887571 F
A1395_04070 transposase 887663:888322 F
A1395_04075 hypothetical protein 888858:889109 F
A1395_04080 hypothetical protein 889288:889503 F
A1395_04085 hypothetical protein 889555:890160 F
A1395_05130 hypothetical protein 1109019:1109246 R
A1395_05430 hypothetical protein 1167530:1167827 R
A1395_05475 hypothetical protein 1177038:1177223 F
A1395_05770 hypothetical protein 1253202:1254143 F
A1395_06200 hypothetical protein 1349559:1350614 F
A1395_06205 DNA cytosine methyltransferase 1350967:1352031 R
A1395_06215 hypothetical protein 1352605:1353651 R
A1395_06220 hypothetical protein 1353656:1354189 R
A1395_06225 hypothetical protein 1354186:1354803 R
A1395_06230 hypothetical protein 1354880:1355692 R
A1395_06235 hypothetical protein 1355732:1356082 R
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A1395_06240 transcriptional regulator 1356133:1356375 R
A1395_06245 hypothetical protein 1356372:1356755 R
A1395_06250 hypothetical protein 1356752:1357027 R
A1395_06255 deoxynucleotide monophosphate kinase 1357038:1357613 R
A1395_06260 hypothetical protein 1357610:1357795 R
A1395_06265 hypothetical protein 1357943:1358665 R
A1395_06270 hypothetical protein 1358782:1358994 F
A1395_06275 hypothetical protein 1359133:1359621 F
A1395_06285 hypothetical protein 1359817:1360854 F
A1395_06290 hypothetical protein 1360855:1362348 F
A1395_06295 hypothetical protein 1362596:1362979 F
A1395_06300 hypothetical protein 1362976:1363458 F
A1395_06310 hypothetical protein 1364112:1364855 R
A1395_06315 holin 1365147:1365464 F
A1395_06320 terminase 1365639:1366169 F
A1395_06325 terminase 1366132:1367967 F
A1395_06330 hypothetical protein 1367964:1368152 F
A1395_06335 portal protein 1368155:1369426 F
A1395_06340 capsid protein 1369423:1370406 F
A1395_06345 phage capsid protein 1370488:1371807 F
A1395_06350 hypothetical protein 1:244 R
A1395_06485 hypothetical protein 33006:33248 F
A1395_06725 hypothetical protein 98802:99857 R
A1395_06790 hypothetical protein 112442:114394 F
A1395_06885 lipase 136790:139096 R
A1395_06890 hypothetical protein 139093:139887 R
A1395_06895 hypothetical protein 139928:140722 R
A1395_06900 hypothetical protein 140719:141567 R
A1395_06905 type IV secretion protein Rhs 141564:143638 R
A1395_06925 hypothetical protein 147677:148468 R
A1395_06935 hypothetical protein 149385:150185 R
A1395_07270 hypothetical protein 232630:232917 F
A1395_07740 hypothetical protein 332845:334165 F
A1395_07745 hypothetical protein 334565:335089 F
A1395_07825 hypothetical protein 360614:361339 R
A1395_07830 hypothetical protein 361750:365682 R
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A1395_07910 TonB-dependent receptor 388024:390006 F
A1395_07915 hypothetical protein 390084:390458 F
A1395_07920 hypothetical protein 390452:391807 R
A1395_07925 hypothetical protein 391794:392315 R
A1395_07930 methanobactin biosynthesis cassette protein MbnB 392369:393181 R
A1395_07935 cytochrome-c peroxidase 393485:394621 R
A1395_07940 hypothetical protein 394618:395514 R
A1395_07945 membrane receptor protein 395531:397666 R
A1395_07950 hypothetical protein 397739:398164 R
A1395_08120 hypothetical protein 449154:449438 R
A1395_08125 hypothetical protein 449605:451452 F
A1395_08130 hypothetical protein 451449:453092 F
A1395_08135 hypothetical protein 453093:454982 F
A1395_08140 hypothetical protein 455032:456114 F
A1395_08590 zinc-binding alcohol dehydrogenase 568197:568754 R
A1395_08595 NADPH dehydrogenase 568890:569954 R
A1395_08600 HxlR family transcriptional regulator 570095:570517 R
A1395_08605 NmrA family transcriptional regulator 570753:571616 F
A1395_08610 alcohol dehydrogenase 571694:572683 F
A1395_08615
branched-chain amino acid ABC transporter substrate-binding
protein 573081:574361 F
A1395_08620 ABC transporter permease 574358:575260 F
A1395_08625 branched-chain amino acid ABC transporter permease 575260:576201 F
A1395_08630 ABC transporter ATP-binding protein 576198:576938 F
A1395_08635 ABC transporter ATP-binding protein 576950:577669 F
A1395_08640 aldehyde dehydrogenase 577666:579099 F
fabG 3-ketoacyl-ACP reductase 579144:579896 F
A1395_08650 alcohol dehydrogenase 580164:581261 F
A1395_08655 aldehyde dehydrogenase 581304:582761 F
A1395_08660 hypothetical protein 582777:583748 R
A1395_08665 aminomethyltransferase 584187:585845 F
A1395_08670 sarcosine oxidase 585847:586452 F
A1395_08680 cation transporter 589461:589790 R
A1395_08685 cation transporter 589793:590134 R
A1395_08690 mammalian cell entry protein 590800:592491 R
A1395_08695 paraquat-inducible protein A 592484:593104 R
A1395_08700 paraquat-inducible protein A 593101:593706 R
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A1395_08705 two-component sensor histidine kinase 593970:595154 R
A1395_08710 DNA-binding response regulator 595151:595852 R
A1395_08715 hypothetical protein 596057:597445 F
A1395_08720 hypothetical protein 597442:598275 F
A1395_08725 acriflavin resistance protein 599430:602516 F
A1395_08730 hypothetical protein 603883:604071 R
A1395_08735 hypothetical protein 605103:605381 F
A1395_08740 hypothetical protein 605666:606421 F
A1395_08745 AlpA family transcriptional regulator 606531:606761 F
A1395_08750 cobyrinic acid a,c-diamide synthase 606766:607605 F
A1395_08755 hypothetical protein 607691:607900 F
A1395_08760 chromosome partitioning protein ParB 607915:609495 F
A1395_08765 hypothetical protein 609492:610040 F
A1395_08770 hypothetical protein 610037:611227 F
A1395_08775 conjugal transfer protein 611373:612128 F
A1395_08780 integrase 612125:612643 F
A1395_08785 single-stranded DNA-binding protein 612640:613110 F
A1395_08790 DNA topoisomerase III 613333:615300 F
A1395_08795 hypothetical protein 615342:615596 R
A1395_08800 transcriptional regulator 615805:616146 F
A1395_08805 hypothetical protein 617059:617640 F
A1395_08810 hypothetical protein 617711:617968 F
A1395_08815 DNA repair protein RadC 618069:618563 F
A1395_08820 ABC transporter substrate-binding protein 618616:619371 F
A1395_08825 pili assembly chaperone 619460:620002 F
A1395_08830 chemotaxis protein 619999:620667 F
A1395_08835 hypothetical protein 620677:621390 F
A1395_08840 lytic transglycosylase 621372:621920 F
A1395_08845 conjugal transfer protein 621917:622432 F
A1395_08850 conjugal transfer protein TraG 622442:624547 F
A1395_08855 hypothetical protein 624637:625368 F
A1395_08860 hypothetical protein 625389:625970 R
A1395_08865 conjugal transfer protein 626270:626605 F
A1395_08870 conjugal transfer protein 626602:626841 F
A1395_08875 conjugal transfer protein 626859:627230 F
A1395_08880 conjugal transfer protein 627238:627651 F
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A1395_08885 hypothetical protein 627648:628289 F
A1395_08890 conjugal transfer protein 628286:629101 F
A1395_08895 conjugal transfer protein 629091:630608 F
A1395_08900 conjugal transfer protein 630571:630987 F
A1395_08905 conjugal transfer protein 630987:633725 F
A1395_08910 hypothetical protein 634115:634690 F
A1395_08915 hypothetical protein 634928:635185 R
A1395_08920 transcriptional regulator 635357:635611 F
A1395_08925 conjugal transfer protein 635717:636673 F
A1395_08930 conjugal transfer protein 636670:638052 F
A1395_08935 conjugal transfer protein TraG 638375:639916 F
A1395_08940 hypothetical protein 639905:640303 R
A1395_08945 hypothetical protein 640761:641090 F
A1395_08950 DNA primase 641226:642185 F
A1395_08955 hypothetical protein 642323:642520 R
A1395_08960 relaxase 642742:644466 F
A1395_08965 hypothetical protein 644784:648611 F
A1395_08970 DNA helicase UvrD 648635:650521 R
A1395_08975 ATP-dependent endonuclease 650524:652494 R
A1395_08980 hypothetical protein 656186:656383 F
A1395_08985 hypothetical protein 657752:658132 F
A1395_08990 hypothetical protein 658179:659084 R
A1395_08995 hypothetical protein 659406:660026 F
A1395_09000 DNA-binding protein 660019:661137 F
A1395_09010 hypothetical protein 662506:663186 R
A1395_09015 hypothetical protein 663173:664132 R
A1395_09020 hypothetical protein 664147:664704 R
A1395_09025 hypothetical protein 664841:665104 F
A1395_09030 hypothetical protein 665341:666342 R
A1395_09035 hypothetical protein 667043:668242 R
A1395_09040 phytanoyl-CoA dioxygenase 668534:669403 F
A1395_09045 glycosyl hydrolase 669520:670482 R
A1395_09050 RND transporter 670493:672907 R
A1395_09055 arylsulfatase 672916:674502 R
A1395_09060 hypothetical protein 674587:675768 R
A1395_09065 hypothetical protein 676483:677178 R
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A1395_09070 hypothetical protein 677308:677523 R
A1395_09075 phytanoyl-CoA dioxygenase 677595:678482 R
A1395_09080 TetR family transcriptional regulator 678865:679443 F
A1395_09085 hypothetical protein 679437:679652 R
A1395_09090 FAD-containing monooxygenase EthA 679745:681271 F
A1395_09095 alpha/beta hydrolase 681268:682143 F
A1395_09100 1,3-propanediol dehydrogenase 682337:683494 F
A1395_09105 amino acid permease 683507:684838 F
A1395_09110 gamma-aminobutyraldehyde dehydrogenase 684918:686342 F
A1395_09115 diaminobutyrate--2-oxoglutarate transaminase 686388:687641 F
A1395_09120 hypothetical protein 687917:688174 F
A1395_09125 oxidoreductase 688326:689126 F
A1395_09130 amino acid permease 689194:689346 F
A1395_09135 cation acetate symporter 689397:691055 R
A1395_09140 hypothetical protein 691052:691375 R
A1395_09145 acyl-CoA synthetase 691432:693084 R
A1395_09155 acyl-CoA dehydrogenase 693935:695107 R
A1395_09160 acyl-CoA dehydrogenase 695161:695517 R
A1395_09165 aminoglycoside phosphotransferase 695514:696572 R
A1395_09170 propionate catabolism operon regulatory protein PrpR 696772:698724 F
A1395_09175 transcriptional regulator 698910:699470 F
A1395_09180 transcriptional regulator 699667:700188 R
A1395_09185 mammalian cell entry protein 700230:702542 R
A1395_09190 paraquat-inducible protein A 702535:703155 R
A1395_09195 multidrug transporter 703156:704592 R
A1395_09200 multidrug efflux RND transporter permease subunit 704592:707723 R
A1395_09205 efflux transporter periplasmic adaptor subunit 707751:708902 R
A1395_09210 transcriptional regulator 709027:709632 F
A1395_09215 paraquat-inducible protein A 709658:710296 F
A1395_09220 hypothetical protein 710906:711655 R
A1395_09670 ATPase 824172:828644 R
A1395_09675 diguanylate cyclase 828673:830373 R
A1395_09880 hypothetical protein 878131:878385 R
A1395_09930 Cro/Cl family transcriptional regulator 890638:890889 F
A1395_09935 hypothetical protein 890940:891221 R
A1395_09940 hypothetical protein 891442:894669 R
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A1395_09945 hypothetical protein 894859:895572 R
A1395_09975 hypothetical protein 899701:900729 R
A1395_10010 alpha/beta hydrolase 908065:908679 F
A1395_10035 hypothetical protein 911077:911289 R
A1395_10195 hypothetical protein 943968:944363 F
A1395_10225 hypothetical protein 950446:950694 R
A1395_10465 hypothetical protein 1001825:1002019 F
A1395_10540 ABC transporter permease 1017547:1019631 R
A1395_10610 hypothetical protein 1035794:1036242 F
A1395_11195 hypothetical protein 1162351:1162548 F
A1395_11295 hypothetical protein 1183129:1183890 F
A1395_11300 hypothetical protein 1183887:1184528 F
A1395_11355 hypothetical protein 1193655:1193972 F
A1395_11420 hypothetical protein 1204360:1204701 F
A1395_11475 hypothetical protein 1213964:1214329 F
A1395_11510 hypothetical protein 1218427:1218633 F
A1395_11515 GCN5 family acetyltransferase 1218715:1218951 F
A1395_11570 hypothetical protein 1231649:1232203 F
A1395_11575 fimbrial assembly protein 1232896:1235331 F
A1395_11585 hypothetical protein 1236144:1236635 F
A1395_11590 hypothetical protein 1236632:1237129 F
A1395_11595 hypothetical protein 1237126:1237629 F
A1395_11600 hypothetical protein 1237638:1238168 F
A1395_11605 hypothetical protein 1238690:1239010 F
A1395_11610 hypothetical protein 1239531:1240047 R
A1395_11615 DNA-binding response regulator 1240178:1240807 R
A1395_11620 diguanylate phosphodiesterase 1241030:1242229 F
A1395_11625 hybrid sensor histidine kinase/response regulator 1242327:1245974 F
A1395_11635 hypothetical protein 1247131:1247337 F
A1395_11665 hypothetical protein 1253113:1253742 F
A1395_11785 hypothetical protein 1281902:1282573 F
A1395_11790 hypothetical protein 1282586:1283764 R
A1395_30045 hypothetical protein 44393:44761 R
A1395_30240 Rhs element Vgr protein 118205:118801 R
A1395_31585 flagellar M-ring protein FliF 94:774 F
A1395_31590 sigma-54-dependent Fis family transcriptional regulator 1:434 R
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A1395_31595 hypothetical protein 442:756 R
A1395_30260 hypothetical protein 4380:5180 F
A1395_30525 hypothetical protein 73155:73391 R
A1395_30530 hypothetical protein 73463:73933 F
A1395_30630 hypothetical protein 98586:100481 F
A1395_30635 integrase 103147:104211 R
A1395_30640 hypothetical protein 104215:104457 R
A1395_30645 hypothetical protein 104481:105113 F
A1395_30675 hypothetical protein 107690:108856 F
A1395_30695 pyocin R2, holin 114067:114408 F
A1395_30700 holin 114469:114786 F
A1395_30705 terminase 114961:115491 F
A1395_31605 hypothetical protein 1:214 R
A1395_31615 hypothetical protein 1:260 R
A1395_31620 hypothetical protein 257:613 R
A1395_31625 glutamine synthetase 1:741 R
A1395_31630 hypothetical protein 1:739 F
A1395_31635 ribosome maturation factor 1:198 F
nusA transcription termination/antitermination protein NusA 246:737 F
A1395_30810 hypothetical protein 22280:22522 F
A1395_30835 hypothetical protein 26864:27322 R
A1395_30840 antibiotic biosynthesis monooxygenase 27355:27723 R
A1395_30845 MarR family transcriptional regulator 27856:28284 F
A1395_30850 hypothetical protein 28478:28909 F
A1395_30860 hypothetical protein 29672:29854 R
A1395_30865 hypothetical protein 29935:30177 F
A1395_30870 transposase 30241:30501 R
A1395_30875 hypothetical protein 30634:31209 R
A1395_30880 hypothetical protein 31808:32395 F
A1395_30885 acetylornithine aminotransferase 33761:34999 F
A1395_30890 hypothetical protein 35052:36764 F
A1395_30895 short-chain dehydrogenase 36861:37706 F
A1395_30900 hypothetical protein 37699:38322 F
A1395_30905 NTD biosynthesis hydrolase NtdB 38329:39114 F
A1395_30910 acetylserotonin O-methyltransferase 39133:40158 F
A1395_30915 hypothetical protein 40205:41458 F
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A1395_30920 CopG family transcriptional regulator 41929:42286 R
A1395_30925 hypothetical protein 42452:43045 R
A1395_30930 hypothetical protein 43042:43515 R
A1395_30935 CopG family transcriptional regulator 45501:45902 R
A1395_30940 hypothetical protein 46384:46626 R
A1395_30945 His-Xaa-Ser system radical SAM maturase HxsC 47222:48451 R
A1395_30950 His-Xaa-Ser system radical SAM maturase HxsB 48457:49944 R
A1395_30960 hypothetical protein 51891:52589 F
A1395_31055 hypothetical protein 75592:75848 R
A1395_31645 leucyl aminopeptidase 1:453 F
A1395_31650 DNA polymerase III subunit chi 511:733 F
A1395_31660 type IV secretion protein Rhs 1:731 R
A1395_31215 phage head-tail joining protein 55:417 R
A1395_31220 hypothetical protein 419:1006 R
A1395_31225 hypothetical protein 1009:1356 R
A1395_31230 phage capsid protein 1411:2730 R
A1395_31235 capsid protein 2812:3795 R
A1395_31240 portal protein 3792:5063 R
A1395_31245 hypothetical protein 5066:5254 R
A1395_31250 terminase 5251:5913 R
A1395_31665 transposase 70:730 R
A1395_31670 FAD-dependent oxidoreductase 1:442 R
A1395_31675 phage tail protein 1:720 R
A1395_31680 hypothetical protein 1:717 F
A1395_31685 SAM-dependent methyltransferase 89:493 F
A1395_31690 hypothetical protein 25:701 F
A1395_31695 hypothetical protein 1:699 R
A1395_31705 hypothetical protein 494:693 F
A1395_31710 phage tail protein 1:504 R
A1395_31715
bifunctional  ADP-dependent  (S)-NAD(P)H-hydrate  dehyd-
ratase/NAD(P)H-hydrate epimerase 1:501 R
A1395_31720 hypothetical protein 1:675 F
A1395_31725 3-oxoadipate enol-lactonase 80:672 F
A1395_31280 hypothetical protein 1:564 F
A1395_31285 hydroxyacid dehydrogenase 569:1819 F
A1395_31290 baseplate protein 1823:2938 F
A1395_31295 hypothetical protein 2935:3441 F
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A1395_31300 hypothetical protein 3444:3842 F
A1395_31730 hypothetical protein 1:329 F
nudF ADP-ribose pyrophosphatase 1:441 R
purH
bifunctional  phosphoribosylaminoimidazolecarboxamide
formyltransferase/inosine monophosphate cyclohydrolase 1:276 F
A1395_31745 hypothetical protein 476:658 F
A1395_31750 glycosyl transferase family 2 1:280 F
A1395_31755 polysaccharide deacetylase 294:655 F
A1395_31760 sulfate adenylyltransferase 80:655 F
A1395_31765 hypothetical protein 1:193 F
A1395_31770 threonine synthase 299:654 F
A1395_12330 TonB-dependent receptor 34512:36953 R
A1395_12355 hypothetical protein 40912:41250 R
A1395_12455
mannose-1-phosphate  guanylyltransferase/mannose-6-phos-
phate isomerase 73239:73983 F
A1395_12905 hypothetical protein 168536:169027 R
A1395_12910 hypothetical protein 170792:171199 F
A1395_12920 integration host factor subunit beta 173045:173335 R
A1395_13445 MFS transporter 284483:285688 R
A1395_13450 TetR family transcriptional regulator 285781:286326 F
A1395_14880 hypothetical protein 591485:591763 R
A1395_15255 fatty acid desaturase 669195:670061 R
A1395_15710 integrase 770635:771876 F
A1395_15715 hypothetical protein 772123:773061 F
A1395_15720 hypothetical protein 773395:773700 F
A1395_15725 hypothetical protein 774231:774515 F
A1395_15730 hypothetical protein 774512:774781 F
A1395_15735 DNA/RNA helicase, superfamily II protein 774778:777672 F
A1395_15740 chromosome segregation protein SMC 777899:778741 F
A1395_15745 hypothetical protein 778805:778990 F
A1395_15750 transcriptional regulator 779060:779425 F
A1395_15755 hypothetical protein 782247:783194 R
A1395_15760 hypothetical protein 784016:784897 F
A1395_15835 hypothetical protein 801542:801751 R
A1395_15870 ArsR family transcriptional regulator 808925:809590 R
A1395_15875 hypothetical protein 809700:810209 F
A1395_16655 AraC family transcriptional regulator 968805:969740 R
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A1395_16660 phenylacetaldoxime dehydratase 970296:971354 F
A1395_16665 phenol degradation protein meta 971446:972312 F
A1395_16670 amidase 972504:974018 F
A1395_16675 nitrile hydratase subunit alpha 974095:974688 F
A1395_16680 nitrile hydratase subunit beta 974730:975392 F
A1395_16685 hypothetical protein 975389:976669 F
A1395_16690 chemotaxis protein 976666:977958 F
A1395_16845 hypothetical protein 1006137:1006355 F
A1395_31305 phage head-tail joining protein 1:245 F
A1395_31310 hypothetical protein 238:759 F
A1395_31315 hypothetical protein 821:1315 F
A1395_31325 hypothetical protein 2061:2651 F
A1395_31775 pyridoxalphosphate dependent aminotransferase 1:654 F
A1395_31785 hypothetical protein 251:651 R
A1395_31330 hypothetical protein 21:611 R
A1395_31335 hypothetical protein 1058:1393 F
A1395_31345 hypothetical protein 2183:2419 R
A1395_31790 4-hydroxy-tetrahydrodipicolinate synthase 3:646 F
A1395_31795 hypothetical protein 1:644 R
A1395_31800 signal recognition particle-docking protein FtsY 1:629 F
A1395_31350 hypothetical protein 1665:2337 F
A1395_31805 hypothetical protein 1:524 R
A1395_31355 phage tail protein 1:1173 F
A1395_31360 phage tail protein 1231:1578 F
A1395_31365 ArsR family transcriptional regulator 1575:1871 F
A1395_31810 gamma-glutamylputrescine oxidoreductase 1:621 R
A1395_31815 hypothetical protein 1:573 R
A1395_31375 phage tail tape measure protein 1:1790 R
A1395_31380 hypothetical protein 1790:1980 R
A1395_31820 aminodeoxychorismate lyase 89:613 F
A1395_31825 carbamoyltransferase 1:611 R
A1395_31835 hypothetical protein 1:605 F
A1395_31385 phage tail tape measure protein 1:1790 R
A1395_31390 hypothetical protein 1790:1980 R
A1395_31395 hypothetical protein 41:241 R
A1395_31400 hypothetical protein 1:1655 F
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A1395_17490 addiction module toxin RelE 117211:117525 R
A1395_17495 toxin-antitoxin system protein 117491:117781 R
A1395_17640
cytotoxic  translational  repressor  of  toxin-antitoxin  stability
system 155044:155298 F
A1395_17645 transcriptional regulator 155282:155605 F
A1395_18870 hypothetical protein 415076:416449 F
A1395_19425 hypothetical protein 538177:538509 R
A1395_19430 hypothetical protein 538910:539713 R
A1395_20090 hypothetical protein 681599:682114 F
A1395_20095 hypothetical protein 682303:682815 F
A1395_20100 hypothetical protein 682812:683195 F
A1395_20310 hypothetical protein 720727:720930 F
A1395_31410 hypothetical protein 491:898 R
A1395_31415 hypothetical protein 1:1200 F
A1395_20755 hypothetical protein 23916:24176 F
A1395_20760 hypothetical protein 25221:25973 F
A1395_20765 transcriptional regulator 26092:26304 F
A1395_20770 cobyrinic acid a,c-diamide synthase 26347:27222 F
A1395_20775 hypothetical protein 27206:27454 F
A1395_20780 hypothetical protein 27447:29096 F
A1395_20785 coproporphyrinogen III oxidase 29112:29672 F
A1395_20790 hypothetical protein 29676:30902 F
A1395_20795 conjugal transfer protein 31221:32000 F
A1395_20800 integrase 31997:32524 F
A1395_20805 single-stranded DNA-binding protein 32597:33037 F
A1395_20810 DNA topoisomerase III 33316:35328 F
A1395_20820 hypothetical protein 37698:38255 F
A1395_20825 hypothetical protein 38587:38799 F
A1395_20830 hypothetical protein 38821:39213 F
A1395_20835 hypothetical protein 39387:40073 F
A1395_20840 ABC transporter substrate-binding protein 40154:40891 F
A1395_20845 uridylate kinase 40989:41267 F
A1395_20850 GTPase 41556:42368 F
A1395_20855 hypothetical protein 42493:42846 F
A1395_20860 hypothetical protein 43215:44132 F
A1395_20865 hypothetical protein 44190:44879 F
A1395_20870 conserved plasmid protein 44974:45297 F
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A1395_20875 hypothetical protein 45400:45807 F
A1395_20880 hypothetical protein 45824:46084 F
A1395_20885 hypothetical protein 46161:46808 F
A1395_20890 methyltransferase 46873:47982 F
A1395_20895 methyltransferase 48034:48354 F
A1395_20900 hypothetical protein 48445:48750 F
A1395_20905 DEAD/DEAH box helicase 48886:51165 F
A1395_20910 hypothetical protein 51281:51487 F
A1395_20915 integrating conjugative element protein pill, pfgi-1 51635:52234 F
A1395_20920 hypothetical protein 52231:52872 F
A1395_20925 hypothetical protein 52887:53612 F
A1395_20930 lytic transglycosylase 53594:54199 F
A1395_20935 hypothetical protein 54196:54735 F
A1395_20940 conjugal transfer protein TraG 54740:56929 F
A1395_20945 hypothetical protein 56926:57675 F
A1395_20950 RAQPRD family plasmid 57774:58157 F
A1395_20955 hypothetical protein 58154:58387 F
A1395_20960 conjugal transfer protein 58404:58763 F
A1395_20965 hypothetical protein 58775:59173 F
A1395_20970 hypothetical protein 59170:59859 F
A1395_20975 hypothetical protein 59856:60761 F
A1395_20980 conjugal transfer protein 60751:62169 F
A1395_20985 conjugal transfer protein 62150:62590 F
A1395_20990 conjugal transfer protein 62590:65457 F
A1395_20995 disulfide bond formation protein DsbA 65471:66235 F
A1395_21000 DNA repair protein RadC 66411:66905 F
A1395_21005 hypothetical protein 67067:67513 F
A1395_21010 conjugal transfer protein 67510:68457 F
A1395_21015 conjugal transfer protein 68467:69861 F
A1395_21020 hypothetical protein 69858:70214 F
A1395_21025 conjugal transfer protein TraG 70230:71750 F
A1395_21030 hypothetical protein 71762:72127 R
A1395_21035 hypothetical protein 72212:72844 R
A1395_21040 integrase 72857:73483 R
A1395_21045 relaxase 73801:75639 F
A1395_21050 excinuclease ABC subunit A 75720:78371 R
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A1395_21055 sodium:proton antiporter 78397:80262 R
A1395_21060 recombination factor protein RarA 80323:81636 R
A1395_21065 NADH dehydrogenase 81688:82995 R
A1395_21070 S-formylglutathione hydrolase 83014:83844 R
A1395_21075 Egg lysin 83903:85237 R
A1395_21080 glyoxalase 85420:85818 R
A1395_21085
S-(hydroxymethyl)glutathione  dehydrogenase/class  III  alco-
hol dehydrogenase 85862:86971 R
A1395_21090 regulator 87031:87306 R
A1395_21095 nitrilase 87589:88479 R
A1395_21100 GNAT family acetyltransferase 88476:89084 R
A1395_21105 isopropylmalate/homocitrate/citramalate synthase 89086:89493 R
A1395_21110 LysR family transcriptional regulator 89648:90553 F
A1395_21115 excinuclease ABC subunit B 90704:92680 R
A1395_21120 hypothetical protein 93055:93486 R
A1395_21125 hypothetical protein 94342:94596 R
A1395_21130 formaldehyde dehydrogenase, glutathione-independent 95387:96601 F
A1395_21135 D-alanyl-D-alanine endopeptidase 97105:97995 F
A1395_21140 LysR family transcriptional regulator 98431:99084 F
A1395_21145 peroxidase 99203:100171 F
A1395_21150 integrase 100209:102152 R
A1395_21190 hypothetical protein 108981:109181 R
A1395_21330 hypothetical protein 143709:144818 F
A1395_21345 hypothetical protein 152027:152341 F
A1395_21350 hypothetical protein 152313:152576 F
A1395_21555 hypothetical protein 204959:205849 F
A1395_21560 hypothetical protein 205985:206746 F
A1395_21605 hypothetical protein 216743:217222 R
A1395_21645 type IV secretion protein Rhs 236722:241398 F
A1395_21650 hypothetical protein 242512:242862 F
A1395_21720 AraC family transcriptional regulator 260277:261314 R
A1395_21725 hypothetical protein 261575:262525 F
A1395_21730 alanine racemase 262890:264164 R
A1395_21735 FAD-linked oxidoreductase 264181:265575 R
A1395_21740 cytochrome C 265595:266017 R
A1395_21955 hypothetical protein 313262:313555 R
A1395_21965 transcriptional regulator 314840:315220 F
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A1395_21970 hypothetical protein 315204:315701 F
A1395_21985 hypothetical protein 317310:318137 R
A1395_21990 hypothetical protein 318137:318427 R
A1395_22015 hypothetical protein 323655:323834 R
A1395_22020 hypothetical protein 323831:324046 R
A1395_22040 hypothetical protein 329641:330837 R
A1395_22045 nucleotide pyrophosphohydrolase 330848:331198 R
A1395_22080 hypothetical protein 334278:334631 F
A1395_22090 hypothetical protein 335135:335443 R
A1395_22100 hypothetical protein 336454:337170 R
A1395_22105 hypothetical protein 337253:337576 R
A1395_22120 terminase 340133:341434 R
A1395_22135 hypothetical protein 342605:343057 F
A1395_22140 hypothetical protein 343127:343471 R
A1395_22145 MFS transporter 343468:343797 R
A1395_22170 hypothetical protein 347093:348025 R
A1395_22180 Rha family transcriptional regulator 348979:349401 R
A1395_22185 repressor 349484:349687 R
A1395_22190 XRE family transcriptional regulator 349804:350592 F
A1395_22195 hypothetical protein 350649:351194 F
A1395_22200 hypothetical protein 351238:351471 F
A1395_22205 hypothetical protein 351540:352436 F
A1395_22210 hypothetical protein 353231:353824 F
A1395_22215 hypothetical protein 353990:354463 F
A1395_22220 hypothetical protein 355263:355694 F
A1395_22255 hypothetical protein 358913:359226 F
A1395_22260 hypothetical protein 360105:361214 F
A1395_22265 hypothetical protein 361698:361928 R
A1395_22270 DNA methyltransferase 362013:364058 F
A1395_22275 hypothetical protein 364071:365123 R
A1395_22285 hypothetical protein 366960:367427 F
A1395_22290 hypothetical protein 367464:367706 F
A1395_22305 hypothetical protein 370262:370966 R
A1395_22310 hypothetical protein 371003:371311 F
A1395_22315 hypothetical protein 371668:371862 F
A1395_22320 hypothetical protein 372076:372927 R
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A1395_22325 hypothetical protein 373346:373537 R
A1395_22330 hypothetical protein 373728:374240 R
A1395_22335 hypothetical protein 374590:377007 R
A1395_22340 hypothetical protein 377922:378350 F
A1395_22345 hypothetical protein 378531:379022 F
A1395_22350 hypothetical protein 379057:380211 F
A1395_22355 hypothetical protein 380208:380804 F
A1395_22360 hypothetical protein 380816:381574 F
A1395_22365 hypothetical protein 381587:381994 F
A1395_22370 toll-Interleukin receptor 382350:382931 R
A1395_22375 hypothetical protein 382973:383812 R
A1395_22380 hypothetical protein 384179:384589 F
A1395_22385 hypothetical protein 385017:385727 R
A1395_22390 transposase 386457:386735 F
A1395_22395 transposase 386726:387607 F
A1395_22400 serine/threonine protein phosphatase 387604:388326 R
A1395_22405 Cro/Cl family transcriptional regulator 388655:389089 F
A1395_22410 hypothetical protein 389254:389664 R
A1395_22415 DNA helicase UvrD 389710:391692 R
A1395_22420 ATP-dependent endonuclease 391689:393752 R
A1395_22425 transposase 394336:394968 R
A1395_22430 transposase 394910:395289 F
A1395_22435 transposase 395429:396121 F
A1395_22440 hypothetical protein 398352:399188 R
A1395_22445 hypothetical protein 399420:399605 F
A1395_22450 hypothetical protein 399909:401375 R
A1395_22455 hypothetical protein 401344:402396 R
A1395_22460 metal-chelation protein CHAD 403252:404037 R
A1395_22465 tautomerase 404227:404676 R
A1395_22470 AraC family transcriptional regulator 404773:405732 F
A1395_22475 diguanylate cyclase 406144:407076 F
A1395_22660 hypothetical protein 442275:443483 F
A1395_22665 nucleotide pyrophosphohydrolase 443829:444212 F
A1395_22670 ATP-binding protein 444237:446111 F
A1395_22680 HNH endonuclease 447689:448012 F
A1395_23230 hypothetical protein 563038:563412 F
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A1395_23580 hypothetical protein 639622:640011 R
A1395_23660 type IV secretion protein Rhs 658803:660354 F
A1395_31420 hypothetical protein 1:1017 R
A1395_31425 phage tail protein 2:1174 R
A1395_31430 hypothetical protein 1:639 R
A1395_31435 phage tail protein 1:623 R
A1395_31440 hypothetical protein 623:823 R
A1395_31445 hypothetical protein 820:1098 R
A1395_23730 hypothetical protein 15421:15603 R
A1395_23825 hypothetical protein 35919:36125 R
A1395_25190 poly(3-hydroxyalkanoate) granule-associated protein PhaI 356247:356669 R
A1395_25370 prevent-host-death protein 394005:394277 F
A1395_25375 plasmid stabilization protein 394274:394606 F
A1395_25575 cell filamentation protein Fic 440614:441768 F
A1395_25715 amidase 472403:472711 R
A1395_26040 3-ketoacyl-ACP reductase 542830:543183 F
A1395_31460 aminotransferase 1:448 F
A1395_31465
spermidine/putrescine ABC transporter substrate-binding pro-
tein 621:1023 F
A1395_31470 hypothetical protein 440:1019 F
A1395_26330 hypothetical protein 53031:53210 R
A1395_26335 diguanylate phosphodiesterase 53351:54526 F
A1395_26730 hypothetical protein 138575:138997 R
A1395_27220 hypothetical protein 246137:246745 F
A1395_27225 hypothetical protein 246742:247392 F
A1395_27325 cell filamentation protein Fic 274924:276087 F
A1395_31475
autotransporter outer  membrane beta-barrel domain-contain-
ing protein 1:949 F
A1395_31480 isoleucine--tRNA ligase 1:939 R
A1395_31485 nitrate reductase 1:917 F
A1395_31490 transcriptional regulator 1:905 F
A1395_31495 hybrid sensor histidine kinase/response regulator 1:900 F
A1395_31500 TfdA 170:896 R
A1395_27905 hypothetical protein 56315:56497 F
A1395_27915 NAD-dependent deacylase 58451:59227 R
A1395_27920 hypothetical protein 59452:59841 R
A1395_27925 transposase 60441:61322 R
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A1395_27930 transposase 61313:61591 R
A1395_27935 hypothetical protein 62187:62468 F
A1395_27940 hypothetical protein 62623:62861 F
A1395_27945 hypothetical protein 62895:63926 R
A1395_27955 hypothetical protein 65471:65728 R
A1395_27960 hypothetical protein 65725:66099 R
A1395_27965 structural protein P5 66096:66539 R
A1395_27975 hypothetical protein 67050:68558 R
A1395_27990 host specificity protein 69790:73524 R
A1395_27995 phage tail protein 73577:74161 R
A1395_28000 hydrolase Nlp/P60 74158:74940 R
A1395_28005 phage tail protein 74943:75644 R
A1395_28010 phage tail protein 75681:76028 R
A1395_28015 phage tail tape measure protein 76028:79423 R
A1395_28020 hypothetical protein 79480:79815 R
A1395_28025 hypothetical protein 79828:80082 R
A1395_28030 hypothetical protein 80112:80450 R
A1395_28035 phage tail protein 80460:81182 R
A1395_28040 hypothetical protein 81235:81603 R
A1395_28045 hypothetical protein 81611:82075 R
A1395_28050 head-tail adaptor protein 82068:82409 R
A1395_28055 hypothetical protein 82409:82885 R
A1395_28060 hypothetical protein 82889:83278 R
A1395_28065 capsid protein 83322:84536 R
A1395_28070 peptidase 84551:85426 R
A1395_28075 portal protein 85440:86837 R
A1395_28080 terminase 86837:88528 R
A1395_28085 hypothetical protein 88531:88749 R
A1395_28090 HNH endonuclease 89093:89431 R
A1395_28095 hypothetical protein 89431:89796 R
A1395_28105 hypothetical protein 90628:91179 R
A1395_28110 antitermination protein Q 91516:91890 R
A1395_28115 hypothetical protein 91887:92174 R
A1395_28120 helicase DnaB 92167:93555 R
A1395_28125 ATP-binding protein 93552:94352 R
A1395_28130 hypothetical protein 94402:95094 R
186
A1395_28135 hypothetical protein 95091:95318 R
A1395_28140 hypothetical protein 95315:95692 R
A1395_28145 hypothetical protein 95689:96420 R
A1395_28150 hypothetical protein 96417:96677 R
A1395_28155 hypothetical protein 96670:96942 R
A1395_28160 hypothetical protein 96939:97271 R
A1395_28165 XRE family transcriptional regulator 98111:98878 F
A1395_28170 helix-turn-helix transcriptional regulator 99006:99242 F
A1395_28175 carbon storage regulator 99397:99699 F
A1395_28180 hypothetical protein 99686:100051 F
A1395_28185 hypothetical protein 100048:100809 F
A1395_28190 hypothetical protein 100806:101030 F
A1395_28195 hypothetical protein 101117:101329 F
A1395_28200 integrase 101329:102441 F
A1395_28370 type B chloramphenicol O-acetyltransferase 129607:130240 F
A1395_28555 hypothetical protein 162602:162793 F
A1395_28660 RelA/SpoT family protein 186651:187541 R
A1395_28665 hypothetical protein 187541:189664 R
A1395_28670 hypothetical protein 190222:190911 F
A1395_28675 hypothetical protein 191051:191389 F
A1395_28680 hypothetical protein 191663:192586 F
A1395_28685 lysozyme 192649:193164 R
A1395_28695 phage tail protein 193764:194189 R
A1395_28700 hypothetical protein 194617:195462 R
A1395_28705 phage tail protein 195463:196071 R
A1395_28710 baseplate J protein 196059:197099 R
A1395_28715 hypothetical protein 197089:197302 R
A1395_31505 hypothetical protein 562:747 F
A1395_31510 diguanylate cyclase 1:454 F
A1395_31515 hybrid sensor histidine kinase/response regulator 416:881 R
A1395_31520 ribonuclease R 1:876 F
A1395_31525 peptide transporter 1:160 F
dppD peptide ABC transporter ATP-binding protein 171:870 F
A1395_31535 hypothetical protein 178:378 F
A1395_28720 hypothetical protein 1:214 F
A1395_28725 baseplate J protein 204:1244 F
187
A1395_28730 phage tail protein 1232:1840 F
A1395_28735 hypothetical protein 1841:2686 F
A1395_28745 lysozyme 3591:4142 F
A1395_28755 hypothetical protein 6618:7547 F
A1395_28780 hypothetical protein 12281:13408 R
A1395_28785 hypothetical protein 13647:14726 R
A1395_28790 transposase 14816:15091 R
A1395_28795 hypothetical protein 15800:16138 R
A1395_28820 glyoxalase 20599:20991 F
A1395_28920 integrase 34843:35840 R
A1395_28930 hypothetical protein 36350:36622 R
A1395_28935 hypothetical protein 36667:36897 F
A1395_28945 hypothetical protein 37367:37681 R
A1395_28950 hypothetical protein 37766:37963 F
A1395_28955 hypothetical protein 40672:40977 R
A1395_28975 GNAT family acetyltransferase 45039:45638 F
A1395_31540 histidine kinase 1:624 R
A1395_31545 DNA-binding response regulator 617:859 R
A1395_31550 ABC transporter ATP-binding protein 1:840 F
A1395_31555 helicase 1:839 R
A1395_31560 AraC family transcriptional regulator 261:835 F
A1395_29380 large adhesive protein 7637:23593 R
A1395_29460 addiction module toxin RelE 44112:44393 R
A1395_29465 antitoxin of toxin-antitoxin stability system 44390:44668 R
A1395_29555 hydroxyacid dehydrogenase 59845:60849 R
A1395_29560 phosphoserine phosphatase 60851:61687 R
A1395_29565 hypothetical protein 62334:62681 R
A1395_29660 cytochrome C 80509:81828 F
A1395_29665 sorbitol dehydrogenase 81825:82337 F
A1395_29670 dehydrogenase 82334:84571 F
A1395_29710 hypothetical protein 90401:90658 F
A1395_31565 hypothetical protein 1:813 F
A1395_31570 SfnB family sulfur acquisition oxidoreductase 1:577 R
A1395_31575 zinc metallopeptidase RseP 1:777 F
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 6.2  Genomic structural variations during clonal expansion of Pseudo-
monas syringae pv. actinidiae biovar 3 in Europe
Table  6.2.1 –  Primer  used  in  this  work.  Expected  PCR  products  were  fX1/rX2  (933
bp);fX1/rX4 (686 bp); fX3/rX4 (739 bp).
Primer name Primer sequence 5′-3′
fX1 TAGCCACGGTTTTCTTTGCT
rX2 GACGTTTTACCCCATGCACT
fX3 TTCACGGCCAAGAACAACTG
rX4 CCGCTGACTCGTCTTCTCTC
Table 6.2.2 – Summary of the differences between the chromosomes of strains CRAFRU 12.29
and CRAFRU 14.08
Position
Event 12.29_left 12.29_right 14.08_left 14.08_right
ISPsy31 insertion 1.474.713 1.476.386 1.474.713 1.474.714
Chromosomal inversion 1.852.631 5.490.147 5.490.627 1.850.961
ISPsy32 insertion 2.118.457 2.118.458 5.224.801 5.223.546
SNP 3.409.171 / 3.932.833 /
VNTR 4.554.472 4.554.473 2.787.533 2.786.633
SNP 4.604.846 / 2.736.260 /
seq0_leftend seq0_rightend seq1_leftend seq1_rightend
1474711 1476386 1474710 1474715
1852630 –4554477 1850959 1852272
–5488836 –2118462 2786629 2787533
204
–4554472 –1852633 5223542 5224801
–2118457 5490148 5490625 5490628
6548978 6552959 6549454 6553426
6620009 1474712 6620488 0
1476385 5488837 0 0
5490147 6548979 0 0
6552958 0 0 1850960
0 0 1852271 2786630
0 0 2787532 5223543
0 0 5224800 6549455
0 0 6553425 0
Table  6.2.3 – Summary of major structural differences between the chromosomes of strains
CRAFRU 12.29 and ICMP 18884.
Position
Event 12.29_left 12.29_right 18807_left 18808_right
Reverse transcriptase/maturase insertion 1023375 1025252 1023375 /
Reverse transcriptase/maturase  insertion 5708293 / 5715260 5717133
Transposase insertion 3694419 / 3287490 3288700
Chromosomal inversion 3380078 3697838 3284077 3603006
IS631 transposase insertion 6513331 / 6522179 6523356
VNTR 4554392 4459558 4460460
VNTR 4824720 4730787 4730844
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Table 6.2.4 – Gene finding and annotation in filtered assemblies of reads not mapping on the
CRAFRU 12.29 chromosome.
Strain Contig Pos. Start Pos. End Strand Annotation
CRAFRU 14.25 3 1694 1236 – hypothetical protein
CRAFRU 14.25 3 1951 1691 – Phage single stranded DNA synthesis
CRAFRU 14.25 3 3543 1948 – Phage DNA replication protein
CRAFRU 14.25 3 4539 3553 – Phage minor capsid protein - DNA pilot pro-
tein
CRAFRU 14.25 3 5120 4548 – Phage major spike protein
CRAFRU 14.25 3 5332 5186 – Phage major capsid protein
CRAFRU 12.54 1 535 275 – Phage single stranded DNA synthesis
CRAFRU 12.54 1 2127 532 – Phage DNA replication protein
CRAFRU 12.54 1 3123 2137 – Phage minor capsid protein - DNA pilot pro-
tein
CRAFRU 12.54 1 3704 3132 – Phage major spike protein
CRAFRU 12.54 31 943 29 – Phage major capsid protein
CRAFRU 12.54 43 487 642 + Error-prone, lesion bypass DNA polymerase
V (UmuC)
CRAFRU 12.54 46 620 453 – hypothetical protein
CRAFRU 12.54 48 410 120 – Lyzozyme M1 (1,4-beta-N-acetylmurami-
dase)
CRAFRU 12.54 49 441 298 – hypothetical protein
CRAFRU 12.54 49 440 553 + hypothetical protein
CRAFRU 12.29 2 31 465 + Phage major capsid protein
CRAFRU 12.29 2 531 1103 + Phage major spike protein
CRAFRU 12.29 2 1112 2098 + Phage minor capsid protein - DNA pilot pro-
tein
CRAFRU 12.29 2 2108 3703 + Phage DNA replication protein
CRAFRU 12.29 2 3700 3960 + Phage single stranded DNA synthesis
CRAFRU 12.29 2 3957 4415 + hypothetical protein
CRAFRU 14.21 1 7 654 + Phage major capsid protein
CRAFRU 14.21 1 720 1292 + Phage major spike protein
CRAFRU 14.21 1 1301 2287 + Phage minor capsid protein - DNA pilot pro-
tein
CRAFRU 14.21 16 620 453 – hypothetical protein
CRAFRU 14.21 3 1 579 + Phage DNA replication protein
206
CRAFRU 14.21 3 576 836 + Phage single stranded DNA synthesis
CRAFRU 14.21 40 192 79 – hypothetical protein
CRAFRU 14.21 40 191 334 + hypothetical protein
CRAFRU 14.08 1 535 275 – Phage single stranded DNA synthesis
CRAFRU 14.08 1 2127 532 – Phage DNA replication protein
CRAFRU 14.08 1 3123 2137 – Phage minor capsid protein - DNA pilot pro-
tein
CRAFRU 14.08 1 3704 3132 – Phage major spike protein
CRAFRU 14.08 1 4684 3770 – Phage major capsid protein
CRAFRU 14.08 14 750 127 – Lyzozyme M1 (1,4-beta-N-acetylmurami-
dase)
CRAFRU 14.08 22 169 56 – hypothetical protein
CRAFRU 14.08 22 168 311 + hypothetical protein
CRAFRU 14.08 29 620 453 – hypothetical protein
CRAFRU 14.08 63 191 316 + hypothetical protein
CRAFRU 14.08 73 168 37 – hypothetical protein
CRAFRU 13.27 4 1399 941 – hypothetical protein
CRAFRU 13.27 4 1656 1396 – Phage single stranded DNA synthesis
CRAFRU 13.27 4 3248 1653 – Phage DNA replication protein
CRAFRU 13.27 4 4244 3258 – Phage minor capsid protein - DNA pilot pro-
tein
CRAFRU 13.27 4 4825 4253 – Phage major spike protein
CRAFRU 13.27 4 5358 4891 – Phage major capsid protein
CRAFRU 14.10 4 905 447 – Phage external scaffolding protein #Protein 
D
CRAFRU 14.10 4 1162 902 – Phage single stranded DNA synthesis
CRAFRU 14.10 4 2754 1159 – Phage DNA replication protein
CRAFRU 14.10 4 3750 2764 – Phage minor capsid protein - DNA pilot pro-
tein
CRAFRU 14.10 4 4331 3759 – Phage major spike protein
CRAFRU 14.10 4 5311 4397 – Phage major capsid protein
CRAFRU 12.50 14 577 317 – Phage single stranded DNA synthesis
CRAFRU 12.50 14 1152 574 – Phage DNA replication protein
CRAFRU 12.50 18 1 684 + Phage minor capsid protein - DNA pilot pro-
tein
CRAFRU 12.50 36 60 227 + hypothetical protein
CRAFRU 12.50 39 320 30 – Lyzozyme M1 (1,4-beta-N-acetylmurami-
207
dase)
CRAFRU 12.50 8 7 654 + Phage major capsid protein
CRAFRU 12.50 8 720 1292 + Phage major spike protein
CRAFRU 12.64 1 1749 1066 – Phage minor capsid protein - DNA pilot pro-
tein
CRAFRU 12.64 10 19 549 + Phage DNA replication protein
CRAFRU 12.64 14 576 433 – hypothetical protein
CRAFRU 12.64 14 575 688 + hypothetical protein
CRAFRU 12.64 17 620 453 – hypothetical protein
CRAFRU 12.64 4 79 651 + Phage major spike protein
CRAFRU 12.64 43 143 18 – hypothetical protein
CRAFRU 10.29 1 102 449 + Phage minor capsid protein - DNA pilot pro-
tein
CRAFRU 10.29 10 30 224 + Phage major spike protein
CRAFRU 10.29 121 198 55 – hypothetical protein
CRAFRU 10.29 16 535 275 – Phage single stranded DNA synthesis
CRAFRU 10.29 18 564 397 – Phage external scaffolding protein #Protein 
D
CRAFRU 10.29 25 422 132 – Lyzozyme M1 (1,4-beta-N-acetylmurami-
dase)
CRAFRU 10.29 6 7 654 + Phage major capsid protein
CRAFRU 10.29 89 138 269 + hypothetical protein
Table 6.2.5 – Inventory of the Insertion Sequences (IS) in the chromosome of strain CRAFRU
12.29.
IS Family IS elements Copies
IS4 (subgroup IS4) 1 27
ISL3 5 5
IS5 (subgroup IS427) 4 4
IS5 (subgroup IS5) 1 1
IS3 (subgroup IS3) 5 97
IS256 1 11
208
IS481 2 2
IS66 3 15
IS91 1 1
Tn3 1 2
IS1182 2 30
IS21 1 15
IS5 (subgroup IS1031) 1 1
IS630 4 127
IS3 (subgroup IS51) 2 3
IS110 1 3
Total 35 344
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 6.3  An Effective Pipeline Based on Relative Coverage for the Genome 
Assembly of Phytoplasmas and Other Fastidious Prokaryotes
Figure 6.3.1 – Flowchart of the Phytoassembly pipeline.
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